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Thesis Abstract 
Background: Nanoparticles (NPs) of different material composition (silica, gold) have 
gained increasing attention in drug therapeutics and diagnosis of disease. In particular, 
Gold nanoparticles (AuNPs) demonstrate potential for cell tracking and imaging 
diagnostics, however, their impact on cellular and vascular function remains uncertain. The 
AuNPs emission characteristics can vary when they are suspended in different 
physiological fluids due to their aggregation; hence, to overcome this effect, organic 
polymer composite coatings have been applied. The aim of the present study is to 
investigate the effects AuNPs and their surface modifiers on endothelial cell and murine 
aortic vascular function, ex vivo.  
Methods: A number of nanoparticles were fabricated (silica, gold), but AuNPs were 
selected because they were simple to synthesise and characterise. AuNPs (12±3nm) were 
synthesised according to the Turkervich method. They were then surface modified with the 
polymers polyvinylpyrrolidone (PVP) and mercapto-polyethylene glycol - (mPEG) and 
characterised by transmission electron microscopy (TEM), energy dispersive X-ray 
spectroscopy (EDAX) and UV-Vis spectroscopy. Silica NPs (SiNPs, 100 and 200 nm) 
were synthesised using a modification of the Stöber method. They were characterised 
using TEM and the Malvern Zeta Sizer. Cellular uptake of AuNPs by cultured bovine 
aortic endothelial cells (BAECs) was visualized using transmission electron microscopy 
(TEM). The effects of AuNPs on BAEC proliferation, cell viability and apoptosis were 
determined using the automated cell counter and flow cytometry for cell number counting, 
exclusion dye propidium iodide (PI) and Annexin V/PI detection, respectively. Aortic 
vessel rings from male Wistar rats were mounted between two fine steel wires in an organ 
bath system and constantly superfused in oxygenated physiological salt solution (PSS) at 
37
o
C. Cumulative doses of the endothelial dependent agonist acetylcholine (ACh; 0.01-
100µM) and endothelial independent sodium nitroprusside (SNP; 0.1nm-10µM) were 
added to KCl preconstricted vessels, before and 30 minutes after incubation with modified 
and non-modified AuNPs.  
Results: Maximum cellular uptake of AuNPs was observed 24 hours and 48 hours, after 
incubation in non-modified and modified AuNPs, respectively. Both non-modified and 
  
 
 
modified AuNPs significantly decreased cell viability and proliferation and increased 
apoptosis up to 24 hours after incubation, whereas no inhibitory effect was observed after 
48 hours of incubation. Both modified and non-modified AuNPs influenced cellular 
signalling and reduced Erk and Akt phosphorylation. Non-modified AuNPs had no overall 
effect on ACh responses, but significantly reduced responses to SNP. PVP modified 
AuNPs (AuPVP), but not mPEG modified AuNPs (AumPEG) lead to a significant 
attenuation in ACh responses (ACh concentration 0.01-100µM; p<0.05). AumPEG at 
2.9µg/mL had no overall significant effect on either ACh or SNP responses; however, at 
higher concentration (5.8µg/mL) AumPEG NPs led to a significant reduction in ACh 
dilator response at most ACh concentrations. PVP alone, at the minimal concentration 
required to stabilise the AuNPs, reduced ACh dilator responses. 
Conclusions: We demonstrate that surface modification of AuNPs using polymers 
enhances their stability in physiological solutions and culture media, and also reduces 
cellular uptake by BAECs. Furthermore, we show that cellular and vascular effects of 
AuNPs depends on the type and concentration of polymer modification used. mPEG 
modified AuNPs show greater biocompatibility and are less detrimental to vasodilator 
function, than PVP modified AuNPs, thus showing greater potential use as agents for 
diagnostic imaging and therapeutics.  
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CELLULAR study (Chapter 4)  
Aims 
 To determine the effect of mPEG and PVP Modified gold nanoparticles on bovine aortic endothelial cell’s  
(BAEC) viability, apoptosis, and proliferation. 
 To determine the cellular uptake of NPs. 
 
 
VASCULAR study (Chapter 5) 
Aims 
 Determine the influence of AuNPs on vascular function using whole aortic vessels  ex vivo. (Can non-modified 
and modified AuNPs affect vascular function? Specifically, do they affect: Endothelium dependent (ACh) and 
endothelium independent (SNP) vasodilator function?). 
 
 
 
Characterisations (Chapter 3) 
A. Scanning electron microscopy (SEM) 
and transmission electron microscopy 
(TEM) will indicate the dispersion and 
sizes of SiNPs. 
B. Sizes and stability will also be determined 
using dynamic light scattering (DLS) and 
Malvern’s Zetasizer. 
C. Fluorescence spectroscopy will identify 
the presence of the encapsulated RH 
dye on the NPs. 
 
A 
B 
+ 
+ 
Non -modified gold nanoparticles  (AuNPs) and modified 
gold nanoparticles with  A) polyvinylpyrrolidone (PVP) 
and  B) mercapto polyethylene glycol - (mPEG)   
 
Silica Nanoparticles (SiNPs) (100nm) 
encapsulated with Rhodamine B 
isothiocyanate (RH) dye  
Silica 
Nanoparticles 
without dye    
Silica 
Nanoparticles 
with RH dye    
Characterisations (Chapter 3) 
A. TEM will indicate the dispersion of modified and non- 
modified AuNPs and stability will be determined using 
Ultraviolet-visible spectroscopy (UV-vis). 
B. Thermogravimetric analysis for decomposition analysis, 
infra-red spectroscopy for surface groups attachment.  
C. Surface-enhanced Raman scattering (SERs) will also be 
employed to identify the functional groups attached on 
AuNPs. 
D. Determination of the relative amount of gold in NPs is 
done by Inductively  coupled  plasma mass spectroscopy 
(ICP-MS) and  Energy-dispersive X-ray spectroscopy 
analysis  will identify the element of gold in AuNPs. 
  
Discussion and Conclusions (Chapter 7) 
 
Nanoparticles synthesis (Chapter 2) 
 
AuNPs 
 
 mPEG 
PVP 
Thesis outline 
  
 
 ii 
                      List of abbreviations  
              Acetylcholine  
 
Alkoxide silica    
 
(3aminopropyl) 
triethoxy silane  
 
Ammonium hydroxide  
 
Ammonium nitrate  
 
Back-scattered electrons  
 
Blood–brain barrier  
 
Bovine Aortic Endothelial 
Cells 
 
Bovine Serum Albumin 
 
 
Calcium  
 
Calcium chloride 
dihydrate 
 
Caveolae-mediated 
endocytosis  
 
Central nervous 
 System 
 
Clathrin mediated 
endocytosis  
 
Cyclic adenosine 
monophosphate  
 
Cyclic guanosine 
monophosphate  
 
 
 
 
 
ACh 
 
Si(OR)4 
 
APS 
 
 
NH4OH 
 
NH4NO3 
 
BSE 
 
BBB 
 
BAEC 
 
 
BSA  
 
 
Ca
2+
  
 
CaCl2.2H2O 
  
 
CvME 
 
 
CNS 
 
 
CME 
 
 
cAMP 
 
 
cGMP 
 
 
 
 
 
 
4',6-diamidino-2-phenylindole 
 
Debye Landau Verwey 
Overbeek 
 
Diffuse reflectance infra-red 
Fourier transform spectroscopy  
 
Dulbecco's Modified Eagle's 
medium   
 
Dynamic  light scattering 
 
Energy-dispersive X-ray 
spectroscopy analysis   
 
Electrochemical  
Double layer 
 
Endothelium  
 
Endothelin receptors A and B 
 
 
Endothelium –delivered  
hyperpolarizing factor 
 
Endothelium derived 
contracting 
Endothelium derived 
Relaxing 
 
Ethanol  
 
 
 
 
 
DAPI 
 
 
DLVO 
 
DRIFTS  
 
 
 
DMEM 
 
 
DLS 
 
EDAX 
 
 
EDL 
 
 
ECs  
 
ETA and ETB 
 
 
EDHF 
 
 
EDCF 
 
EDRF 
 
 
EtOH 
  
 
 
  
 
 iii 
Endothelial nitric oxide 
syntheses 
 
Extracellular-signal-
egulated   kinase  
 
 
Ethylenediaminetetraa
cetic acid dipotassium 
salt dehydrate  
 
Fibroblast growth 
 factor 
 
Fluorescein 
isothiocyanate 
 
Fluorescein tagged 
silica particles  
 
Fourier transform 
infrared spectroscopy  
 
Functionalized carbon 
nanotubes  
 
Gold (iii) chloride 
sodium  
 
Gold Nanoparticles 
 
Helmholtz layer 
 
Helacyton gartleri 
 
Human Dermal 
Microvascular  
Endothelial Cells  
 
Human 
umbilicalvein  
endothelial cells   
 
Human liver 
carcinoma cell line  
 
Hydrogen peroxide  
eNOS 
 
 
ERK 
 
 
 
K2EDTA.2H2O 
 
 
 
FGF 
 
FITC 
 
 
FITC-SiO2 
 
 
FTIR 
 
 
f-CNT 
 
 
HAuCl4 
 
 
AuNPs 
 
HL  
 
HeLa 
 
HDMEC 
 
 
 
HUVEC 
 
 
 
HepG2  
 
 
H2O2 
Inductively  coupled  plasma 
mass spectroscopy  
 
Inward rectifier Potassium 
Channels  
 
Isopropanol 
L-Arginine 
 
 
Laser Doppler Velocimetry  
 
 
Magnetic nano-particle 
 
Magnesium sulphate 
heptahydrate 
 
Mercapto polyethylene glycol 
 
Mercapto polyethylene glycol 
modified gold nanoparticles  
 
Mercaptoundecanoid acid  
 
Michigan Cancer Foundation  
 
Nanoparticle  
 
Nitric oxide  
 
Nitric oxide synthase 
 
Oxidative phosphorylation 
  
Phenylephrine 
 
 
Phenylmethylsulfonyl fluoride  
 
ICP-MS 
 
KIR 
 
 
IP 
L-Arg  
 
LDV 
 
MNP 
 
MgSO4.7H2O  
 
 
mPEG 
 
AumPEG  
 
 
MUA 
 
MCF-7  
 
NP  
 
NO 
 
NOS 
 
OXPHOS 
 
Phe  
 
 
PMSF 
 
  
 
 iv 
 
Physiological salt 
solution  
 
Photon Correlation 
Spectroscopy  
Positron emission 
tomography 
 
Potassium channels 
 
Potassium chloride 
 
Potassium phosphate 
monobasic  
 
Potassium Physiological 
salt solution  
 
Polyethylene glycol 
 
Polyethylene 
glycol  single-walled 
carbon nanotube  
 
Polyvinilpirrolidine  
 
Polyvinilpirrolidine 
modified gold 
nanoparticles 
 
Porcine brain endothelial 
cells 
 
Propidium iodide  
 
Program cell death 
 
Protein kinase G 
 
 
Quasi Elastic Light  
 
 
Sodium orthovanadate 
 
Sodium biocarbonate  
 
 
PSS 
 
 
PCS 
 
PET 
 
 
KCA 
 
KCl  
 
KH2PO4 
 
 
KPSS 
 
 
PEG 
 
PEG- 
SWCNTS 
 
 
PVP 
 
AuPVP 
 
 
 
PBEC 
 
PI 
 
 
PCD 
 
PKG 
 
 
QELs 
 
 
EGTA 
 
NaHCO3 
Phosphate Buffered Saline  
Radioimmuno- 
precipitation 
 
Reactive oxygen species 
 
Receptor mediated endocytosis  
 
 
Rhodamine B isothiocyanate 
 
Smooth muscle cells  
 
Surface Plasmon Resonance 
 
Surface-enhanced Raman 
scattering 
Scanning electron microscope 
 
Sarcoplasmic reticulum  
 
Serum poor medium 
 
Sodium nitroprusside 
 
Silica nanoparticles 
  
Silicon dioxide  
 
Secondary electron imaging  
 
Standard error of mean 
 
Spinal cord injury 
Standard deviation  
 
Sarcoendoplasmic reticulum 
Ca2+ ATPase 
 
 
Thermogravimetric  analysis  
 
PBS 
 
RIPA 
 
ROS 
 
RME 
 
 
RH 
 
SMC  
 
SPR 
 
SERs 
 
 
SEM 
SR 
 
SPM 
  
SNP 
 
SiNPs 
 
SiO2  
 
SEI 
 
S.E.M 
 
SCI 
SD 
 
 
SERCA  
 
 
TGA 
 
  
 
 v 
 Sodium chloride 
 
Targeted drug delivery 
system  
Tetraethyl orthosilicate  
 
 
 
            
 
NaCl 
 
TDDS 
 
 
TEOS 
 
 
 
 
 
 
 
 
Transmission electron 
microscope 
 
 
Vascular endothelial 
growth factor 
TEM 
 
 
VEGF 
  
 
 vi 
Contents 
Thesis outline ......................................................................................................................... i 
List of abbreviations ............................................................................................................ ii 
Contents ............................................................................................................................... vi 
List of Figures ................................................................................................................... xiii 
List of Tables ..................................................................................................................... xvi 
List of Equations .............................................................................................................. xvii 
Declaration ...................................................................................................................... xviii 
Ethical consideration for experimental animals ............................................................ xix 
Dedication ........................................................................................................................... xx 
Acknowledgment ............................................................................................................... xxi 
Publications and conferences  ......................................................................................... xxii 
 
 
1. Introduction .................................................................................................................... 30 
1.1 Overview of Nanoparticles and their Applications ................................................... 30 
1.2  Synthesis of Nanoparticles .......................................................................................... 33 
1.2.1 Growth mechanisms of Silica nanoparticles ........................................................... 34 
1.2.2  Sol-gel method .......................................................................................................... 35 
1.2.3  Synthesis of gold nanoparticles ............................................................................... 37 
1.2.3.1 Turkevich method .................................................................................................. 37 
1.3 Stability of  colloidal nanoparticles (Gold and silica) ............................................... 38 
1.3.1 Debye Landau Verwey Overbeek theory ................................................................ 40 
1.3.2 Influence of surface charge on stability .................................................................. 42 
1.3.3 Polymeric Stabilisation of nanoparticle surfaces ................................................... 44 
1.3.3.1 Polymers .................................................................................................................. 45 
1.3.3.1.1 Polyvinylpyrrolidone .......................................................................................... 46 
1.3.3.1.2 Thiol Modified PEG (Mercapto polyethylene glycol - (mPEG)) .................... 47 
1.4 Characterisation of nanoparticles .............................................................................. 48 
1.4.1 Electron microscope .................................................................................................. 48 
1.4.1.1 Scanning electron microscopy ............................................................................... 49 
1.4.1.2 Transmission electron microscopy ....................................................................... 51 
1.4.2 Confocal fluorescent microscopy ............................................................................. 52 
1.4.3 Photon correlation spectroscopy .............................................................................. 53 
1.4.4 Zeta potential ............................................................................................................. 54 
1.4.4.1 Electrical double layer ........................................................................................... 55 
1.4.5 Energy-dispersive X-ray spectroscopy analysis ..................................................... 57 
1.4.6 Thermal Gravimetric analysis ................................................................................. 58 
1.4.7 Surface Enhanced Raman Spectroscopy ................................................................. 59 
1.4.8 Diffuse reflectance infra-red Fourier transform spectroscopy (DRIFTS) ........... 60 
Contents 
Chapter 1: Introduction 
  
 
 vii 
1.4.9 Fluorescence spectroscopy ........................................................................................ 61 
1.4.10 Ultraviolet-visible spectroscopy ............................................................................. 62 
1.5 Nanoparticles and their application in biomedical science ...................................... 63 
1.5.1 Diagnostic imaging .................................................................................................... 63 
1.5.2 Drug delivery ............................................................................................................. 64 
1.5.3 Gene therapy ............................................................................................................. 65 
1.5.4 Cancer treatment ...................................................................................................... 66 
1.6 The influence of Nanoparticles on endothelial cellular function ............................. 69 
1.6.1 Regulation of endothelial cell function .................................................................... 69 
1.6.1.1 Intracellular and Extracellular signalling pathways .......................................... 70 
1.6.1.2 Cell Death (Apoptosis and necrosis ) .................................................................... 72 
1.6.2 Nanoparticle uptake by cells .................................................................................... 72 
1.6.3 Pathways of Nanoparticles uptake by cells ............................................................. 74 
1.6.3.1 Phagocytosis ............................................................................................................ 75 
1.6.3.2 Non phagocytic Pathways ...................................................................................... 76 
1.6.3.3 Clathrin-mediated endocytosis (CME) ................................................................ 76 
1.6.3.4 Caveolae-mediated endocytosis (CvME) ............................................................. 76 
1.6.3.5 Macropinocytosis ................................................................................................... 76 
1.6.3.6 Clathrin and Caveolae independent endocytosis ................................................ 77 
1.6.4 Nano-bio interface ..................................................................................................... 77 
1.6.5 Cytotoxicity of Nanoparticles ................................................................................... 78 
1.7 Influence of Nanoparticles on Vascular function ...................................................... 80 
1.7.1 Regulation of vascular function ............................................................................... 81 
1.7.1.1 The mechanism of vasoconstriction ...................................................................... 82 
1.7.1.2 The mechanism of vasodilation ............................................................................. 83 
1.7.2 Assessment of vascular function .............................................................................. 85 
1.7.2.1 Assessment of vessel viability ................................................................................ 85 
1.7.2.2 Assessment of endothelial function-ACh ............................................................. 85 
1.7.2.3 Assessment of smooth muscle cell responsiveness-(SNP) ................................... 86 
1.7.3 Assessment of vascular function ex vivo ................................................................. 87 
1.7.4 Influence of  Nanoparticles  on the function of  aortic vessel ................................ 88 
1.8 Aims and Objectives .................................................................................................... 89 
 
 
2. Method ............................................................................................................................ 91 
2.1 Drugs and chemicals .................................................................................................... 91 
2.2 Animal preparation ...................................................................................................... 91 
2.3 Nanoparticle Synthesis ................................................................................................ 92 
2.3.1 Silica Nanoparticles ................................................................................................... 92 
2.3.1.1  Preparation of dye for silica nanoparticles ......................................................... 92 
2.3.1.2 Synthesis of 100nm and 200nm  silica nanoparticles .......................................... 93 
Chapter 2: Methodology 
  
 
 viii 
2.3.1.3 Surface charging silica nanoparticles with amine group (APS) ........................ 94 
2.3.2 Gold Nanoparticle synthesis ..................................................................................... 95 
2.3.3 Modification with Polyvinylpyrrolidone ................................................................. 95 
2.3.4 Determining the minimum concentration of Polyvinylpyrrolidone   required to 
stabilise NPs ........................................................................................................................ 95 
2.3.5 Determining the minimum concentration of Mecapto polyethylene glycol  
required to stabilise NPs .................................................................................................... 95 
2.3.6  Modification with Mecapto polyethylene glycol .................................................... 96 
2.3.7 Preparation of non thiol modified polyethylene glycol (PEG) .............................. 96 
2.4 Characterisation of Nanoparticles .............................................................................. 97 
2.4.1 Scanning electron microscopy .................................................................................. 97 
2.4.2 Transmission electron microscopy .......................................................................... 97 
2.4.3 Zeta Potential of  silica nanoparticles...................................................................... 97 
2.4.4 Analysing the rhodamine B isothiocyanate dye coated silica nanoparticles using 
fluorescence spectroscopy .................................................................................................. 97 
2.4.5 Determining the stability of the modified and non-modified gold nanoparticles 98 
2.4.5.1 Ultraviolet-visible spectroscopy ............................................................................ 98 
2.4.6Assessment of functional groups on gold nanoparticles ......................................... 98 
2.4.6.1 Energy-dispersive X-ray spectroscopy analysis .................................................. 98 
2.4.6.2 Thermogravimetry analysis .................................................................................. 98 
2.4.6.3 Surface Enhanced Raman Spectroscopy ............................................................. 99 
2.4.6.4 Diffuse reflectance infra-red Fourier transform spectroscopy .......................... 99 
2.4.7 Quantification of the relative amount of metal in the modified and non-modified 
gold Nanoparticles .............................................................................................................. 99 
2.4.7.1 Inductively-coupled plasma mass spectrometry ................................................. 99 
2.5 Cellular study of endothelial cells: Cell culture ...................................................... 101 
2.5.1 Preparation of cell culture medium ....................................................................... 101 
2.5.2 Culture of bovine aortic endothelial cells.............................................................. 101 
2.5.3 Trypsinization of cells ............................................................................................. 101 
2.5.4 Process for freezing the cells .................................................................................. 102 
2.5.5 Thawing of cells ....................................................................................................... 102 
2.5.6 Cell proliferation and Cell viability ....................................................................... 102 
2.5.7 Cell morphology ...................................................................................................... 103 
2.5.8 Cell Viability ............................................................................................................ 103 
2.5.8.1 Haemocytometer chamber .................................................................................. 103 
2.5.8.2 Automated cell counter ........................................................................................ 104 
2.5.8.3 Determining cell viability with propidium iodide (PI) staining using FACs flow 
cytometer ........................................................................................................................... 104 
2.5.9 Confocal analysis of nanoparticle uptake via cells ............................................... 105 
2.5.9.1 Cell membrane labelling ...................................................................................... 105 
2.5.9.2 Cell Nuclei labelling ............................................................................................. 105 
  
 
 ix 
2.6 Analysis of Cellular signalling pathways ................................................................. 106 
2.6.1 Protein estimation for western blotting................................................................. 106 
2.6.2 Western blotting ...................................................................................................... 107 
2.7 Analysis of Cell death ................................................................................................ 108 
2.7.1 Induction of Apoptosis and  quantification using Annexin V-FITC             
detection kit ...................................................................................................................... 108 
2.8 Cellular uptake of AuNPs .......................................................................................... 108 
2.9 Vascular function study of rat aortic rings using organ bath system ................... 109 
Table 2.5 Calculated surface area and mass of nanoparticles and stabilisers to be 
added to each experiments .............................................................................................. 111 
2.10 Tissue fixation and transmission electron microscopy analysis of nanoparticle 
uptake ................................................................................................................................ 112 
2.11 Statistical analysis .................................................................................................... 112 
 
 
3. Chemical characteristics of synthesised nanoparticles ............................................. 114 
3.1 Characteristics of synthesised nanoparticles ........................................................... 114 
3.2 Characteristics of synthesised Silica nanoparticles ................................................. 114 
3.2.1 The influence of surface charge on the hydrodynamic diameter and zeta 
potential of Silica nanoparticles ...................................................................................... 115 
3.2.2 Effect of pH alteration on Silica particle size ....................................................... 115 
3.2.3 Production of 100nm silica NPs from a minimum amount of ammonia    and 
H2O .................................................................................................................................... 116 
3.2.4 Determining the nanoparticles sizes using DLS  vs. Microscopy ....................... 117 
 3.2.5 Scanning electron microscopy to clarify the sizes of silica nanoparticles ......... 117 
3.2.6 Determination of dye present using fluorescence spectroscopy .......................... 120 
3.3 Characteristics of synthesised gold nanoparticles ................................................... 121 
3.3.1 Transmission electron microscopy of modified and non-modified AuNPs ....... 121 
3.3.2 Determining the stability of modified and non- modified AuNPs in H2O, 
complete media and PSS .................................................................................................. 122 
3.3.3 Quantification of the relative amount of metal in the modified and non-gold 
Nanoparticles .................................................................................................................... 125 
3.3.3.1 Energy-dispersive X-ray spectroscopy analysis ................................................ 125 
3.3.3.2 Inductively-coupled plasma mass spectrometry ............................................... 126 
3.3.4 Assessments of functional groups on Gold Nanoparticles ................................... 127 
3.3.4.1 Thermogravimetric analysis ............................................................................... 127 
3.3.4.2 Surface Enhanced Raman Spectroscopy ........................................................... 128 
3.3.4.3 Diffuse reflectance infra-red Fourier transform spectroscopy analysis of the 
functional groups within the gold nanoparticles. .......................................................... 129 
 
 
Chapter 3: Chemical characteristics of synthesised nanoparticles 
  
 
 x 
 
4. Influence of modified and non-modified gold nanoparticles on cellular function . 131 
4.1 Influence of  Gold Nanoparticles on Cell proliferation .......................................... 131 
4.2 Determining the Cell viability after incubation with modified and non-modified 
gold nanoparticles ............................................................................................................ 132 
4.2.1 Determination of Cell viability using the Haemocytometer ................................ 134 
4.2.2 Determination of Cell viability using the Automated Cell Counter ................... 135 
4.2.3 Determination of Cell viability using Fluorescence-activated cell sorting (FACS) 
flow cytometer .................................................................................................................. 136 
4.3 Determination of Apoptosis and necrosis ................................................................ 136 
4.3.1 Induction of BAEC apoptosis and necrosis after incubation with modified and 
non-modified AuNPs and their stabilizers ..................................................................... 138 
4.3.2 Apoptotic Cells ........................................................................................................ 138 
4.3.3 Necrotic Cells ........................................................................................................... 139 
4.4. Influence of Nanoparticles on Cell morphology ..................................................... 140 
4.5 Visualisation of AuNPs using Fluorescence microscopy ........................................ 143 
4.5.1 Cellular localization of 13 nm gold nanoparticles ................................................ 144 
4.6. Determining the membrane integrity of BAECs using confocal microscopy ...... 145 
4.7 Cellular uptake of Modified and non-modified NPs ............................................... 148 
4.8Analysis of Cellular signalling pathways .................................................................. 150 
4.8.1 Influence of ACh on ERK expression.................................................................... 150 
4.8.2 Influence of modified and non-modified AuNPs on ACh-induced                         
p-ERK1/2 expression ....................................................................................................... 151 
4.8.3 Influence of ACh on Akt expression ...................................................................... 152 
4.8.4 Influence of modified and non-modified AuNPs on ACh-induced p-Akt 
expression .......................................................................................................................... 153 
 
 
 
5. Vascular function studies ............................................................................................ 155 
5.1 Control experiments .................................................................................................. 156 
5.1.1 Repeatability of Acetylcholine responses .............................................................. 156 
5.1.2 Repeatability of Sodium nitroprusside responses ................................................ 157 
5.2 Effect of non-modified gold nanoparticles on dilator responses ............................ 158 
5.2.1 ACh response after non-modified AuNP incubation ........................................... 158 
5.2.2 SNP response after non-modified AuNP incubation ........................................... 159 
5.3 Effect of Polyvinilpirrolidine modified gold nanoparticles on dilator responses . 160 
5.3.1 Initial studies on the influence of Polyvinylpyrrolidone polymer on dilator 
function ............................................................................................................................. 160 
Chapter 4: Influence of modified and non-modified gold 
nanoparticles on cellular function 
Chapter 5: Influence of Modified and Non-modified Gold 
Nanoparticle on Vascular function  
  
 
 xi 
5.3.2 Minimum concentration of Polyvinylpyrrolidone needed to stabilize Gold 
Nanoparticles .................................................................................................................... 162 
5.3.3 ACh responses ......................................................................................................... 163 
5.3.4 SNP responses .......................................................................................................... 164 
5.4 Effect of polyethylene glycol modified gold nanoparticles on dilator responses .. 165 
5.4.1 Minimum concentration of polyethylene glycol needed to stabilize Gold 
Nanoparticles .................................................................................................................... 165 
5.4.2 ACh responses ......................................................................................................... 166 
5.4.3  SNP responses ......................................................................................................... 167 
5.5 Modified and non-modified gold nanoparticle uptake into vasculature ............... 168 
5.5.1 Transmission electron microscopy images of nanoparticle uptake by aortic 
vessels ................................................................................................................................ 169 
 
 
6. Overall Summary of results ........................................................................................ 171 
6.1 Synthesis and characterisation of Nanoparticles (silica and gold) ........................ 171 
6.2 Influence of   gold nanoparticles on cellular function ............................................. 172 
6.3 Influence of gold nanoparticles on vascular function ............................................. 173 
 
 
7. Discussion ...................................................................................................................... 176 
7.1 Characteristics of Nanoparticles (Silica and Gold) ................................................. 176 
7.1.2 Assessment of Polyvinilpirrolidine, and Polyethylene glycol attached on gold  
Nanoparticles .................................................................................................................... 180 
7.1.3 Inductively coupled plasma Mass spectroscopy (ICP-MS) ................................. 181 
7. 2 Effect of gold nanoparticles and their stabilisers on cellular function ................. 182 
7.2.1 Cellular uptake of modified and non-modified AuNPs ....................................... 182 
7.2.2 Cell proliferation and viability ............................................................................... 185 
7.2.3 Cellular localization of gold nanoparticles ........................................................... 187 
7.2.4 Cell apoptosis and necrosis ..................................................................................... 188 
7.2.5 Influence of gold nanoparticles on ERK and Akt pathways ............................... 189 
7.3 Effect of stabilisers (Polyvinylpyrrolidone and polyethylene glycol), modified and 
non-modified particles on vascular function ................................................................. 190 
7.3.1 Gold nanoparticles uptake into vasculature ......................................................... 190 
7.3.2 Effects of gold nanoparticles on aortic dilation responses .................................. 193 
7.3.2.1 Influence of non- modified gold nanoparticles on  dilator responses .............. 193 
7.3.2.2 Influence of Polyvinilpirrolidine- modified gold nanoparticles on dilator 
responses ........................................................................................................................... 194 
7.3.2.3 Influence of Mecapto polyethylene glycol - modified gold nanoparticles on 
dilator responses ............................................................................................................... 196 
7.3.2.4 Mechanisms of attenuated vasodilation induced by AuNPs ............................ 197 
Chapter 6: Overall Summary of results 
Chapter 7: Discussion and Conclusion 
  
 
 xii 
7.3.3. Study limitations .................................................................................................... 199 
7.4 Conclusion ................................................................................................................... 200 
7.5 Future work ................................................................................................................ 201 
8. REFERENCES ............................................................................................................. 204 
9.1 Appendix A- Chemistry ............................................................................................. 229 
9.2 Appendix B- Cellular study ....................................................................................... 248 
9.3 Appendix C- Vascular study ..................................................................................... 251 
 
 
 
  
  
 
 xiii 
Figure 1.1 Representation the  process involved during nanoparticle 
formation 
33 
Figure 1.2 The reaction step involved in formation of monodisperesed 
silica nanoparticles  
35 
Figure 1.3  Schematic diagram of Stöber method for the sol-gel reaction 
forming silica microspheres reaction  
36 
Figure 1.4 Empirical equation showing the relationship between the 
concentration of  reactants and the  diameter of the particles  
36 
Figure 1.5 Schematic illustration represents  the synthesis of AuNPs  38 
Figure 1.6 Stable colloidal nanoparticles and unstable particles 
undergoing coagulation  and sedimentation process of 
aggregation 
39 
Figure 1.7 The total energy potential of interaction (Vt)  between two 
particles 
41 
Figure 1.8 Electrochemical double layer on a particle surface in a 
solution containing  electrolytes  
43 
Figure 1.9 Schematic illustration showing the dispersion  of A) non-
modified AuNPs  B) polymerstabilised  AuNPs in salt solution 
45 
Figure 1.10 The structure of the polyvinyl-pyrrolidone compound 46 
Figure 1.11 The structure of the mercapto polyethylene glycol compound 47 
Figure 1.12 Schematic diagram of the reaction of  mPEG with AuNPs 47 
Figure 1.13 The scanning electron and transmission electron microscope 
differences in imaging process 
48 
Figure .14.1 An image demonstrating an Scanning electron  microscope 50 
Figure .14.2 An illustration image of a TEM consisting of several 
components 
51 
Figure 1.15 Image of confocal microscopy attachted to computer for 
analysis 
52 
Figure 1.16 Image demonstrates Malvern zetasizer used for photon 
correlation spectroscopy and zeta potential 
53 
Figure 1.17 The colloidal  stability indication by the Zeta potential 56 
Figure .17.1 Samples are  held in the capillary cell and their zeta potentials 
are  measured using Laser Doppler Velocimetry 
56 
Figure 1.18 Representation of components within the thermogravimetric 
instrument 
58 
Figure 1.19 Schematic diagram of SER illustrating how the samples are 
detected 
59 
Figure 1.20 Hitachi fluorescence spectrophotometer F-2500 61 
Figure 1.21 The beneficial effect of TDDS 65 
Figure 1.22 The activation of  ERK pathway 71 
Figure 1.23 Formula established by Potts and Guy explaining the rule of 
penetration based on the molecular properties of particles 
73 
Figure 1.24 A Cross section of aorta containing the inner intima, the media 
and the adventitia 
81 
Figure 1.25 The mechanism of vasodilation 84 
Figure 1.26 The alternative pathways which ACh can induce eNOS and 
resulting NO pathways 
85 
Figure 2.1 The standard curve used to work out protein estimation 
 
106 
List of Figures 
  
 
 xiv 
Figure 2.2 Dissection of an aortic ring mounted in an oxygenated organ 
bath chamber 
109 
Figure 2.3 Schematic image of organ bath setup 110 
Figure 2.4 An example of data recorded on a computer using the software 
lab chart 7  
110 
Figure 3.1 Scanning electron microscopy image of  silica nanoparticles 118 
Figure 3.2 The fluorescence spectroscopy of samples (RH28 and TMNA) 
indicating the presence of rhodamine B isothioscyanate dye in 
the particles 
120 
Figure 3.3 TEMs shows the distribution of monodispersed black dots 
which are the non-modified AuNPs and modified AuNPs  
121 
Figure 3.4  Absorption of AuNPs and AuPVP in PSS,  H2O and  
complete media 
123 
Figure 3.5 Image of gold nanoparticles in solution 123 
Figure 3.6 Spectra of  AuNPs,  AuPVP, in H2O,  complete  media  PSS  
and 2) Image of modified and non modified  in complete 
media and physiological salt solution. 
124 
Figure 3.7 Energy-dispersive X-ray spectra of AuNPs 125 
Figure 3.8 Cellular uptake of  modified and non-modified gold 
nanoparticles  determined by ICP-MS 
126 
Figure 3.9 TGA analysis of PVP modified AuNPs and PVP alone. 127 
Figure 3.10 SERs of a)AuNPs b) AumPEG and c) AuPVP 128 
Figure 4.1 The cell proliferation after exposure to modified and non-
modified AuNPs and their stabilisers after 24 hours and 48 
hours incubation 
132 
Figure 4.2A The viability of cells after exposure to modified and non-
modified AuNPs and their stabilisers using haemocytometer. 
134 
Figure 4.2B The viability of cells after exposure to modified and non-
modified AuNPs and their stabilisers using automated counter 
135 
Figure 4.2C The viability of cells after exposure to modified and non-
modified AuNPs and their stabilisers using FACs flow 
cytometer 
136 
Figure 4.3 Flow analysis of non-induced BAEC cells after incubation 
with cell media 
137 
Figure 4.4 Flow analysis of Staurosporine (1µg/mL ) induced BAEC 
cells and stained with a)  Annexin-negative/PI-negative , b) 
Annexin-positive/PI-negative and c) Annexin- positive /PI-
positive 
137 
Figure 4.5 Flow analysis of untreated (control) and treated  BAEC cells 
with modified and non-modified and their stabilizers at 2 hrs 
and 24 hrs. 
138 
Figure 4.6 Effect of modified, non-modified and their stabilizers on the 
progressive apoptosis of BAEC after 2 hrs. and 24 hrs. 
139 
Figure 4.7 Effect of modified, non-modified and their stabilizers on the 
progressive of necrosis of BAEC after 2 hrs. and 24 hrs. 
140 
Figure 4.8A Photomicrograph representing modified and non-modified 
AuNPs and their stabilisers  on BAEC morphology after 24 
hours exposure 
141 
Figure 4.8B  Photomicrograph representing modified and non-modified 
AuNPs  on BAEC cell morphology after 48 hours exposure 
142 
  
 
 xv 
  
  
Figure 4.9 Fluorescent imaging of AuNPs preparation in PSS 143 
Figure 4.10 Image demonstrates BAEC uptake of 13 nm AuNPs  after  
stimulation at  1 hr and 18 hrs 
144 
Figure 4.11 Image demonstrates BAEC uptake of 50nm AuNPs  after  
stimulation at   30 min,  1 hr and 18 hrs  
145 
Figure 4.12 Confocal  imaging of BAEC after exposure to AuNPs 146 
Figure 4.13 Integrity of cells after exposure to AuNPs 147 
Figure 4.14 TEM images of BAEC uptake of AuNPs at different 
incubation time 
149 
Figure 4.15 Western blot showing the effect of 1, 10 and 100 µM ACh on 
phosphorylation of ERK (p-ERK) in BAEC 
150 
Figure 4.16 Western blot showing the effect of AuNPs, AuPVP, PVP, 
AumPEG and  mPEG  after stimulated with 10 µM  ACh on 
phosphorylation of ERK (p-ERK) in BAEC 
151 
Figure 4.17 Western blot showing the effect of 1, 10 and 100 µM ACh on 
phosphorylation of Akt (p Akt) in BAEC 
152 
Figure 4.18 Western blot showing the effect of AuNPs, AuPVP, PVP, 
AumPEG and mPEG  after stimulation with 10 µM  ACh on 
phosphorylation of Akt (p Akt) in BAEC 
153 
Figure 5.1 The influence of high potassium solution (KPSS) on aortic 
vessels before and after incubation, where ‘N’ is the number 
of vessels 
155 
Figure 5.2 Average percentage response of vessels to ACh, before and 
after incubation in PSS 
156 
Figure 5.3 Average percentage dilator response of vessels to SNP, before 
and after incubation in PSS 
157 
Figure 5.4 Average percentage dilator response of vessels to ACh, after 
incubation with non-modified AuNPs 
158 
Figure 5.5 Responses of vessels to SNP after incubation with non-
modified AuNPs. 
159 
Figure 5.6 Responses of vessels to ACh after incubation with PVP 
modified AuNPs 
160 
Figure 5.7 Responses of vessels to SNP after incubation with PVP 
modified AuNPs 
161 
Figure 5.8 Responses to 0.1 µM ACh concentration before and after 
incubation in serial dilutions of PVP 
162 
Figure 5.9 Responses of vessels to Ach after minimum concentration of 
PVP modified AuNPs and PVP alone 
163 
Figure 5.10  Responses of vessels to  SNP after minimum concentration of 
PVP modified AuNPs and PVP  alone 
164 
Figure 5.11 Responses to ACh after incubation with mPEG modified 
AuNPs at low and high concentration and PEG alone  
166 
Figure 5.12 Responses of vessels to SNP after incubation with PSS, mPEG 
modified and PEG alone 
167 
Figure 5.13 Responses of vessels to SNP after incubation with mPEG 
alone. 
167 
Figure 5.14 Representative TEMs illustrating modified and non modified  
AuNP uptake by the ECs lining of  the vessel wall  
169 
   
  
 
 xvi 
               List of Tables   
 
  
Table 2.1 Molar ratio of regents used for dye preparation in each silica 
nanoparticles samples 
92 
Table 2.2 Molar ratio of reagents used for synthesising a variety of 
silica nanoparticle sizes. 
93 
Table 2.3 Amount of APS and ethanol used to functionalise the silica 
nanoparticles 
94 
   Table 2.4 Dilution of BSA used for protein estimation in order estimate 
standard curve for western blotting. 
106 
Table 2.5 Calculated surface area and mass of NPs to be added to each 
experiment 
111 
   Table 3.1 Determination of nanoparticles sizes using DLS vs. 
Microscopy and the effect of surface modification on the 
hydrodynamic diameter and zeta potential of silica 
nanoparticles 
117 
Table 3.2 The peaks representing the groups contained within the 
modified and non-modified AuNPs 
129 
Table 4.1 Number of nanoparticles (AuNPs, AumPEG and AuPVP) 
taken up by BAEC after incubation at different  times (30 
min, 2hrs, 24hrs and 48 hrs) 
148 
Table 5.1 Determining the minimal concentration of mPEG needed to 
stabilise AuNPs in physiological salt solution 
165 
  
 
 xvii 
     List of Equations 
 
 
Equation 1.1 Empirical equation showing the relationship between the  
concentration   reactant the  diameter of the particles 
where Term d is the average particle diameter 
36 
Equation 1.2 Specifies Term  A in Equation 1.1 36   
Equation 1.3 Specifies Term B in Equation 1.1 36 
Equation 2 The attractive forces (VTotal) formed from the 
electrostatic repulsive and van der Waals attraction 
forces can be calculated 
40 
Equation 3 The average Hydrodynamic particle size ( Z-Average) is 
also calculated according to the intensity of the light 
scattered 
54 
  
 
 xviii 
Declaration 
 
This thesis contains no material which has been accepted for the award of any other degree 
or diploma in any university, to the best of my knowledge and belief, contains no material 
previously published or written by another, except where due reference has been made in 
the text. In addition, no parts of this thesis have been copied from other sources. I 
understand that any evidence of plagiarism and/or the use of unacknowledged third party 
data will be dealt with as a very serious matter. 
 
 
 
 
Signature: Teba Mohamed    Date: 20/08/2014 
  
  
 
 xix 
Ethical consideration for experimental animals 
 
The physiological function experiments in this study were performed using animal tissue 
excised from dead animals (Male Wistar rats, 200-300 g in weight, aged 7-13 weeks), 
obtained from the BSU, University of Manchester. The Wistar rats were housed under 
standardised conditions (12 hour light/ dark cycles at 24 ºC). The animals were humanely 
killed by stunning and cervical dislocation. All procedures are conducted in accordance 
with institutional guidelines of the MMU and the University of Manchester and the United 
Kingdom Animals (Scientific Procedures) Act of 1986 (schedule 1 killing- Experiments 
were performed with the approval of the Review Board of the University of Manchester 
and the Home Office. A risk assessment for the use and handling of animal tissue was 
conducted.  
  
  
 
 xx 
 
 
 
 
Dedication 
This piece of work is dedicated to my loving parents, 
(Zubeda Mohamed and Hamid Mohamed); 
I will forever strive to make them proud. 
They have always been my greatest inspiration and I thank them for their 
endless support throughout this long journey. 
 They are the number one reason 1 am where I am today. 
I love you. 
  
  
 
 xxi 
    In the name of Allah, the Most Gracious and the Most Merciful  
Alhamdulillah, all praises to Allah for the strengths and His blessing in completing this 
thesis. This thesis has been a long enjoyable journey that has allowed me to expand my 
scientific knowledge through the various projects explored. The ability for me to pursue 
this avenue would not have occurred without the support and love that surrounded me. 
There are many invaluable supporters that have enabled me to succeed, without whom I 
would have felt lost. I would like to send my heartfelt thanks to my director of studies Dr. 
May Azzawi. This thesis would never be completed without your help, support, extreme 
patience, unsurpassed knowledge and constant advice. I am also truly grateful for the 
guidance and experience of my second supervisor Dr. Debra Whitehead, who has ensure 
my triumph through the chemistry section of my research investigations. I would also like 
to thank my third supervisor Dr. Nessar Ahmed for his help in the cell culture investigation 
of this research thesis. I would also like to express my appreciation to Dr. Sabine Matou -
Nasri, for her help in teaching me the step by step procedure for cell culture. I also want to 
thank Professor Bill Gilmore for his kind support. 
I would like to further express my thanks to a very special technical staff who does not 
have “no” in his vocabulary, thank you Mr Dave Maskew. I am also grateful for the 
technical help I received from Glenn Ferris.  
Words cannot express the gratitude I feel towards my family. I am extremely grateful for 
the support, love and care I received from both my mother and father. I would also like to 
thank both my brothers, Abdulrahim and Abdulrahman, for all the support I received from 
them. I am also grateful to my little cousin Waleed  for all the times he took my mind off 
my thesis by pestering me. 
Finally, this is a special thank you to all my friends! 
Acknowledgment 
  
 
 xxii 
Publications and conferences : 
Conferences: 
Mohamed T, Whitehead D and Azzawi M ‘The influence of PVP and mPEG- Coated Gold 
Nanoparticles on cellular and vascular function’ International Cell Tracking Symposium 
on the use of nanoparticles as imaging agents for cell tracking University of Liverpool  
2013. 
 
Mohamed T, Whitehead D and Azzawi M ‘The Effect of gold nanoparticle stabilisers on 
aortic vessel function  Alternative Muscle Club ‘AMC’ 2011 conference in Univeristy  of  
Oxford. 
 
Mohamed T, Azzawi M, Whitehead D, Jones C, Akbar N, Azhar M ‘Attenuation of 
vasodilator responses, induced by nanoparticle uptake, in rat aortic rings’, The 
physiological society conference, University of Manchester  2010. 
 
Whitehead D, Azzawi M, Farooq A and Mohamed T. Novel nanoparticle systems for use 
in bioapplications tested using novel physiological systems(microfluidics and nanotech in 
Drug Discovery conference, 2010. 
 
Publication: 
Akbar, N., Mohamed, T., Whitehead D. and Azzawi, M. ‘Biocompatibility of amorphous 
silica nanoparticles: size and charge effect on vascular function, in vitro’,  Biotechnology 
and Applied Biochemistry, 2011, 58( 5),  353–362. 
 
Mohamed T., Matou-Nasri S., Farooq A., Whitehead D. and Azzawi, M. The influence of 
polyvinylpyrrolidone and mercapto polyethylene glycol coated gold nanoparticles on 
cellular and vascular function. In submission. 
 
Farooq, A., Mohamed, T., Whitehead, D. and Azzawi, M. ‘Restored endothelial dependent 
vasodilation in aortic vessels after uptake of ceria coated silica nanoparticles,ex vivo’. (In 
Press).
  
 
 29 
 
 
 
   
 
 
 
 
   
 
 
 
 
 
 
  
 
Chapter 1: 
 Introduction 
  
 
 30 
1. Introduction  
 
1.1 Overview of Nanoparticles and their Applications  
 
According to British Standards Institution (BSI), nanoparticles (NPs) are ‘nano-object 
(material) with all three external dimensions in the nanoscale’, where nanoscale is defined 
as dimension sizes ranging from approximately 1 to 100 nm (BSI, 2011). NPs are one type 
of nanomaterial, described as a material which has external dimensions or internal/surface 
structure, all existing in a nanoscale dimension. Due to their small size, nanomaterials are 
different from the bulk materials and have made a vast impact on the world of 
nanotechnology. 
 
The fabrication of NPs has witnessed great progress in research and application in the area 
of nanoscience; the study of matter on an ultra-small scale. NPs are engineered to allow 
advances in diagnosis and treatment of disease and are used in biomedical applications, 
including  drug  and  gene  delivery (Ghosh et  al, 2008), bio  detection  of  pathogens (Gu 
et al, 2006),  fluorescent  biological  labels (Huang et al, 2009)  and  tissue  engineering 
(Hachani et al, 2013). Moreover, as NPs exist in the same size domain as  proteins this 
makes them  suitable agents  for  biotagging  or  labelling  (Bergman et  al, 2008; Nitta and 
Numata, 2013).  
 
NPs have a large surface area to volume ratio and dimensions which gives them the ability 
fit into cells. Such characteristics of NPs have enabled biomedical scientists to discover 
that NPs exhibit bioactivity functions. It has been demonstrated that size is one of the 
characteristics of NPs that influences cell function (Suh et al, 1998; Suh et al, 2009). In 
order to allow interaction between biological targets and NPs, NPs have to be coated with 
layers that act as a bioorganic interface to allow attachment between target site and the NPs 
and to improve delivery into target tissues (Kamaly et al, 2011). 
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Silica nanoparticles (SiNPs), in particular surface modified silica NPs, the such type of 
nanoparticles that are currently being explored due to their biocompatibility (Barandeh et 
al, 2012; Akbar et al, 2011). Dye doped SiNPs possess important characteristics required 
to make them an excellent biolabel agent, due to the fact that they are highly photostable 
with reduced photobleaching effect (Pellach et al, 2012), intense luminescence signal, and  
easy bio-conjugation (Canton et al, 2011). 
 
Metal NPs (gold and silver) are also currently being studied for use in biomedical 
applications due to their unique optical properties, which allow them to be useful in 
imagining diagnostics. The optical properties are due to their unique interaction with light. 
The oscillating electromagnetic field of the light stimulates the electrons on the metal 
particles causing the electrons to oscillate; this effect is referred to as the surface plasmon 
resonance (SPR) (Mody et al, 2010). Using the standard methods of Turkervich and Fern, 
a wide range of sizes can be fabricated by a chemical reaction involving a reduction of 
citrate (Kimling et al, 2006).  
 
Gold nanoparticles (AuNPs) have been shown to be great potential use in anticancer drug 
delivery systems and photothermal cancer treatment. They have allowed researchers to 
easily identify the location of diseases, where cancerous cells have been shown to easily 
uptake AuNPs (Alkilany et  al,  2010; Chandra et  al,  2010;  Libutti  et al,  2010  and  
Murphy  et  al, 2008). AuNPs are also attractive agents in research as they are easy and 
inexpensive to synthesise and characterise by UV-spectra and TEM. For instance; a study  
has  looked  at  quantifying  collagen  fibril  morphology  under  the  influence  of  AuNPs  
and were able to identify uptake using TEM (Haidekker et al, 2006). Furthermore, AuNPs 
are widely applicable in radiation research due to their high atomic number (Z). 
Subsequently, this results in a  different mass energy absorption  property. For example, in 
an X-ray analysis of a tissue uptake of AuNPs, the mass energy absorption property of gold  
is greater than that of the soft tissue. The high atomic number corresponds to a large bound 
of electrons, which results in high mass absorption coefficient of  the gold than the tissue 
for X-ray. Hence AuNPs are described as being effective X-ray agents (Butterworth et al, 
2013). 
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The size, stability and cell specificity of functionalised nanoparticles for targeted drug 
delivery is dependent on surface modification and can influence the NP’s biodistribution 
and may affect cell function (Suh et al, 2009). Other crucial factors, such as cytotoxicity 
and the efficiency of cellular uptake, are also associated with nanoparticle size. 
Furthermore, Yu et al, (2009) gave evidence that the concentration and size dependent 
toxic effects are cell specific.  
 
Useful analytical techniques have been introduced to allow characterisation of studied 
nanoparticles. These include TEM, SEM, and dynamic light scattering (DLS) (Lim et al, 
2013). The Zeta potential measurements are also necessary to determine the colloidal 
stability of NPs which signify the repulsive force that is present between NPs. It is used to 
show the effect of suspension of NPs in a given solution and the resultant stability of 
functionalised NPs. 
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  1.2  Synthesis of Nanoparticles 
Recently, scientists have established different approaches for the synthesis of NPs. 
Furthermore, the process and chemical reactions in which nanoparticles undergo during 
synthesis have also been explored. In this study, the focus will be on the formation of 
nanoparticles from inorganic (Silica) and metal organic (gold) compounds in liquid phase. 
 
 A simplified flow chart below (Figure 1.1), illustrated the process that occurs during 
synthesis of nanoparticles from inorganic compounds (silica). 
 
Critical supersaturation 
(Mixing of reactants, 
temperature, pH, etc.) 
 
Growth of particles 
Nanoparticles  
 EDUCTS (inorganic 
precursors) 
Nucleation formation 
Nucleus 
Formation of  
primary particles  
Agglomeration / 
Deagglomeration  
  
 
     
 Figure 1.1: Representation the process involved during nanoparticle formation. 
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The  silica nanoparticles (SiNPs) formation can be divided into two stages: nucleation and 
growth (Rahman and Padvettan, 2012). There are two types of models involved in the 
growth mechanism of SiNPs being either, monomer addition or controlled aggregation. 
The monomer addition involves the addition of hydrolyzed monomers, on the primary 
particle surface. Whereas, controlled aggregation involves expanding the nucleation of 
particles continuously. During the reaction, the primary particles are formed which then 
aggregate together, resulting in larger particles known as secondary particles. However, 
both models lead to the formation of spherical or gel, depending on the reaction condition 
(Rahman and Padvettan, 2012). The processes of SiNP formation are described in detail in 
the following section (Section 1.2.1). 
1.2.1 Growth mechanisms of Silica nanoparticles  
Silica NPs formation is most commonly used in nanotechnology, due to its various 
structure arrangements and its properties. According to its structure arrangements, the 
silica material can define whether particles produced are porous or non-porous. The 
formation of monodispersed silica nanoparticles is currently been described by several 
models. These include the sol gel method and the microemulsion method. The sol gel 
method involves developing NPs using inorganic precursors usually metal salts, metal 
halides and alkoxides (M(OR)x).   
The mircoemulsion method, on the other hand involves a system of  thermodynamically 
stable liquid solution which is dispersed with two or more immiscible mixture, for instant 
water, oil and an amphiphilic molecule such as hydrocarbon based surfactant (Wang and 
Zhang, 2013). The sol-gel method will be described in more detail below.    
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1.2.2  Sol-gel method  
The sol-gel method allows the manipulation of particle sizes by altering certain parameters 
including pH, temperature and concentration of reactants. There are several steps that 
occur before particles are completely fabricated during the sol gel process. The steps 
include hydrolysis and condensation, and these steps are considered the important stages 
during NPs formation. It is the rate of either hydrolysis or condensation that influences the 
rate of reaction. Consequently, the formation of NPs with the desired size is produced. The 
influence of low pH conditions (acidic), causes slow rate of hydrolysis and slow 
condensation. Furthermore, gelation is formed. In high pH conditions (basic), a slow rate 
of hydrolysis occurs, and in turn fast condensation takes place which leads to the formation 
of colloidal particles (Buckley and Greenblatt,1994). 
 
Originally, it was in 1968 when Stöber et al pioneered a method which resulted in the 
formation of colloidal particles. The Stöber method involves preparation of silica spheres 
from tetraethylorthosilicate (TEOS) in mixtures of ammonia, water and ethanol. TEOS in 
the reaction represents the silica precursor which allows the first step of hydrolysis reaction 
to occur when mixed with alcohol.  Ammonia acts as a catalyst once added to the reaction 
mixtures. The next step of the reaction, known as condensation, occurs when alcohol or 
water molecules are added in the reaction (Green et al, 2003) (Figure 1.2). 
 
 
 
 
 
 
 
 
 
Figure 1.2: The scheme represents the reaction step involved in formation of monodisperesed silica 
nanoparticles; in order 1. represents the first step hydrolysis, 2. condensation reaction involving alcohol 
and finally (3) condensation reaction involving water 4.  the overall reaction involved in NP synthesis, 
where R is ethanol (ETOH)  in the form of  C2H6O. 
 
Hydrolysis, previously described,  is the first step of the reaction in which  TEOS reacts 
with alcohol. A further second step reaction takes place which involves the condensation of 
alkoxide silica Si(OR)4  to form monodispersed silica microspheres (Figure 1.3). 
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Figure 1.3 Schematic diagramc of Stöber method for the sol-gel reaction forming silica microspheres 
reaction. Image adapted from Korzeniowska et al (2013). 
Studies have reported ways to control the size of the NPs by manipulating the 
concentration of ammonia, water, alcohol solvent and temperature used in the experiment 
(Venkatathri, 2007; Geishe, 1993).  Geishe, found that parameters such as temperature and 
ammonia influenced the size of NPs. The decrease of temperature or the increase of 
ammonia concentration leads to large particle formation. Bogush et al (1988), introduced 
an empirical equation, which was later adapted by Razink et al (2007) to directly show that 
diameter (d) of particles is influenced by concentration (mol.l
−1
) of reactants at 25°C 
(Figure 1.4). 
 
 
 
 
 
 
 
Figure 1.4: Empirical equation showing the relationship between the concentration of reactants and the  
diameter of the particles  where in Equation 1.1 Term d is the average particle diameter . Term A is 
specified in Equation 1.2 later adapted by Razink et al (2007) and, Term B is specified in   Equation 1.3. 
d=A [H2O]
2
exp(-B[H20]
1/2
)                                                                     Eq. (1.1) 
Where A and B is defined as: 
 A= [TEOS]
1/2
(82+151[NH3]+1200[NH3]
2
-366[NH3]
3
)                      Eq. (1.2) 
B=1.05+0.523[NH3]-0.128[NH3]
2. 
                                                          Eq. (1.3)
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The sol-gel method is considered advantageous over the microemulsion methods, as it 
allows the formation of porous particles, for instance; mesoporous NPs. Mesoporous NPs 
with large surfaced area have been developed. These have been shown to improve the 
solubility of poorly dissolution drugs in vitro and in vivo (Lin et al, 2005; Martines et al, 
2005; Lu et al, 2007).   
1.2.3  Synthesis of gold nanoparticles  
It is known that gold (Au) has common oxidation states which includes +1 (Au [I] or 
aurous compounds) and +3 (Au [III] or auric compounds) (Jain et al, 2012). AuNPs are 
produced from the reduction of chloroauric acid. The process of AuNP synthesis involves 
dissolving HAuCl4 in water  under vigorous stirring conditions at boiling temperature. A 
reducing agent is then introduced to the reaction. As a result, the Au ions are reduced to 
neutral Au atoms. In addition, more gold atoms are formed. Subsequently, the atoms start 
to precipitate in order to form NPs. The gold particles formed then stick to other NPs. If 
the particles are left under vigorous stirring over a longer period, the particles will 
eventually aggregate. The length of stirring time influences the size of particles.  A number 
of methods have been  developed to allow the fabrication of AuNPs. A well simplified 
method is known as the Turkevich method (Kimling et al, 2006). 
1.2.3.1 Turkevich method 
The Turkevich method was firstly developed by J. Turkevich et al in 1951 and was further  
improved by G. Frens in 1970s. The Turkevich method produces monodispersed spherical 
AuNPs in water suspension. Large particles as well as small particles ranging from 10-20 
nm can also be achieved using this method. However, it is difficult to produce large 
monodisperesed spherical particles using this method. The reaction of AuNPs formation 
involves chlorauric acid in hot water solution, mixed with sodium citrate solution. In this 
process the gold is reduced by the citrate ions which  acts as a reducing agent as well as  a 
capping agent (Ojea-Jiménez and Campanera, 2012). A capping agent is a stabiliser which 
prevents aggregation of particles. The concentration of sodium citrate influences the 
diameter of particles produced. Large particles can be obtained using less amount of 
sodium citrate in the reaction. The particles aggregate into larger particles because the 
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amount of reducing agents to stabilise the gold particles is reduced. Hence, the particles 
synthesized by citrate reduction have a negative surface charge due to the weak citrate 
attachment on the particles. These particles can be characterized without difficulties by 
their plasmon absorbance band (~ 520 nm for 13 nm particles), (Murawska et al, 2012). 
 
 
 
 
 
    
 
 
                                 
 
  
1.3 Stability of  colloidal nanoparticles (Gold and Silica) 
Colloidal particles are considered favourable in most studies of NPs. The term colloidal 
refers to a system whereby particles are finely dispersed in a suspension and are in the size 
range between 1-1000 nm. Colloidal particles are classified as being irreversible colloid 
and hydrophobic (water-hating colloid). They tend to remain dispersed in a continuous 
phase (suspension) due to the minimal interaction between the hydrophobic particles and 
their suspension (Shaw et al, 1992). One common property of colloidal particles is the 
Tyndall effect. When a beam of light passes through a colloidal solution the light is 
scattered due to the colloidal particles and this scattering of light is known as the Tyndall 
effect. Stabilising NPs prevents the attraction between particles known as aggregation. 
According to Brownian motion, there is a natural kinetic energy in particles which causes 
random movements of particles in suspension. Hence, the particles collide with each other, 
subsequently; they may attract or repel (Souza and Miller, 2010). 
 
 
Figure 1.5: Schematic illustration represents  the synthesis of AuNPs by reduction of HAuCl4 with 
sodium citrate. 
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Debye Landau Verwey Overbeek (DLVO) theory, explains that to prevent aggregation, 
suspension should acquire greater electrostatic force than van der Waals forces, as 
colloidal stability is dependent on van der Waals attraction and electrostatic repulsion 
(Toma et al, 2010; Ojea-Jiménez and Puntes, 2009). This is explained in more detail in the 
next section. Therefore stabilisers are designed to prevent aggregation of particles. This 
allows particles to be well dispersed in the media. There are different types of aggregations 
which can occur. These include coagulation, flocculation and gelation. Coagulation refers 
to particles being packed on each other as clumps. Flocculation type is a reversible 
aggregation in which, particles are linked together from the weak interaction bonds formed 
between particles. Finally, gelation aggregation occurs when three dimensional networks 
are formed by particles which are linked in to branches. This results in the increase of 
viscosity. Consequently, a solid field network is formed (Figure 1.6) (Hench and West, 
1990). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Stable colloidal nanoparticles and unstable particles undergoing coagulation and 
sedimentation. 
  
Stable particles 
Sedimentation 
Aggregation  
The aggregated 
particles will increase 
in size and 
consequently settle on 
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sedimentation and 
eventually the 
particles will become 
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Stability of particles is considered critical, depending upon the application the particles are 
used. For instance, if particles are designed for medical applications, the particles need to 
be stable colloidal in order to increase the uptake of particles by the target cells or tissue.  
Particle aggregation could increase the risk of toxicological side-effects (Dominguez-
Medina et al, 2013).  
1.3.1 Debye Landau Verwey Overbeek theory 
The importance of studying surface characteristics in chemistry is considered one of the 
critical phases in NP fabrication, as this concepts determines the aggregation of NPs. 
Studies have considered that particle aggregation has an impact on NP uptakes by cells, 
thus particle aggregation should be avoided. Surface chemistry has reflected that solutions 
are used in wide ranges of pH values as well as ionic strengths. Hence the Derjaguin, 
Landau, Verwey, and Overbeck (DLVO) theory was introduced. DLVO theory stated that 
colloidal stability in solution is dependent on van der Waals attraction and electrostatic 
repulsion. DLVO theory is viewed as an acceptable model for stability (Doane and Bruda, 
2013; Dukhin et al, 2010; Ojea-Jiménez and Puntes, 2009; Park and Borsa, 2004).  Particle 
stability is influenced by the strength of pH and ionic strength of the solution. Furthermore, 
in order to prevent particles from aggregating, the colloidal particles in suspension should 
emit a greater electrostatic repulsive force then the van der Waals attraction forces. 
According to the DLVO theory, the attractive forces (VTotal) formed from the electrostatic 
repulsive and van der Waals attraction forces can be calculated (Equation 2). 
              Eq.2 
Where (VR) is electrostatic repulsive force and (VA) is van der Waals attraction forces, 
(expressed in Figure 1.7) (Aulton and Taylor, 2013). 
Generally, in a lyophobic colloidal system, the electrostatic repulsive force between 
particles is due to osmotic pressure produced from the overlap between diffuse layer and 
closer interaction with the charged particles. An increase of the electrolyte concentration 
causes the reduction of repulsive force. This occurs as a result of the compression on the 
diffuse layer. A reduction effect on electrostatic repulsive force leads to particle 
aggregation, as they are able to overcome the electrostatic repulsion energy barrier (Figure 
1.7).  
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Figure 1.7:  The total energy potential of interaction (Vt)  between two particles, the schematic expresses  
the equation VTotal=VR+VA . Additionally, the effect of increasing the electrolyte is shown (Adapted from 
Aulton and Taylor, 2013) 
The curve of potential energy refers to the VTotal and distance between the particles. Figure 
1.7  illustrates that at a small distance  results in the primary minimum, hence indicates the 
instability of  colloidal particles in solution. At a greater inter- particle distance, due to fall 
off energy, results in the secondary minimum. However, at an intermediate distance, the 
repulsive energy gives a secondary maximum in the curve and therefore the colloidal 
solution are well dispersed. Moreover, the addition of the electrolyte in a solution causes 
the secondary maximum curve to lower and also  deepens the secondary minimum curve, 
which in turn results in  flocculation of particles (Aulton and Taylor, 2013).  
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1.3.2 Influence of surface charge on stability  
Surface charges on NPs are known to influence particle stability, flocculation and viscosity 
(Bizi et al, 2012). Understanding surface charge gives insight on interaction between 
particles. Hence, it is important to determine surface charge including dispersion and 
stability of particles and to reduce aggregation of the particles. DVLO theory has described 
in details how surface charge of particles influences the particle characteristics. It describes 
the behaviour of particles, when interacting with other particles as well as its dispersion 
ability in solution. For instance, the stability of gold particles can be achieved by surface 
coating the particles with citrate anions. Similarly, stability of silica particles can also be 
achieved by coating the particle through subsequent chemical reactions, such as 3-
aminopropyltrimethoxysilian (APS). Electrical double layer (EDL) describes the structure 
of a coating on a surface when interacting with a solution, the interface potential is 
described as being responsible for forming the EDL. The interface is the boundary which is 
formed from two different phases i.e. solid to gas, solid to liquid or two immiscible liquids, 
the interface has different properties compared to the bulk phase. The stern model has been 
introduced to explain the potential of the EDL which is different to both phases. The model 
(Figure 1.8) shows the distribution charge of the particles in the electrolyte solutions 
(Aulton and Taylor, 2013). The surface of the particle adsorbs the monolayer of the 
electrolyte; this area is known as the inner Helmholtz layer (HL), it causes the surface to be 
negatively charged. The ions adsorbed are known as dehydrated ions. The monolayer can 
either be anions or cations and these ions can either be indifferent or specifically adsorbed 
ions. Indifferent absorption refers to ions which are not involved in specific interaction on 
the surface, whereas, specifically adsorbed ions by the particle surfaces, causes chemical 
interaction between the surfaces of the particle (Hubbard, 2002). Stronger interaction 
between ions and the surface on the particles can also lead to reversal charge on the 
surface. Whereas, ions with the same overall charge with the particle surface, can lead to 
greater overall potential (Shaw et al, 1992; Aulton and Taylor, 2013). 
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Figure 1.8:  Electrochemical double layer on a particle surface in a solution containing electrolytes . 
Where  o is surface potential  is a stern potentialand  is zeta  potential.  (Image adapted from: 
http://www.silvercolloids.com/Tutorials/Intro/zetaintro.html).  
  
The overlay of different ions and changes in electric potential with distance from the 
particles surface, also referred to as the thickness of the EDL (1/K) is illustrated in Figure 
1.8. K is dependent on the concentration of electrolytes. If concentration of media 
increases the K increases, resulting in the decrease value of 1/K (Aulton and Taylor, 2013). 
The inner HL plane is the first layer of the absorbed ions, whereas, the outer Helmholtz 
plane layer is of non-specifically absorbed, hydrated counter ions. Both the inner and outer 
HL thickness () are known as the stern layer.  The potential changes from o to  in the 
stern layer and decays from to zero in the diffuse layer (Figure 1.8) (Nitzsche and 
Connah, 2012).  
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1.3.3 Polymeric Stabilisation of nanoparticle surfaces 
AuNPs with organic polymer composite coatings have been developed to overcome the 
effect of interparticle force attraction between gold and water. A polymer molecule creates 
repulsive force, which counterbalances the attractive force of van der Waals force on the 
particles when approaching nearby particles. This approach using polymeric stabilisers has 
aided many studies to overcome aggregation of particles, especially in biomedical 
application where it has allowed particles to be well dispersed in media. It is crucial for 
particles to be highly stable, in order for them to carry out their desired properties. For 
instance, in the delivery of drugs to tissues in order to allow effective release of drugs. 
Particles have to be highly stable in physiological media in order to prevent aggregation, 
hence, particles can become internalized by cell (Voliani et al, 2012). There are currently 
two types of polymeric stabilisation, these are steric and depletion stabilisation of colloids. 
Steric refers to the polymer molecules which form a coating on the particles by attaching 
on the surface of the particle and forming hairy layers. Consequently, the molecules 
prevent attraction between particles. It creates a repulsive force causing particles to 
separate from other particles (Fritz, 2002). On the other hand, the depletion stabilisation 
involves free polymer molecules in solution which creates repulsive attraction between the 
approaching particles (Seebergh and Berg, 1994). 
 
 
 
  
  
 
 45 
  
1.3.3.1 Polymers   
Polymers are chain structured and hydrophilic. They are currently been used in 
nanotechnology as they have properties which tend to allow the AuNPs to remain well 
dispersed even at high salt concentrations (Figure 1.9). They cause steric repulsion and 
prevent coagulation of the colloid particles and therefore make them good stabilisers. 
(Nagdi et al, 2008; Liu et al, 2006; Zhang et al, 2009; Gasaymeh et al, 2010). Many 
studies on the fabrication of AuNPs built with polymer coatings such as mercapto 
polyethylene glycol - (mPEG) and polyvinilpirrolidine (PVP) have remarkably proven that 
nanosized dispersion is enhanced. Interestingly other studies have reported that encrypted 
polymers target and direct cellular uptake, as well as enhance cytosolic delivery by 
disrupting endosomal membranes in a pH-dependent fashion. However, the toxicity effect 
of AuNP stabilisers on vascular function as well as cellular is not known and remains 
poorly investigated. 
  
 
Influence of steric stabilisation on metal nanoparticles 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Schematic illustration showing the dispersion  of A) non-modified AuNPs  B) polymer 
stabilised  AuNPs  in salt solution. 
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     1.3.3.1.1 Polyvinylpyrrolidone 
The polymer compound, polyvinylpyrrolidone (PVP) (Figure 1.10) has a structure and 
formula of (C6H9NO)n and an average molecular weight of 360,000. It has a long repeating 
structure. PVP was first discovered by Walter Reppe in 1939, and has been since used in 
many industrial applications due to its binding abilities. PVP is used in the field of 
medicine as a blood plasma expander in trauma victims with huge blood loss. It is mostly 
found in tablets as a binding agents. However, as well as having beneficial properties, large 
quantities of PVP can be toxic as it has the ability to absorb water. PVP is also known to be 
lethal as it can cause  pulmonary vascular injury if taken by injection other than orally. The 
molecular structure of polyvinylpyrrolidone (PVP) contains both N and C=O groups. The 
nitrogen molecule is conjugated with adjacent carbonyl groups. The properties of PVP is 
determined by its structural formula and is adapted for (a) forming passivating layers 
around the AuNP core due to the coordination of bond formation between the nitrogen 
atom of PVP and (b) the polyvinyl groups has a steric repulsion force which  prevents 
agglomeration of the particles (Robinson et  al, 1990; Astruc et al, 2005; Xie et al, 2012). 
 
 
 
 
 
 
 
 
 
 
        Figure 1.10: The structure of the polyvinylpyrrolidone compound 
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1.3.3.1.2 Thiol Modified PEG (Mercapto polyethylene glycol - (mPEG)) 
The molecular formula of PEG is C2nH4n+2On+1. Polyethylene glycol is a polymer with 
many applications including industrial and medicinal applications. A series of mercapto 
compounds containing polyethylene glycol (PEG) group (Figure 1.11), have been 
synthesised and show advantageous properties such as solubility in water and bio-
compatibility. In addition, modified PEG allows chemical bonding to form between PEG 
and the surface of AuNPs (Figure 1.12), as compared to being physically adsorbed by 
AuNPs. Many studies are in favour of using PEG for stabilising AuNPs (Manson et al, 
2011). According to Soel et al (2013) the action of PEG chains is  related to their affinity 
to AuCl4(-) ions and conformation on the primary AuNPs. However, Knop and colleagues 
stated that PEG may also have side effects and complications (Knop et al, 2010).  
 
 
 
 
   Figure 1.11: The structure of the mercapto polyethylene glycol compound 
 
 
 
 
 
 
 
 
 
 
Figure 1.12: Schematic diagram of the reaction of mPEG with AuNPs 
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1.4 Characterisation of nanoparticles 
1.4.1 Electron microscope   
Electron microscopes (EMs) are used for characterisation of smaller objects, for example, 
NPs or cell organelles. The EMs produces a highly magnified image of specimens. There 
are different types of EM instruments which operate differently from each other. 
According to the type of EM instrument used, the electron beam can either travel through 
or over the  surface of the specimen. The two common types of  EMs are scanning and 
transmission electron microscope (SEM and TEM) (Figure 1.13), (Staniforth and Aulton, 
2007). The following sections (1.4.1.1 and 1.4.1.2) will explain in detail the differences 
between SEM and TEM.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13: An Illustration highlighting the difference in the process of image acquisition between the 
scanning electron microscope (SEM) and the transmission electron microscope (TEM). In SEM, the 
electrons interact either on or near to the surface of the specimen to produce an image. In TEM, however, 
the image is produced when the beam passes through the specimen. 
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1.4.1.1 Scanning electron microscopy  
The scanning electron microscope (SEM) can be used to measure particle sizes. The 
magnification and resolution of SEMs are lower than TEMs. Unlike the TEM, the 
resolution of SEM depends on the emission of the instrument (Cortadellas et al, 2012). 
Using a tungsten filament as a source of electrons, the SEM has a spacial resolution of 50-
100 nm (Swapp, 2013). The SEM can collect data from an area that ranges from 
approximately 1 cm to 5 microns in width (Swapp, 2013). Small sized specimens can be 
imaged at an increased resolution, however, an increased resolution reduces the signal 
level of detection of the sample, thus  the quality of the images is affected (Dunlap and 
Adaskaveg, 1997). 
  
SEM instruments (Figure 1.14.1) can be used to produce images of both conductive and 
non-conductive samples. It is essential that conductive samples are coated with metal; this 
is carried out to prevent the sample from conducting once under the microscope. In the 
SEM the energy electron is produced from the tungsten filament. There are two types of 
signals which the SEM produces to analyse the samples, these are known as the back 
scattered (BSE) and secondary electron imaging (SEI). However, the most common 
detection used in the SEM is SEI. In this process electrons are produced from the 
ionisation of atoms within the samples rather than from the primary source of radiation, in 
this case the tungsten filament. Whereas the BSE beam detects electrons which are  
reflected from the sample by elastic scattering (Pennycook, and Nellist, 2011). SEM has 
low vacuum capabilities, hence it is able to produce images of samples which are non-
conductive: They are also compatible with samples which contain moisture or oily 
deposits.  
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Figure 1.14.1: An image demonstrating an Scanning electron microscope 
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1.4.1.2 Transmission electron microscopy  
Observation of particle morphology and measurement of particles diameter can be 
conducted using transmission electron microscope (TEM) (Figure1.14.2). TEM instrument 
was employed for characterisation in the present study. TEM functions by detecting 
electrons which are transmitted through the specimen. The image of the specimen is 
produced when the interaction of the beam passes through the specimen. On the other 
hand, SEM works differently whereby the electrons interact either on or near the surface of 
specimen and thus produces an image. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14.2 An illustration image of a TEM consisting of several components: An electron source, an 
electromagnetic lens,  a sample holder, an Airlock chamber  and an imaging system. (Image adapted from: 
http://www.hk-phy.org/atomic_world/tem/tem02_e.html). 
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As illustrated on Figure1.14.2, TEM consists of several components, including an electron 
gun which is  the electron emission source found on the top column of the TEM, and 
contains a tungsten filament  which  generates  stream of  electrons (electron beam). The 
TEM contains a vacuum pipe for electrons to travel, and  electromagnetic lenses for the 
operator to control the beam. There is also an airlock chamber for holding a specimen into 
the vacuum in order to prevent an increase of pressure in other areas of the microscope. 
Also required is a specimen holder which is designed to hold a standard sized  grid in 
which the sample is placed. An imaging system is present for creating an image from the 
electrons which exit the system (Pennycook and Nellist, 2011). 
 
1.4.2 Confocal fluorescent microscopy 
A fluorescent microscopy is an electromagnetic spectroscopy which works on the 
principles of fluorescence. It can irradiate an object at specific wavelength. The light at a 
specific wavelength excites the electrons on an object, in turn light is emitted and detected 
at a certain wavelength. Using a confocal microscope will show a florescent structure 
overlaid with a dark background. A confocal microscope has several advantages compared 
to the conventional microscopy. For instance, the focal plane of a confocal microscope can 
be controlled, and this allows the imaging system to achieve out-of-focus rejection, a 
pinhole aperture is present in the system to remove the out of focus interference, when 
light emitted from the focal plane passes through (Visser and Wiersma, 1994; Shaw, 2006). 
 
  
Figure 1.15: image of confocal microscopy attachted to computer for analysis 
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1.4.3  Photon correlation spectroscopy 
Malvern Zetasizer Nano ZS is built with the capability of allowing one to optimize and 
simplify measurement of different types samples. It has the ability to carry out three 
fundamental techniques: particle size, potential and molecular weight. Particle size 
measurement is carried out by Photon Correlation Spectroscopy (PCS) measurements, also 
known as Dynamic light scattering (DLS) and Quasi Elastic Light Scattering (QELS) 
(Tscharnuter, 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.16:  Image demonstrates Malvern zetasizer used for photon correlation spectroscopy and zeta 
potential arrow shows where the cuvette containing sample is placed for measurement.  
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Malvern Zetasizer Nano ZS determines the size of particle in relation to the measurement 
of the Brownian motion. The instruments functions by illuminating the sample by a laser. 
The light which hits the particles in the suspension is then scattered in all direction. The 
scattered light is then detected and further determines for its rate of diffusion. The average 
hydrodynamic particle size ( Z-Average) is also calculated according to the intensity of the 
light scattered from the particles  using the Stokes-Einstein equation: 
                                                                            
             Eq.3 
 
  
 
Where N
A 
is the Avogadro number, T is the constant temperature and η is the viscosity of 
the solution, and  r
u 
is the radius of the solute expressed in the equation 3. Einstein was the 
first to derive this equation. According to the Brownian motion, small particles tend to  
move or diffuse more rapidly than larger particles (Sharma and Yashonath, 2007). 
 
1.4.4 Zeta potential 
Zeta potentials of colloidal dispersed nanoparticles were investigated using the Malvern 
Zetasizer Nano ZS. The zeta potential measurement signifies the repulsive force that is 
present and is used to show the effect of suspension stability of both surface modified and 
non-modified NPs; hence the Malvern Zetasizer will be employed in the present study to 
determine the stability of the non-modified and modified SiNPs in the presence of 
physiological salt solution (PSS), water and complete medium. During the  measurement  
of zeta potential, electrophoresis  takes place  on  the samples. The velocity of the sample 
is then measured using Laser Doppler Velocimetry (LDV).  It is considered important for a 
dispersed suspension of nanoparticles to have appropriate repulsive forces between the 
particles within the suspension. Otherwise, a greater amount of force between the particles 
may result in the aggregation of the particles (Shaw et al, 1992). 
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1.4.4.1 Electrical double layer   
A double layer, also known as electrical double layer (EDL)  refers to a  structure  which 
appears on the surface  of an object such as particles exposed to a fluid. The EDL consists 
of a cloud of ions with high concentration of counter ions followed by low concentration of 
co-ions. The layer is described to be a few nanometers in thickness (Kirby and 
Hasselbrink, 2004). The electrical double layer occurs when the net charge of a particle 
influences the ions to surround the interfacial region causing a concentrated counter ions to 
surround the surface of the particle. The counter ions which are attracted to the surface  of 
the particle is referred to as the stern layer, whereas the ions less  attached on the  outer 
region are referred to as diffused region. Within the diffused region there is  a boundary 
region where the ions move when the particles move. This boundary is known as a national 
boundary. Beyond the national boundary, ions do not move with the particles and this 
region is known as the surface of hydrodynamic shear or the slipping plane. The potential  
on the boundary region is known as the zeta potential. For a particle to be dispersed in a 
solution, the given zeta potential value has to be  ≤ +30Mv or ≥ -30mv charged (Shaw et 
al, 1992). Measurement of a Zeta potential is calculated from the electrophoretic mobility 
in the samples (Figure 1.17), using a  micro capillary electrophoresis cell  (Figure 1.17.1). 
The cells are designed with electrodes at each opposite side and are used to promote the 
potential. When the electrical field is applied to the suspension in the cell, the particles 
move towards an electrode of the opposite charge. The zeta potential can then be measured 
by the velocity of the particles, as the velocity it proportional to the charge of the particles 
in the suspension (Shaw et al, 1992). 
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Figure 1.17: The colloidal  stability indication by the Zeta potential. (Image adapted from Boonen and Roeven, 
2011).2011   
 
 
 
 
 
 
 
 
 
Figure 1.17.1: Samples are  held in the capillary cell and their zeta potentials are  measured using Laser 
Doppler Velocimetry (LDV) within Malvern zeta sizer nano series. (Image adapted from 
(http://www.malvernstore.com/cnb/shop/malvern?productID=11&op=catalogue-product_info-
null&prodCategoryID=7)). 
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     1.4.5 Energy-dispersive X-ray spectroscopy analysis  
Energy-dispersive X-ray spectroscopy analysis  (EDAX) also known as the following 
acronyms (EDX, EDS, or XEDS), is a technique used for characterizing elements or 
chemicals within a sample under SEM or TEM. It uses the interaction between source of 
X-ray excitation and samples to provide analysis. Each element has its unique atomic 
structure, and this property allows the technique to have the capability of producing a 
unique set of peaks on its X-ray spectrum. The system detects the X-rays generated as a 
results of high-energy beam interaction with the samples, which consequently produce 
charged particles such as electrons or protons. Specimens usually contain atoms which are 
not excited and have electrons in discrete levels, these electrons are excited by the incident 
beam. The excited electrons move from their electron shell level, forming an electron hole. 
The electron from a higher energy level move and fill the holes. The difference from the 
movement of the high energy electron to filling the hole at the lower shell is released as an 
X-ray form. Energy-dispersive spectrometer is then used to measure the number and 
energy of X-rays emitted from the sample. It is the energy of the difference between the 
lower and higher shell and the atomic structure of the element that characterizes the X-ray 
energy formed and  allows the chemical or element composition of  the sample to be 
measured (Pennycook and Nellist, 2011). 
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1.4.6 Thermal Gravimetric analysis   
Thermal Gravimetric analysis (TGA) is a thermal analysis techniques, which determines 
the mass change which occur from heating a sample. Thermogravimetry measures the 
changes in reaction during decomposition and the material becomes volatile with the 
surrounding atmosphere. The instrument contains four components, each have different 
functions during the analysis: The furnace, sensor, sample container and the computer. An 
electrical furnace is used and is purged with suitable gas to burn the sample, consequently 
allowing decomposition. The thermocouple resistance sensor measures the temperature. 
The heating is controlled by a system connected to the computer. A ceramic material 
crucible is used as an inert material; a sample of roughly 10mg is measured on a thermo 
balance. The balance is electrically sensitive and is designed to avoid the effect of heat 
(Kealey and Haines, 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.18: Representation of components within the thermogravimetric instrument 
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     1.4.7 Surface Enhanced Raman Spectroscopy 
Surface Enhanced Raman Spectroscopy (SERS) is a highly sensitive Raman spectroscopic 
analytical technique which is similar to the infra-red technique. It looks at the vibration of 
molecules and produces a spectrum of compounds which are present on the analysed 
sample. The technique provides the enhanced Raman signal from the analyte molecule, 
which has beam absorbed on the metal surface from a prepared sample. The excitation laser 
on the Raman produces a surface plasmon (electron oscillations) on the surface of the metal 
sample. These surface plasmon are electrical waves which are stationary. The surface 
plasmon interacts with the analysed sample to enhance the Raman emission and this creates 
a strong electrical fields which gives an enhanced Raman spectra (Haynes, 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Figure 1.19: Schematic diagram of SER illustrating how the samples are detected 
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1.4.8  Diffuse reflectance infra-red Fourier transform spectroscopy (DRIFTS) 
Using the  Thermo Nicolet NEXUS 670 DRIFTS, the Diffuse reflectance infra-red Fourier 
transform spectroscopy (DRIFTS) analysis was conducted in the present study. The 
DRIFTS  technique is commonly used to obtain a spectrum of absorption emission, 
photoconductivity or Raman’s scattering of a sample in any state (solid, liquid or gas). 
DRIFTS spectra collects data from a wide range of spectra. This technique is useful for 
analysis as compared to other spectrometers, such as the dispersive spectrometer which 
only analyses as at a narrow range of wavelength compared to the DRIFTS which gives a 
wide range of wavelengths at a time. The infra-red spectroscopy is an important tool for 
specifying the chemical function of groups present in samples. The instruments work by 
detecting the vibration caused from the infra-red beam interacting with the samples. Each 
chemical functional group absorbs the infra-red light at their specific wavelength which as 
a result  causes vibration. The vibration is caused from stretching, contracting and the 
flexibility of the groups within the samples. The wavenumber band identifies the specific 
functional groups without interference from the chemical groups within the molecules. The 
wavelength produced is at a different rate; henceforth the beam produced has a different 
spectrum. The temperature and pressure within the other chemicals are also not affected. 
DRIFT is an advantage technique which involves analysing and preparing samples without 
any difficulties. The techniques directly analyses samples in powder form. The  light from 
the infrared  beam is then reflected from the samples. The amount of beam absorbed by the 
sample is then measured. The reflected light from samples is then collected by either/ or 
ellipsoid and parabolod mirrors. These mirrors are present in the instruments in order to 
allow the light absorptions to be processed by a computer to give data of light absorption 
for each wavelength by the samples (Kealey and Haines, 2002). 
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1.4.9 Fluorescence spectroscopy  
Fluorescence occurs when the molecule of a sample absorbs a photon from the U.V-visible 
light spectrum resulting in a change to an excited electronic high-energy state. Photons are 
then emitted once the energy returns to its ground electronic state again. Consequently, the 
energy within the molecule is lost through heat or vibrational energy, hence the emission 
wavelength is considered to be longer than the excited molecule wavelength. The 
difference between the  wavelengths is known as the Stokes shift. The fluorescence 
spectroscopy is used to measure the fluorescence of samples. The spectroscopy  involves a  
light   from an excitation source  which can be from the LED or laser, passing  through  a  
monochromator, in which an excited wavelength of a beam is then selected and passes 
through the  sample held in a cuvette. Once the sample is excited, it then results in the  
fluorescent light being  emitted in all directions. Some of the  emitted  fluorescent light 
passes through a second monochromator which is placed  at 90°angle  to allow the sample 
to reach the detector, (Glencross et al, 2007; Kealey and Haines, 2002). 
 
 
 
 
 
 
 
 
 
 
Figure 1.20:  Hitachi fluorescence spectrophotometer F-2500  
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1.4.10 Ultraviolet-visible spectroscopy 
Ultraviolet-visible (UV-vis) spectroscopy, also known as absorption or reflectance 
spectroscopy is an instrument used to measure the wavelength a sample absorbs or emits. 
The absorption or reflectance of the sample at a particular wavelength influences the 
colour observed for the chemical. At that wavelength of the electromagnetic spectrum the 
molecule undergoes electronic transitions. This analytical technique is complementary to 
the method used in fluorescence spectroscopy. In fluorescence spectroscopy the transition 
of the molecules is measured from the excited state to the ground state, while during 
absorption the transition is from the ground state to the excited state. This instrument 
contains visible and/or UV light source that split into its component wavelength as it 
passes through a prism or diffraction grating. The single wavelength beam 
(monochromatic) will split into two equally intense beams by a half-mirror. The sample 
beam will pass through the cuvette containing the sample diluted in transparent solvent. 
While, the reference beam will pass through another cuvette that only contains the solvent. 
An electronic detector will measure the intensities of these light beams. The intensity of 
the reference and sample beam is abbreviated as I0 and I respectively. The UV region of 
the wavelength is 200 to 400 nm and visible is 400 to 800 nm (Glencross et al, 2007).        
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1.5 Nanoparticles and their application in biomedical science 
The integration of nanotechnology into the field of medical science has allowed the 
development of therapeutic intervention strategies by the use of nanoparticles. NPs have 
been engineered to allow advances in the treatment of disease through drug delivery 
(Blanco-Andujar et al, 2010) and imaging diagnostics (Jain, 2012). Using NPs has given 
the potential for providing novel methods in treating diseases which were difficult to target 
and treat, due to their sizes restrictions (Blanco-Andujar et al, 2010). Therapeutic 
interventions using NPs have been successful in the treatment of cancer (Jain, 2012), 
diabetes, allergy, infection and inflammation (Nitta and Numata, 2013). There are many 
reasons for the use of NPs in therapeutic intervention, including the size, since as 
previously mentioned nanoparticles exist in the same size domain as proteins. The large 
surface area of the NPs can allow the addition of  surface functional groups. In particular, 
the large surface area, gives NPs greater absorption capability (Jong and Borm, 2008). NP 
sizes and surface characteristics can thus be modified and controlled, allowing them to be 
used for targeted drug delivery (Kumar et al, 2012) and gene delivery systems (Nitta and 
Numata, 2013). For example, NPs have been used to enhance delivery across the blood–
brain barrier-impermeable probes, to allow in vivo optical and magnetic resonance imaging 
(Koffie et al, 2011).  
             1.5.1 Diagnostic imaging 
Gold nanoparticles have been used successfully for imaging diagnostics. A study by Su et 
al (2006) managed to synthesize Au(3) and Cu(1) (gold and copper) nanoshells as contrast 
agents in Magnetic Resonance Imaging (MRI). Guerrero et al (2012) studied the in vivo 
biodistribustion of modified gold nanoparticles with [18F]-fluorobenzoate administered 
intravenously in rats. Using  positron emission tomography (PET) as their analytic 
technique,  they were able to determine that the highest concentration of the radiolabeled 
conjugate was accumulated in the  bladder and urine, where as, less concentration was 
obtained in the intestine. This finding has as impact in allowing researchers to understand 
that conjugated NPs can be used for drug delivery, and once these NPs have administrated 
the drugs to its targeted location, the particles did not  accumulate around,  but were easily 
excreted. PET imaging was useful in Guerrero et al (2012) study in providing  a better 
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understanding of biodistirbution of gold NPs. AuNPs are considered readily imaged and 
can be tracked on their fate in cells. However, once these AuNPs are modified, they maybe 
less useful as agents for diagnostic imaging, Chien and co-workers (2012), justified that 
non modified AuNPS provided high contrast  which  allowed  them to detect  small 
capillaries in vivo, whereas AuNPs modified with mercaptoundecanoid acid (MUA) gave 
less positive results in detection of small vessels. In their study they used 15.76 mg/ml and 
15.5 ± 5.1 nm non modified AuNPs and 31.52 mg/ml and 3.91 nm MUA-modified AuNPs. 
Nune et al (2011) stated that surface functionalization has allowed nanoparticles to be used 
as probes for molecular imaging. 
1.5.2. Drug delivery   
Drugs can be delivered in a number of ways such as being dissolved, entrapped,  
encapsulated or attached to nanoparticles (Chandra et al, 2010). Development of the 
delivery vehicles can vary, as nanoparticles can be colloidal or mesoporous, nanospherical  
or nanocapsules, and  these variations of shape can be obtained depending on the method 
of preparation. Presently, the use of NPs has shown promising results as agents for 
effective targeted drug delivery systems (TDDS). TDDS are systems specially designed to 
safely deliver and release drugs to the targeted site to increase therapeutic effects (Figure 
1.21).  AuNPs are being used for targeting cancer and are reported to be highly effective 
(Shenoi et al, 2011; Singh et al, 2014). Furthermore, AuNPs are also found to acquire 
antimicrobial properties when conjugated with antibiotics (Ranghar et al, 2014). Other 
reports have described the design of nanoparticles with various materials used as carriers to 
their targeted location. For instance, Pandey and colleagues (2006) successfully 
demonstrated that the nanoparticles provided a sustained release of the anti-TB drugs and 
considerably enhanced their efficacy after oral administration. Voliani et al (2012) justified 
that AuNPs are more efficient for delivery due to their biocompatibility. Using physico-
chemically stabilised bioconjugated gold nanoparticles synthesized from Marine 
Macroalgae, Padina Gymnospora, as a drug delivery system for controlled cancer therapy, 
Singh et al (2014) found that AuNPs induced a death response in the human carcinoma 
liver cell line, HepG2, however, these gold nanoparticles had less effect on a lung cancer 
cell line. 
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Surface modification of NPs, has also gained an interest to increase specific localization of 
drug delivery with decreased toxic side effects. Poly (D, L-lactide-co-glycolide) coating 
has been reported to allow modern drug delivery through the blood brain barrier. Such 
evidence provides relevant uses of polymers as surface modifiers of AuNPs for uses in 
drug delivery (Tosi et al, 2013). PEG-SWCNTs (polyethylene glycol (PEG)-ylated single-
walled carbon nanotube) have also been found to be an effective vehicle for cancer drug 
delivery (Bhirde et al, 2010). 
 
 
 
 
 
 
 
       1.5.3 Gene therapy 
Gene therapy involves using DNA as a drug to treat diseases. The process involves 
delivering therapeutic DNA (functional gene) into cells containing defective genes (Pérez-
Martínez et al, 2012). However, researchers have proclaimed that the major challenge in 
gene delivery is to further improve the transfection efficiencies of the nonviral carriers 
such as, gene vectors (Liu and Zhang, 2011). Hence, NPs have currently been shown to 
represent alternative agents to viral vectors for gene delivery systems. Furthermore, there 
are important aspects that need to be met by researchers in order to develop effective NPs 
as genetic delivery systems. For instance, NPs shows to able to adapt themselves to pass 
genetic material through the blood brain barrier (Pérez-Martínez et al,  2012). Investigation 
into nanoparticles as intracellular delivery vehicles, have found that nanomaterial such as  
carbon nanotube, have limited efficiency as synthetic vehicles due to their insolubility in 
water and have tendency to aggregate (Tucknott and Yaliraki, 2002). These findings 
suggest that such NPs need to be further modified to improve their potential for delivery of 
genetic material. Functionalised carbon nanotubes (f-CNT), have been developed as 
Enhance treatment efficacy  
Effective at specific 
localization  
Reduced toxic side effects   
Targeted drug 
delivery system 
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Reduced dosage    
Better control of bio-distribution   
Figure 1.21: The beneficial effect of TDDS 
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nanovectors and have been reported to be effective for delivering therapeutic molecules 
(Klumpp et al, 2006). Furthermore, different NP composites, such as magnetics have 
demonstrated the potential to deliver genetic material to neural cells, and are observed to 
be effective at the central nervous system (CNS). Jeffery et al (2009) examined the uptake 
of magnetic nanoparticles (MNP) using a transection model and found uptake of MNPs in 
areas of spinal cord injury (SCI) associated with breakdown of the blood–brain barrier 
(BBB) within 6 hrs of injury. Such findings allow the advance of mediating gene transfer 
to sites of spinal cord trauma. The type of nanoparticle administration also has an impact as  
Pérez-Martínez et al (2012) reviewed  that intravenous administration of the nanoparticles 
allowed  the NPs to reach their targeted location. Recently, Figueroa et al (2014) 
developed AuNP polyamidoamine (PAMAM) conjugates for use as non-viral transfection 
agents. They reported that AuNP PAMAM conjugates were effective agents for non-viral 
gene delivery due to high transfection efficiency as well as having low cytotoxicity. 
Furthermore, Huoe t al (2014) successfully delivered 2nm tiopronin-covered AuNPs 
conjugated with a triplex-forminoligonucleotide (TFO) in the nucleus of MCF-7 cancer 
cells,  to regulate gene expression. They observed that the TFO conjugated NPs were 
effective in reducing  c-myc RNA and c-myc protein and resulted in a greater reduction in 
cell viability than the non conjugated  AuNPs. 
 
 In another study, Kim et al (2012) also observed that modified AuNP conjugates make 
promising intracellular gene regulation agents. They found in their study that gold 
nanoparticles stably functionalized with covalently attached oligonucleotides were able to 
activate immune-related genes and pathways in human peripheral blood mononuclear cells. 
Such advantageous findings allow NPs to be used as part of the development of 
therapeutics and gene delivery systems.  
              1.5.4. Cancer treatment 
According to Jain et al (2012) many new nanocomplexes are being developed, however, 
their full impact for clinical use remains poorly identified. To date, more than 180 
nanomaterials have been tested in vitro and in vivo by the NCL (Nanotechnology 
Characterization Laboratory) (Jain et al, 2012). This organization has been collaborating 
with well-known organizations including the National Cancer Institute, the US Food and 
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Drug Administration and the National Institute of Standards and Technology, to aid with 
their research in the study of NPs in cancer treatment. Cancer research has established the 
advantaged uses of AuNPs in the treatment of cancer, due to their physical and chemical 
properties. As well as being used for therapy, AuNPs provide a useful tool for imaging 
diagnostics in cancer therapy. 
 
Studies have established positive results in cancer treatments with AuNPs, furthermore it 
has been established that tumour cells readily take up AuNPs as compared to healthy tissue 
(Enhanced retention). This can be observed as being a positive impact, as already 
researchers are determined to use AuNPs as dose delivery to tumours. Such an example of 
dose that has been introduced is radiotherapy dose enhancers. The study which involves 
investigating the effect of AuNPs as dose enhancer has established that AuNPs were 
biologically effective in allowing radiation to deposit near the directed area targeted by the 
AuNPs during uptake by tumour cells. A recent study used gold nanoparticles as probes to 
image mRNA splice variants of the breast cancer susceptibility gene known as BRCA1. 
They demonstrated that by evaluating the hybridization dynamics of the nanoplasmonic 
dimers the mRNA splice variant of the cancer gene can be monitered (Lee et al, 2014). 
Such study aims to build understanding on the cellular protein complexes, in addition, it 
allows for the development of effective genetic diagnosis and gene therapies. Nanorods 
can be used as ablation components for cancer. As well as non-modified AuNPs, it has 
become clear that modified NPs can also have a great impact on cancer treatment. For 
example, polymer coated NPs, PEG in particular, are described to have a prolonged half-
life circulation in vivo (Fang et al, 2012). 
 
Bio conjugates of AuNPs are found to be useful in cancer therapy, for instance, Bernardi et 
al (2008) synthesized gold-silica for the application of photothermal ablation of tumor 
cells. They were able to conclude that the use of antibody targeted gold-silica nanoshells as 
photothermal ablation of cancer cells presents a promising new strategy for the treatment 
of central nervous system tumors and consequently will result in the reduction of damage 
and the spread of toxicity to the surrounding normal brain. On the other hand, non-targeted 
nanoshells did not show cytotoxicity to the tumour cells.  
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Another study by O’Neal et al (2004) found that coating gold nanoshells with PEG 
resulted in positive in vivo effects for photothermal ablation therapy on a mouse model for 
colon carcinoma. Sykes et al (2014) investigated the impact of AuNP size on active and 
passive tumor targeting.They used poly(ethylene glycol)-coated NPs as passive and 
transferrin-coated NPs  as active  targeting of MDA-MB-435 orthotopic tumor xenografts. 
The accumulation of actively targeted nanoparticles of 60nm size in the tumor was 
approximately 2-fold higher than the  passive NPs with  a similar  diameter range. In 
contrast, there was less accumulation of small NPs of 15 nm diameter size for both active 
and passive targeting. Sykes et al (2014) explained that smaller AuNPs are 
thermodynamicallyless favourable for receptor-mediated endocytosis and are therefore less 
likely to remain in tumors. They further explain that their study findings will aid in the 
engineering of the  optimal  spherical gold nanoparticles for cancer applications. 
 
Finally, an interesting study developed polymer nanoparticles which can carry three 
different types of drugs (Doxorubicin (DOX), camptothecin (CPT), and cisplatin (Pt)). The 
NPs are designed as nanoscopic brush arm polymers, with 2 macromolecules featured with 
PEG that release the drugs  DOX and CPT and a cross linker designed for releasing  the Pt 
drug. They demonstrated that such NPs were highly effective in  destroying the ovarian 
cancer cells (OVCAR3) in vitro (Liao et al, 2014). 
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1.6 The influence of Nanoparticles on endothelial cellular 
function 
NPs have a large surface area to volume ratio and therefore are very reactive with cellular 
components. A broad understanding of the effects of NPs on cells after incubation has not 
yet been achieved. It is therefore of major importance to recognise the effects of NPs and 
their characteristics on cellular function. The following section will provide a background 
information on endothelial cells (EC) function and mechanism of NPs uptake by EC. The 
mechanisms by which NP can lead to cytotoxicity will also be discussed.  
.  
1.6.1 Regulation of endothelial cell function   
ECs make up the luminal layer of all blood and lymphatic vessels (Marcelo et al, 2013). 
They are formed through a process of vasculogenesis which involves activation of 
receptors for growth factors, including fibroblast growth factor (FGF) and vascular 
endothelial growth factor (VEGF)(Wang and Zhao, 2010). The structure and integrity of 
ECs plays a vital role in maintaining the function of both the circulatory system and the 
vessel wall. ECs are capable of conducting a variety of metabolic and synthetic functions 
(Sumpio et al, 2002), for instance, ECs are involved in the regulation of growth of different 
cell types, in transporting nutrients and /or waste and the coagulation and fibrinolysis 
process. ECs also serve as a barrier against the infiltration of bacteria and viruses as well as 
toxic compounds and molecules (Freese et al, 2012). Furthermore, ECs are crucial in 
immune and inflammatory reactions, as they regulate the movements of lymphocytes and 
other leukocytes into tissues (Sumpio et al, 2002). It has been found that apoptosis of ECs 
(cell death) can occur as a result of inflammation. During inflammation, ECs are activated 
by a stimulus (usually a risk factor), which triggers a cascade of events,  leading to up-
regulation of cell adhesion molecules and recruitment of leukocytes to the lining of the EC 
(Kluger, 2004).  Such events can also lead to endothelial dysfunction (Kolluru et al, 
2012).  
 
During blood vessel development, ECs interacts closely with smooth muscle cells (SMCs). 
Such interaction is reflected to have an influence on both development and function of 
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blood vessels (Bernanke and Velkey, 2002). ECs and SMCs are known to communicate 
through paracrine signalling. This type of signalling involves cell-cell communication 
whereby a cell produces a signal in the form of molecules, in order to induce changes to 
nearby cells, consequently, leading to the alteration of the cell behaviour (Yung et al, 
2009). 
1.6.1.1 Intracellular and Extracellular signalling pathways   
ECs contain a large number of cell surface receptors that are responsive to a wide variety 
of chemical and physical stimuli, including growth factors, cytokines, hormones, 
transmitters and shear stress. These signals are transmitted into the inside of the cell 
through different signal transduction pathways. Each type of pathway contains signalling 
molecules which are important as they convey messages to intracellular spaces. There are 
three types of chemical signalling by soluble extracellular molecules: endocrine, paracrine, 
or autocrine  (Lodish et al, 2000). 
 
The signal molecules derives from extracellular space acts as an adopter which triggers the 
intracellular events. There are a greater number of molecules involved in the intracellular 
space for achieving signalling. The first part of cell signalling is  a transmembrane protein 
known as receptor which interacts with the membrane. The second part is the transduction 
process which passes on the signal. Amplification takes place where one molecule is 
triggered by other set of molecules and they are usually activated by proteins. There are  
also other activator  molecules known as positive activators (kinases) and negative 
activators (phosphatases). Most of the signalling pathways involve phosphorylation events. 
During this event kinase enzymes transfer phosphate groups to the protein causing 
activation. Phosphorylation of the proteins further results in modulating the activity of a 
signalling pathway (Cooper, 2000). Interestingly, the kinase enzymes’ activities 
themselves can be inactivated through phosphorylation of scr (non-receptor tyrosine 
kinases). Furthermore, inactivation of the protein can also occur through a process known 
as dephosphorylation. The donated phosphate groups are snatched by the phosphatase 
enzymes resulting in the inactivation of the protein. This process is important to maintain 
correct responses and prevent production of responses due to errors.   
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Activation of proteins leads to a cellular response. There are different signal transduction 
pathways which can activate a particular part of the gene of the nucleus and produce a 
protein for a particular purpose. Particular signalling molecules have a specific receptor to 
trigger a particular response. Different pathways are being triggered at all times ( Berg et 
al, 2002; Singh and Harris, 2005). Protein Kinase B (Akt) and extracellular-regulated 
kinase (ERK) signalling pathways are examples of intracellular pathways. These pathways 
and activation of responses are illustrated in Figure 1.22.  
  
Figure 1.22: Illustrates the activation of ERK pathway induces cellular proliferation, pathway and AKT 
activation results in apoptosis inhibition by caspase-9 phosphorylation, this pathways also promotes vasodilation 
through eNOS activation and NO production. The Abbreviations indicate: Akt/PKB, protein kinase B; DAG, 
diacylglycerol; eNOS, nitric oxide synthase; ERK, extracellular signal-regulated kinase, GRB2, growth factor 
receptor-bound protein 2; HSP, heat shock protein NO, nitric oxide; P, phosphorylation; PG, prostaglandin; 
PI3K, phosphatidylinositide 3-kinase; PIP2, phosphatidylinositol 4,5-bisphosphate; PKC, protein kinase C; PLC, 
phospholipase C; RAS, rat sarcoma; VEGF, vascular endothelial growth factor and VRAP, VEGF receptor-
associated protein. Image adapted from Taimeh et al (2013). 
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1.6.1.2 Cell Death (Apoptosis and necrosis ) 
The process of cell death involves the death of a cell in any form and can also be mediated 
by an intracellular program known as program cell death (PCD). PCD serves a 
fundamental function which results in apoptosis of the cells (Alberts et al, 2002). 
Furthermore, apoptosis is considered an important component in various processes within 
normal cells, acting as a defense mechanism against harmful agents. This type of cell death 
can be triggered both by physiological and pathological stimuli (Elmor, 2007; Alberts et al, 
2002). Another form of cell death is necrosis which is caused by external factors such as 
trauma. However, necrosis can also be programmed to necroptosis cell death. This 
mechanism act as a backup for apoptosis, if the signaling of apoptosis is prevented by 
inhibitors (Miao and Degterev, 2009).  A range of stimuli have been established to indicate 
whether cell death occurs by apoptosis or necrosis (Elmor, 2007).   
 
1.6.2 Nanoparticle uptake by cells   
Exposure of NPs to cells can lead to cellular uptake. Using in-vitro cell culture model 
systems, studies have developed some understanding of the effect of NPs on cellular 
function after exposure.  
 
AuNPs are found to penetrate through skin, in an orderly manner, according to a study 
based on rat skin. The investigators were able to show that size of NPs had an influence on 
the way they penetrate into the skin and concluded that infusion kinetics of particles on 
skin is dependant on NP size. Interestingly, small sized particles were detected in 
aggregates by TEM in the deeper layer of skin whereas large particles accumulated in the 
dermis and epidermis (Sonavane et al, 2008). In contrast, peptide coupled fullerenes did 
not penetrate the skin unless the skin is exposed to shear stress (Rouse et al, 2007). 
 
NPs without any surface modification can achieve uptake. Furthermore their surface 
modification increases their dispersion and as a result can also increase their uptake by 
cells. The key to engineering particles with modified surfaces is to develop particles with 
optimized properties such as bioavailability (Ghosh et al, 2008). In order to reduce the 
cytotoxic effect of the NPs, their surfaces are also modified with polymer materials such as 
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Polyvinylpyrrolidone (PVP) or polyethylene glycol (PEG). These polymers have been 
shown to prevent aggregation of AuNPs and have the ability to prolong their intention 
within specific targeted organs (Chandra et al, 2010; Ojea-jimenez et al, 2009; Lui et al, 
2006; Lui et al, 2007). In one study, surface modification with PEG polymer allowed an 
increase in blood circulation life time (Ghosh et al, 2008). AuNPs modified with PEG were 
efficiently internalized by non-specific endocytosis (Fu et al, 2005). Similarly according to 
Oh et al (2011), uptake of PEGylated AuNPs was enhanced according to the diameter of 
the NPs. This contradicts a statement made by Hauck et al (2008), who suggested that PEG 
polymers may prevent the cellular uptake of nanorods. Manson et al (2011) have also 
found PEGylation of particles reduced uptake of NPs by the reticular endothelial system.  
 
Rauch et al (2012) verified that iron oxide NPs with different surface coatings can 
differentially activate specific cellular signalling pathways in epithelial cells. In a study by 
Larese et al (2009), PVP coated metallic particles (Silver) were found to penetrate into the 
stratum corneum as demonstrated by TEM analysis. Furthermore, these  modified particles 
also permeated into an aqueous acceptor compartment. Contradicting this study,  Arnica et 
al, 2010 found that 50 nm non-polymer modified NPs had the highest uptake by the human 
prostate cancer cell. However, once these cells were surface modified by PEG, their 
cellular uptake was reduced.  
 
A recent study has looked at ways of achieving uptake of NPs and ways of predicting 
highest uptake by cells. Schneider et al (2009) indicated that size absorption of NPs 
through body surface (skin) can be achieved through a formula first established by Potts 
and Guy in 1993. The concept of the formula is to understand the rule of  penetration  
based on the molecular properties of particles. 
  
 
 
 
 
Figure 1.23: Formula established by Potts and Guy explaining the rule of penetration based on the 
molecular properties of particles, (Schneider et al, 2009). 
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Where D is diffusivity of the permeant in the membrane (skin), h is the  length of the 
diffusion pathway, MW is the molecular weight, P is the octanol/water partition coefficient 
(accessibility of P is better than the value of the membrane/water coefficient Km), and Kp is 
the permeability coefficient (Figure 1.23).  
 
For effective uptake by cells, one study has shown that the material should be nanosized or 
less (Oh et al, 2011). However, uptake as mentioned previously is not dependent on size 
only but the morphology and surface charge of both the cell and the NPs. A study by 
Chithrani et al (2006) suggested that the fabrication of AuNPs with citrate leads to a 
reduced cellular uptake, because surface charge of the NPs were negative due to the citrate 
stabilizing ligand. They defined that anionic structures are taken up less efficiently when 
binding to the cell surface than that of neutral or cationic molecules due to electrostatic 
repulsion. The magnitude of uptake of NPs into cells is also dependent on timing of 
incubation (Boyoglu et al, 2013) and concentration of NPs. For instance, Dragoni et al 
(2012), studied the impact of 5-nm AuNPs modified with PVP on the mammalian liver; 
they demonstrated that AuNPs were taken up by the  endocytotic vesicles of  hepatocytes 
after 30 min of their addition. Similarly, Chawla and Amiji (2003) found that most 
rhodamine123 loaded poly (ε-caprolactone) (PCL) NPs were internalised within MCF-7 
oestrogen receptor positive breast cancer cells after the first 30 minutes of incubation. Hu 
et al (2011) examined the influence of size of fluorescein isothiocyanate (FITC) and 
rhodamine B isothiocyanate labelled silica  NPs  on the cellular endocytosis, exocytosis 
and cell activity of HepG2 cells (Human liver carcinoma cell line), and  further determined 
that their uptake behaviour was dependent on NPs size and concentration as well as 
incubation time. 
       1.6.3 Pathways of Nanoparticles uptake by cells 
A number of studies have investigated the pathways by which NPs enter the cell 
(Mukherjee et al, 2007; Wang et al, 2010; Harush-Frenkel et al, 2007; Aderem and 
Underhill, 1999). It has been demonstrated that cellular internalization of NPs involves 
several types of mechanisms. These mechanisms are described as pathways.  There are two 
distinctive pathways of NP uptake by the cells; the phagocytic and non-phagocytic 
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pathways (endocytic pathways). Exocytosis pathways are also common pathways for NPs 
to enter (Tsai et al, 2013). Contents of a cell vacuole are usually released to the exterior 
through this process. Indeed, it is the surface charge and NP size but not the type of 
nanomaterial which influences the entry into cells through different pathways. Kim et al 
(2006) demonstrated that 50 nm silica-overcoated magnetic NPs containing an organic 
fluorescence dye, rhodamine B isothiocyanate, entered cells through energy dependent 
endocytosis, whereas Lin et al (2012), acknowledged  that both  cationic and neutral  
surfaced 5 nm AuNPs depended on endocytosis for cellular uptake. Anionic charged NPs, 
on the other hand, transported through the cell via the paracellular pathway.  
1.6.3.1 Phagocytosis  
Phagocytosis involves removing pathogen and unwanted debris solid particles and this 
process is considered crucial in immune defence. The mechanism involves engulfing the 
solid particles by a phagocyte (cells typically, macrophages, monocytes, neutrophils and 
dendritic cells). Cells such as epithelial and endothelial can also phagocytose, although less 
efficiently. An interesting study by Krpetić et al, 2010 observed the cellular uptake of gold 
NPs through the phagocytic pathway. They showed using TEM images that AuNPs were 
taken up via phagocytosis mechanism by the murine macrophage cells. It has been shown 
that large NPs or aggregates can be taken up through this pathway (Aderem and Underhill, 
1999). It is important to take into account that the characteristics of NPs may also have an 
effect on phagocytosis. Krpetić et al, 2010 found that surface properties of NPs may have 
an important effect on cellular uptake. They showed that there was an increased movement 
of macrophages toward 5-aminovaleric acid-modified AuNPs which, overall led to a 
greater accumulation of NPs in the cytosol. In contrast, Lui et al (2013) found that the 
extent of uptake of negatively charged AuNPs was similar to that of the positively charged 
AuNPs for phagocytic RAW 264.7 cells. Depending on their application of NPs, studies 
have looked at surface modification as a tool to either decrease or increase phagocytosis of  
NPs. Previously, a review by Jong and Borm (2008) identified the advantageous uses of 
polyethylene glycol (PEG) as a surface modification. The review described studies which 
have managed to prolong the presence of the polymer in the circulation without being 
recognized by the mononuclear phagocytic system. Such type of polymer surface 
modification allows NPs to be implemented as an effective drug delivery agent.  
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     1.6.3.2 Non phagocytic Pathways 
Non phagocytic Pathways are different to the phagocytic pathways, and is also known as 
endocytosis. Most cells undergo non phagocytic pathway mechanisms. There are four 
mechanisms in which endocytic pathways can be further divided into: clathrin mediated 
endocytosis (CME), caveolae-mediated endocytosis (CvME), clathrin and caveolae 
independent endocytosis and macropinocytosis.  
     1.6.3.3 Clathrin-mediated endocytosis (CME)  
Endocytosis is a process by  which cells are able to internalize membrane and extracellular 
materials in the form of a vesicle. Clathrin is a protein which is demonstrated to  function 
in receptor-mediated endocytosis events at the plasma membrane, clathrin-mediated 
endocytosis is important for  nutrient uptake and signal transduction (Le Roy and Wrana, 
2005). Once the clathrin has been activated by stimuli it forms a basket-like vesicle and 
coats the invading particles trapping them in to the cell. This process is known as  clathrin-
mediated endocytosis (CME). Harush-Frenkel et al (2007) studied the effect of negatively 
and positively charged NPs on uptake and concluded that charge influenced NPs 
internalization via the clathrin-mediated endocytosis pathway. 
1.6.3.4 Caveolae-mediated endocytosis (CvME)  
Caveolae are found on the plasma membrane of many types of cells, but enriched in 
endothelial cell. These are lipid raft shaped, like flask invaginations and appear as 
membranes that are round in shape with a diameter of 50-80nm. The  Caveolae lack a 
cytoplasmic coat, however, they have the protein caveolin, which helps to characterise the 
caveolae. In a study by Hao et al (2012), they demonstrated that caveolae-mediated 
endocytosis was the dominant pathway for the intracellular delivery of small-size AuNPs 
into HeLa cells and were able to determine the internalisation mechanism using 
fluorescence microscopy. It is reported that inhibition of tyrosine kinase activity inhibits 
caveolae mediated endocytosis (Kirkham and Parton, 2005). 
     1.6.3.5 Macropinocytosis 
Macropinocytosis is an endocytosis process which allows large amount of uptake of fluid 
and solid cargo into cytoplasmic vacuoles, known as macropinosomes (Falcone et al, 
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2006). The process is accompanied by membrane ruffling. Macropinocytosis process is 
often induced by growth factors (Swanson et al, 1995). Panariti et al (2012) reported that 
NPs with a diameter up to several hundreds of nanometers prefer to enter the cells via 
pino- or macropinocytosis process. 
1.6.3.6 Clathrin and Caveolae independent endocytosis   
Other pathways of clathrin and  caveolae  independent endocytic are being studied, for 
instance, flotillin-dependent endocytic pathway are lipid raft-associated proteins and are 
thought to be involved in clathrin and  caveolae  independent endocytic. Other 
internalization routes are based on lipid microdomains.  Kasper et al, 2012, used 
immunonoflueresecence staining and detected uptake of amorphous organosiloxane 
particles by flotillin-1 and -2 containing vesicles. Using a human microvascular endothelial 
cell line they found   colocalisation of NPs with flotillin-1/2 after 4 hours (hrs.), indicating 
a faster uptake mechanism in these cells was achieved by flotillin-dependent endocytic 
pathway. 
1.6.4 Nano-bio interface   
It is important to understand the cellular uptake behaviour of NPs before their use, such as 
in drug delivery applications. A number of interactions between biomaterials (cells, protein 
and DNA) and NPs is recalled to have an important role in determining the cellular uptake 
of NPs. Hence, over decades the number of studies have increased in determining the 
effect of  such interaction between NPs and biomaterials. The nano-bio interface defines 
the interaction between the surfaces of  biocomponents with the NP surfaces. However, 
their precise effect and complex interaction remains unclear.  
 
Nanomaterials vary in behaviour once they come in contact with biocomponents. Their 
surface modification can have a great impact on the way they behave. Interaction of NPs 
with a number of plasma proteins are known to acquire a ‘corona’ (Rahman et al, 2013) 
and can further influence the cellular uptake, inflammation, accumulation, degradation and 
removal of NPs. Furthermore, size, shape and surface of NPs can affect the NPs capability 
of protein adsorption and may induce a protein conformational change in the absorbed 
protein molecule. This can affect protein function (Saptarshi et al, 2013). Recently, using a 
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technique of confocal Raman microscopy, Lopis et al (2011) were able to analyses uptake 
of NPs at a single cell level. They demonstrated that labelling the surface of NPs can 
interfere with the protein interactions and cellular localization of NPs. 
 
1.6.5 Cytotoxicity of Nanoparticles   
Exposure to NPs is inevitable as NPs are becoming more widely used in the chemical, 
domestic, healthcare and cosmetic industries. Consequently, the study of nanotoxicology is 
very important (Lewinski et al, 2008). In particular, understanding their effect on cell 
proliferation, viability and cell death is essential (Bancos et al, 2012; Selim and Hendi, 
2012). 
 
A number of studies have demonstrated the effects of AuNPs on cells. AuNPs can cause 
impaired viability and proliferation of the cells. For instant, Mukherjee et al (2005) were 
able to determine that AuNPs inhibited VEGF165-induced proliferation of Human 
umbilical vein endothelial cells (HUVECs). On the other hand, Semi and Hendi (2012) 
found that the viability of MCF-7 human breast cells was reduced by AuNPs. It has been 
acknowledged that AuNP cytotoxicity can be influenced by various factors such as size of 
NPs, incubation time and surface modification as well as concentration of NP. (Soenen et 
al, 2012). It is mentioned that particles size >3 nm possess  no toxicity effect. In contrast, 
particle sizes of 1-2 nm seem to have high toxic effect on both healthy and cancerous cells 
(Hartung et al, 2013). Indeed, AuNPs can lead to induction of reactive oxygen species 
(ROS) and as a result cause a reduction of cell viability (Vecchio et al, 2012). Soenen et al 
(2012), used 4 nm diameter poly(methacrylic acid)-coated AuNPs and found that not only 
did the concentration of 200 nM NPs reduce cell proliferation and cellular differentiation 
but also at 50 nM concentration an effect was  detected, though, at 10 nM concentration no 
effect was found. Similarly, Zhang et al (2009) observed that at high concentration (>150 
mg/mL) AuNPs can cause a sharp decrease in Human erythroleukemia cell (K562) 
viability, while at low concentration (<75 μg/mL) they had no effect. AuNPs are also 
known to contribute to cell death, for instance, Selim and Hendi (2012) found that AuNPs 
induced apoptosis in MCF-7 human breast cells using MTT assay. The degree of 
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cytotoxicity was dose dependent and at 25µg/mL  viability was reduced to 70% after 24 
hrs incubation. 
 
 
 In vivo experiments in mice, have found that surface modified AuNPs also induced 
inflammation and apoptosis (Tsai et al, 2013; Tiwari et al, 2011). In contrast, using 
Annexin V/PI double staining to analyse the effect of AuNPs on the cell death program of 
MG63 Osteoblast-Like cells, Tsai et al (2013), found that AuNPs did not alter the cellular 
apoptosis rate during an eight day incubation period even after high concentrations of NPs 
were added.  
 
Freese et al (2012) studied the cytotoxicity of AuNPs on endothelial cells and investigated 
whether cytotoxicity effects on Human Dermal Microvascular Endothelial Cells 
(HDMEC) was due to the concentration of AuNPs applied on the cells. Interestingly, cell 
viability was not affected significantly, rather it was increased. In contrast when they 
stabilised the AuNPs with an excess of sodium citrate on their surface they found that high 
concentration of AuNPs caused decrease in cell viability. Furthermore, they identified that 
AuNPs had an impact on cell proliferation, and observed that AuNPs had an effect on the 
amount of nuclear Ki-67, a protein expressed by all cells in the active cell cycle. Similarly, 
Ng et al (2010), found that 20nm AuNPs led to oxidative stress in the embryonic lung 
fibroblasts which as a result inhibited cell proliferation as well as alteration of the cell 
cycle gene. They proclaimed that their observation was more likely due to immune 
reactions. One interesting study indicated that the detrimental effects caused by AuNPs 
cannot be detected solely by proliferation or apoptosis assays, as AuNPs may be causing 
an interference of other specific functions within the cells (Mironava et al, 2010). The use 
of protein polymers, to modify the NPs’ surface and stabilize it may also affect function. 
For example, using ethidium bromide/fluorescein diacetate staining technique, for cell 
viability,  Xie et al (2012) demonstrated that PVP (10000MW) reduced viability of islet 
cells by 63.4%, whereas, PEG (5000MW) and PEG (8000MW) both further reduced 
viability (58.1% and 60.7%, respectively) after 48 hrs incubation. This suggests that 
cytotoxic effects may depend on chain length. However, Xie et al (2012) indicated that 
PVP polymer was a better cryoprotectant candidate as compared to PEG because PVP 
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showed a fast dissolution rate in culture medium. Currently there is no information on the 
effect of PVP and mPEG polymers on endothelial cell function. 
 1.7 Influence of Nanoparticles on Vascular function  
Nanoparticle exposure studies using animals in vivo, have demonstrated that  NPs  can gain 
entry into the blood stream through a number of routes. They can be inhaled, absorbed or 
they can penetrate through the skin (Oberdoster et al, 2005). NPs can penetrate blood 
vessels via two modes of exposure: Intravascular and Extravascular. Intravascular 
(intralumenal) exposure of blood vessels is achieved mainly through directly injecting the 
NPs into the circulation. These are normally ‘engineered’ NPs for drug delivery and 
imaging, where they come in direct contact with the endothelial cell layer lining the vessel 
wall (Azzawi, 2012). On the other hand, NP inhalation or injection, can lead to 
extravascular exposure of blood vessels to NPs, where NPs can translocate through 
extracellular tissues and come in contact with the vessel’s outer adventitial layer. NPs  
translocating through this route include those that are absorbed through the mucosa via 
inhalation, ingestion or via skin absorption. NP uptake has been shown in areas distal to 
the exposure sites, and are demonstrated to affect vascular function (Azzawi, 2012). For 
example, an animal inhalation study reported that titanium dioxide NPs attenuated dilator 
responses to the agonist acetylcholine [ACh] (Le Blanc et al, 2010). NPs  can lead to  
oxidative stress and the generation of reactive oxygen species (ROS) either by simple 
contact between NPs and cells or by internalisation of the NPs (Roesslein et al, 2013). 
Subsequently, NPs can lead to quenching of the nitric oxide (NO), which is a key 
vasodilator molecule (Nurkiewicz et al, 2009; Park and Park, 2009).  
 
The following sections will provide background information, detailing the mechanisms 
involved in the regulation of vessel diameter and the techniques used to assess vessel 
function, ex vivo. 
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Figure 1.24:  A Cross section of aorta containing the inner intima, the media and the adventitia (image 
adapted from http://www.vcu.edu/hearts/aortic_center.htmhttp://www.vcu.edu/hearts/aortic_center.htm) 
 
1.7.1 Regulation of vascular function  
The vascular wall structure (Figure 1.24) includes an inner intima, which contains the 
endothelium, a middle smooth-muscle cell layer within the media, and an outer adventitia, 
which mainly supports the tissue (Mulvany, 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hence, there are multiple layers of SMCs that surround the endothelium. The apposition of 
the two cell types enables a rapid diffusion of signal derived from one cell to the 
neighbouring cells. Each layer plays a big part in maintaining the function of the blood 
vessel. The vascular endothelium layer is presently considered a vital organ and is made up 
of a number of endothelial cells. It plays a crucial role in the maintenance of vascular 
smooth muscle tone and structure. Vessel diameter is modulated by the release of 
vasodilators and vasoconstrictors. Under physiological conditions, a precise and balanced 
release of relaxing vasodilator and contracting vasoconstrictor factors helps keep arteries 
Aortic Cross Section 
sectionsection 
                                            
Intima          
Media (strong 
muscle layer)  Adventitia 
Aortic 
Lumen 
Endothelium 
Internal 
elastin  
  
 
 82 
open and blood flowing smoothly. Alterations in this balance, for example a decreased 
production of dilative agents or an increased production of constrictive agents, lead to 
impaired vasodilatation with considerable effects on the function and structure of the blood 
vessels (Boulanger et al, 1998).  
      1.7.1.1 The mechanism of vasoconstriction 
Smooth muscle cell contraction leads to vessel constriction (vasoconstriction). Which in 
turn causes the vessels to decreases its diameter and hence increase vascular resistance, 
subsequently, this results in the increase in systemic blood pressure. The process of smooth 
muscle cell contraction is regulated by receptor and the mechanical activation of myosin 
and actin contractile.Vasoconstriction can be achieved by the binding of angiotensin II and 
thrombin on the vascular endothelial cells; this activates the endothelium derived factor 
which then regulates the SM vasoconstriction. A number of potent family of 
vasoconstrictors, such as Endothelin and phenylephrine (an alpha1 adrenergic receptor 
agonist), bind to their specific receptors on the smooth muscle cell membrane, which then 
causes constriction by depolarization from an increase in the release of intracellular-stored 
Ca
2+
 from the sarcoplasmic reticulum (Ross and Pawlina, 2010). The influx of Ca
2+
 can be  
blocked  by  inhibitors of guanylate cyclase and Cyclic guanosine monophosphate 
(cGMP)-dependent protein kinase Ia (Jorgensen  et al, 1996 ). The agonist phenylephrine 
is sometimes used as a vasoconstrictor to increase the blood pressure in patients with 
hypotension. The mechanism of agonist mediated vasoconstriction is known as 
‘Pharmacological coupling’. Vasoconstriction can also be achieved through 
‘electromechanical coupling’ which results from net difference across the membrane 
resulting from the activity of a number of active and passive ion transport mechanisms in 
the cell membrane, due to the addition of high potassium solution (Mulvany and Aalkjaer, 
1990). The extracellular high potassium concentrations shift the membrane electrical 
potential from -70 mV to 0 mV, thus leading to depolarisation of the cell and consequent 
constriction (McCarron et al, 2003). According to Webb (2003) for contraction to occur, 
phosphorylation of the 20-kDa light chain of myosin by the myosin light chain kinase 
(MLC kinase) is essential to enable the interaction of the protein myosin with actin. 
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1.7.1.2  The mechanism of vasodilation  
One of the most important substances released from endothelial cell is endothelium derived 
relaxing factor (EDRF), now identified as nitric oxide (NO). The synthesis of NO is 
controlled by NO synthase and is induced by calcium mobilising agents and fluid shear 
stress (Boulanger and Vanhout, 1998). Three NO synthase (NOS) isoforms exist: Neuronal 
NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). The latter is 
constitutively expressed in endothelial cells and is responsible for basal production of NO. 
NOS is known to have approximately 60% amino acid identity and similar primary 
structures, (Papapetropoulos et al, 1999). NO is formed from the amino acid precursor L-
arginine by eNOS. NO involved in a wide variety of regulatory mechanisms of the 
cardiovascular system (McIntyre and Dominiczak, 1997). It is a diffusible gas and a potent 
vasodilator. In addition to contributing to endothelium-dependent vascular relaxation, it 
also plays important roles in maintaining vascular health, including preventing blood 
clotting and leukocyte adhesion and having antiproliferative and antiapoptotic effects 
(preventing cell death) on the vascular wall (Pleger et al, 2008). Vascular studies have 
provided convincing experimental evidence that intracellular calcium ions (Ca
2+
) 
concentration is the major factor involved in the activation of eNOS synthase in 
endothelial cells. Intracellular Ca
2+
 is increased in the endothelial cells by agonist-receptor 
interaction through both extracellular Ca
2+
 influx and Ca
2+
 release from intracellular stores 
e.g. acetylcholine (ACh). eNOS activity is regulated by its phosphorylation. A number of 
protein kinases can phosphorylate eNOS, for example, Akt, leading to its activation and 
NO production. NO that is formed in endothelial cells causes vasodilation by stimulating 
vascular smooth muscle soluble guanylyl cyclase and elevating cyclic guanosine 
monophosphate (cGMP) levels.  
 
In vascular SMCs, cyclic adenosine monophosphate (cAMP)-dependent protein kinase 
(PKA) and cGMP-dependent protein kinase (PKG) are activated by nitric oxide (NO), and 
lead to Ca
2+
 uptake by sarcoplasmic reticulum (SR) through sarcoendoplasmic reticulum 
Ca
2+
 ATPase (SERCA) channel and releases Ca
2+
 from SR to the submembrane space 
through the plasma membrane which activates the calcium-activated potassium channels 
(KCA) and causes hyperpolarization (Figure 1.25). This hyperpolarization spreads to 
adjacent SMC causing the blood vessels to dilate (Webb, 2003). 
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 Furthermore, Bolotina et al (1994) demonstrated that NO can directly activate calcium-
dependnet potassium channels in SMC. Research has shown that inhibition of any site in 
the L-arginine–NO–guanylyl cyclase pathway can cause an impairment of endothelium-
dependent vasodilation (Webb, 2003).  
 
 
 
   Figure 1.25: The mechanism of vasodilation 
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1.7.2 Assessment of vascular function 
     1.7.2.1. Assessment of vessel viability 
Experimentally, vessel viability can be assessed ex vivo by superfusing vessels in high 
potassium solution.  
     1.7.2.2 Assessment of endothelial function-ACh 
Acetylcholine (ACh) is an endothelium-dependent vasodilator agonist 
 
that acts through 
different signal transduction pathways (Panza et al, 1995). ACh binds to the muscarinic 
receptor on the surface of endothelial cells, which is coupled to G protein. ACh can act 
through a number of signal transduction pathways, including the PI3K/Akt pathway, 
leading to eNOS phosphorylation and activation of NO production (Figure 1.26). 
 
 
 
 
 
 
 
Figure 1.26: The alternative pathways which ACh can induce eNOS and resulting NO 
pathways. The pathway involves JAK2 /IRS-1 /PI3-K and AKT, other alternative 
pathways for NO production is PLC/PKC/NFK and RAS/RAf/MEK and Erk 1/2 (Image 
adapted from Zecchin et al (2007). 
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ACh binding to its G protein coupled receptor causes a rise in Ca
2+
, and the cells 
hyperpolarize as a result from the opening of Calcium activated potassium channels (KCa). 
This hyperpolarization spreads to adjacent SMCs leading to arterial dilatation. Even if only 
a small number of endothelial cells are directly stimulated by the agonist, the entire length 
of the artery can dilate in vivo. The mechanism for this spreading dilatation is intrinsic to 
the vessel wall, and occurs due to the rapid spread of current through gap junctions. 
Investigators have found that the rise in endothelial cell Ca
2+
 only occurs within the area 
where ACh is present, consequently, the cells hyperpolarize along the arterial length 
(Christense et al, 2001). Schffrin et al (1998) demonstrated that ACh stimulated a rise
 
in 
endothelial cell [Ca
2+
] and hyperpolarization in the  rat mesenteric artery
 
endothelial cells. 
Subsequently, hyperpolarization and relaxation
 
occurred at the adjacent SMCs. Reduced 
responses to ACh; reflect endothelial dysfunction (Celermajer et al, 1997). 
 
The major vasodilator identified within aortic vessels, upon ACh stimulation, is NO. Using 
an NOS inhibitor Nw-Nitro-L-arginine (L-NNA), Farooq et al (2014) demonstrated that 
most of the dilatory responses of ACh were lost. ACh may also stimulate other vasodilator 
substances, including endothelial derived hyperpolarising factors (EDHFs). A number of 
candidate molecules have been identified as EDHFs, including EETs. Furthermore, K
+ 
are 
also being classified as EDHF, they were found to extrude from the endothelium  and into 
the myoendothelial gap, where they result in vasorelaxation by activating the vascular 
smooth muscle inwardly rectifying potassium channels and Na
2+
, K
+
-ATPase pumps. 
Subsequently, causing the efflux of K
+
 from the vascular smooth muscle and finally 
inducing hyperpolarization (Coates et al, 2001; Sokoya et al, 2006).   
1.7.2.3  Assessment of smooth muscle cell responsiveness-(SNP)  
Sodium Nitroprusside (SNP) has the following formula: Na2[Fe(CN)5NO], it is a  non-
selective vasodilator otherwise known as an endothelium independent dilator. The 
structure of SNP consists of a ferrous ion centre with five cyanide (CN
−
) moieties and a 
nitrosyl group. It acts as a NO donor in the vessels. It breaks down in the tissue and 
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releases NO.  It does this by binding to oxyhaemoglobin  and forms methemoglobin while 
releasing cyanide and NO. The NO diffuses into the muscle cells in the walls of the blood 
vessels and causes them to relax. When the muscles relax, the blood vessels become wider 
and the blood pressure decreases (Stoelting and Hillier, 2005). 
A study has demonstrated that SNP increased the amplitude of the KIR current of rat-tail 
small artery smooth muscle cell and induced KIR-mediated vasodilation. The KIR channel 
were found on the smooth muscle cells (Schubert et al, 2004). SNP based drugs are 
currently used in therapy to lower the pressure of patients, however, a prolong exposure 
can lead to toxicity effects (Aghababian, 2011).  
    1.7.3 Assessment of vascular function ex vivo 
Vascular function can be assessed ex vivo using an organ bath setup. To investigate the 
ability of the endothelium to produce and release vasodilators, an experimental approach is 
generally used. Pharmacological agents such as
 
endothelium-dependent, acetylcholine 
(ACh) and endothelium-independent, sodium nitroprusside (SNP) vasodilators are used to 
examine dilator responses. Vessels are usually contracted to a steady level ex vivo by 
vasoconstrictors (high potassium or phenylephrine) (Rosas-Hernandez et al, 2009), and 
then are exposed to cumulative concentrations of an agonist drug such as ACh. 
 Production and release of dilator substances may be assessed by the response to ACh; it is 
a characteristic for a functioning and healthy endothelium. Similarly a decrease in the 
maximum dilator response to SNP indicates the lack of SMC sensitivity to NO. 
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1.7.4 Influence of  Nanoparticles  on the function of  aortic vessel 
NP size plays a vital role in cellular uptake and penetration into the vessel through 
intravascular and extra vascular modes. These particles are then localised in intracellular 
vesicles (Nasser et al, 1996). Studies examining the effect of NPs on vessel function have 
demonstrated that silver NPs can induce vasoconstriction and block any endothelial-
dependent responses by isolated aortic rings (Rosas-Hernandez et al, 2009). Similarly 
using isolated aortic rings ex vivo, Farooq et al (2014), demonstrated that SiNPs of            
< 100nm caused attenuation of endothelial dependent (ACh), but not independent dilation 
(SNP) responses. They further determined that the attenuation response was due to the 
surface area of the NPs rather than their size. Furthermore, they found that attenuation 
related to dyed dope SiNPs could be restored using  superoxide dismutase (SOD) but  this 
was not the case with non-dye doped SiNPs, therefore suggesting that their mechanisms of 
dilation for non-dyed and dyed dope SiNPs are different.  Similarly, using SiNPs of 100nm 
and 200nm, our previous published study (Akbar et al, 2011) demonstrated that there was 
no overall detrimental effect on dilatory function. However, once the NPs were surface 
modified with APS the 200nm lead to a significant reduction in dilatory responses of ACh. 
This indicated that both size and surface modification of NPs influenced dilatory 
responses. In a most recent study by Silva et al (2014) the effect of coupling AuNPs to NO 
donors (ruthenium complex) was investigated, demonstrating that NO released from 
AuNPs was lower than that from the ruthenium complex alone. AuNPs did not impair the 
vasodilation induced by the NO donors. An in vivo study by Khan et al (2012) found that 
administration of 10nm AuNPs did not induce any oxidative stress in the lungs and heart of 
a rat model, however led to a significant production of lipid peroxidation in the rat liver. 
Recently, Goverment and scientific organisations have called for the need to assess toxic 
effects of NPs in tissues including the heart and blood vessels. At this moment, the author 
is not aware of any information on the effect of polymer and non-polymer modified  
AuNPs uptake on aortic vessel function. 
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1.8. Aims and Objectives  
The aim of this project was to synthesise and characterise NPs (silica and gold) and to   
determine the influence of AuNPs on cellular and vascular function using isolated cells and 
whole vessels in vivo and ex vivo. 
Specifically the following questions were addressed: 
Q1. Will non-modified and polymer modified AuNPs influence endothelial cell function in 
vitro? 
Q2. Can non-modified and polymer modified NPs affect vascular function? Specifically, 
do they affect: Endothelium dependent (ACh) and endothelium independent (SNP) 
vasodilator function? 
 Hence, the hypotheses of the present study are: 
 AuNPs will influence endothelial cell (EC) viability and proliferation in cell 
culture, the degree of which depends on the type of polymer modification.  
 AuNPs will attenuate dilator function of aortic vessels, the degree of which 
depends on the type of polymer modification. 
In order to answer these questions the following objectives were set out: 
1. To synthesise NPs of different material composition (silica, gold) and  to characterise 
them using Ultraviolet-visible spectroscopy (UV-spectra), transmission electron 
microscopy (TEM), scanning electron microscopy (SEM), thermo-gravimetric analyser 
(TGA), Photon correlation spectroscopy, Energy-dispersive X-ray spectroscopy (EDAX) 
and Surface-enhanced Raman spectroscopy (SERS). AuNPs were surface modified using 
the polymers Polyvinylpyrrolidone (PVP) and mercapto polyethylene glycol (mPEG). 
2. To determine the influence of polymer modified AuNPs and non-modified AuNPs on 
cellular function, in vitro. The effect of AuNP uptake on cell viability, proliferation, 
apoptosis and cell death were investigated using bovine aortic endothial cells (BAECs).  
3. To determine the influence of the AuNPs uptake on arterial function using the organ 
bath system, ex vivo. Uptake was verified by TEM and inductively coupled plasma (ICP). 
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2. Method 
      2.1 Drugs and chemicals 
All chemicals such as: acetylcholine (ACh), sodium nitroprusside (SNP) ammonium 
hydroxide (NH4OH), 3-aminopropyltrimethoxysilian, (APS), rhodamine, 
tetraethylorthosilicate (TEOS),  Ethanol absolute,  gold (iii) chloride sodium (HAuCl4), 
rhodamine dye(RH), sodium citrate, thiolated PEG (5000MW),  PVP (8000MW)   and 
salts for physiological salt solution (PSS) and high potassium (KPSS) were purchased from 
Sigma Aldrich chemical company. 
2.2 Animal preparation 
Male Wistar rats’ hearts were collected in a small bottle containing ice cold PSS solution. 
The rats (150-250g weight)  were humanely killed by stunning and cervical dislocation. All 
procedures were performed in accordance with our institutional guidelines and the United 
Kingdom Animals Act of 1986, also approved by MMU ethics committee. The animal 
hearts containing the aortic vessel were removed and placed in ice-cold PSS of the 
following composition (in mM): sodium chloride (NaCl), potassium chloride (KCl), 
magnesium sulphate (MgSO4), sodium bicarbonate (NaHCO3), Potassium hydrogen 
phosphate (KHPO4), dipotassium ethylenediaminetetraacetic acid ( K2EDTA), glucose and 
calcium chloride dehydrate (CaCl2.2H2O (pH7.4)). The perivascular adipose tissue was 
removed from the vessel while being gassed (95% O2: 5% CO2) in cold PSS. Aortic rings 
of 3-4 mm in size were mounted in an organ bath system filled with PSS solution (35 
oC). 
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 2.3 Nanoparticle Synthesis  
2.3.1 Silica Nanoparticles  
Before NP synthesis, titration of NH4OH was done to determine the concentration of 
ammonia (NH3) in the bottle of NH4OH (Appendix A: Section2). 
Firstly, Silica Nanoparticles were fabricates using methods from previous studies and these 
methods were subsequently modified (Appendix A: section 4), to determine the influence 
of modifying certain parameters during NP synthesis. 
 
2.3.1.1  Preparation of dye for silica nanoparticles   
The  rhodamine  dye for silica nanoparticles was prepared using the  Stöber  method which 
was further developed by Verhaegh et al (1994); briefly 50 µg of rhodamine dye (RH) was 
added to 0.1136ml of 3-aminopropyltrimethoxysilane (APS) (used as coupling agent ) and 
left stirring in the absence of light for 24 hr under inert atmosphere, until the solution 
turned orange. This RH dye was used for NP sample termed RH28. Preparation of dye for 
additional silica nanoparticle samples using  different  molar ratios of  reagent  was carried 
out (see table 2.1 below). 
 
Table 2.1: Molar ratio of reagents used for dye preparation in each silica nanoparticle 
samples. 
 
 
 
 
 
 
 
 
 
Sample name 
 
RITC 
(µg) 
 
APS 
(ml) 
 
EtOH 
 
Reaction time  (hours) 
TMNA 
100  and  200 
40 0.1 - 3 hrs 
TMRHSI 3.50 0.02 0.4ml 24hrs 
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      2.3.1.2 Synthesis of 100nm and 200nm  silica nanoparticles  
Silica nanoparticles were fabricated using a modified Stöber method. Absolute ethanol 
(30ml) was added in a 100ml container along with 2ml NH4OH. An amount of 1.5 ml 
TEOS was pipetted in the mixture and was left stirring at room temperature. After 10 min 
50 µl of the prepared rhodamine dye was added. The solution was left to stir (3hrs); the 
colour of the solution turned from colourless to a clear, slightly milky pink. This solution 
was then centrifuged for 25 min at 6000 rpm. The pellet was collected and was then 
washed and redispersed with deionised water (H2O) and ethanol. The samples were 
sonicated using an Ultrasonic Fisherbrand
®
  FB11022 (Germany), and vortexed to dissolve 
the clumps of particles. Final products were kept in universal tubes and placed in dark 
storage. This same method was carried out for the production of the non-dyed silica NPs; 
however, no dye was added to the solution. The sample changed from colourless to slightly 
milky after 3hrs of stirring. The resultant sample prepared using this method was termed 
RH28. Additional NPs of varying diameter and morphology were also obtained by reacting 
different molar ratios of the reagents (details given in Table 2.2 below).  
 
Table 2.2: Molar ratio of reagents used for synthesising a variety of silica nanoparticle 
sizes.  
 
 
 
 
   
 
 
 
Sample 
 
RITC 
 (µg) 
+ APS 
 
EtOH 
(ml) 
 
H2O 
(ml) 
 
NH4OH 
(ml) 
 
TEOS 
(ml) 
 
Temperature 
(°C) 
 
Particle 
Size 
(nm) 
 
Reaction 
time  
(hours) 
TMNA 
100 
5ul 98.30 2.649 8.744 9.946 25 100 3 
  TMNA  
 200 
5ul 98.70 12.355 4.372 14.94 25 200 24 
TMSI - 90.60 2.808 6.04 3.791 25 100 24 
TMRHSI 20ul - -  - 25 100 24 
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2.3.1.3 Surface charging silica nanoparticles with amine group (APS) 
The amount of APS needed to coat the whole surface of the silica NPs was weighed out 
(An example of APS working out  is given in Appendix A: Section 5) and placed in a beaker 
along with the sample of the silica nanoparticles. An amount of ethanol worked out (see 
table below) was also added to the mixture and it was placed on the oil bath, which is then 
placed on the condenser. The particles were left stirring on the oil bath using a magnetic 
stirrer for 60 min at 40 
o
C.  
 
Table 2.3: Amount of APS and ethanol used to functionalise the silica nanoparticles 
  
 
 
 
Sample 
name 
APS added (µl) Ethanol added (ml) 
TMSI+ 16 3.72 
TMRHSI+ 10  2.80 
TMNA+ 
(100nm) 
10  2.56 
TMNA+ 
(200nm) 
2  0.63 
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2.3.2 Gold Nanoparticle synthesis 
Gold nanoparticles were synthesized according to the method by Turkevich et al  (1951); 
In brief, 0.02g of HAuCl4 was added to 50ml boiling water heated on a magnetic stirrer. 
5ml of a 1% solution of sodium citrate (a reducing agent) was then added to the boiling 
solution. Heating was continued until the colour of the solution changed from colourless to 
red. The solution was removed from the hot plate and was left to cool at room temperature 
for approximately 30 min. The sample was then stored in dark. AuNPs were modified with 
PVP and mPEG. PEG alone was also prepared for studies on cellular and vascular function 
2.3.3 Modification with Polyvinylpyrrolidone 
AuNPs were modified with PVP by dissolving 0.0038g of PVP in 1 mL of deionised H2O, 
giving a final working concentration of 3.8mg/ml. 500 µL of the stock (1x10
5
 µM to 10 
µM) were prepared and left to stir vigorously with  25mL  gold seeds for 24 hours, in order 
to allow attachment of the polymers to AuNPs. The final working concentration of the 
sample was 0.076mg/ml in 1x10
5 µM serial dilution.   
2.3.4  Determining the minimum concentration of Polyvinylpyrrolidone   
required to stabilise NPs 
A serial dilution of PVP (1 µM  to 0.001 µM) stock was prepared in order to obtain the 
minimum concentration to prevent aggregation in physiological solution. Each 
concentration of PVP was incubated with the aortic vessel and their effects on the 
endothelial dependent and independent dilator responses were assessed.  
2.3.5 Determining the minimum concentration of Mecapto polyethylene 
glycol  required to stabilise NPs 
A serial dilution of  mPEG (5000MW) was prepared from 1.478X10
-4
 g/ml of  mPEG stock 
(2.96ml of 0.05g mPEG in 5ml H2O stock  added to  200 ml H2O) in order to obtain the 
minimum concentration to prevent aggregation in physiological solutions. pH of all 
solution was found to be constant at 7.3 in all the mPEG modified AuNPs solutions. The 
following explains the amount of mPEG used to coat 2 ml AuNPs and its stability after 
addition in 2ml PSS: 
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 7.39x 10-5g /ml of mPEG coated on AuNPs was made up by adding  2 ml of AuNPs 
in 1 ml H2O and 0.5 ml of 1.478X10
-4
 g/ml of  mPEG stock  (2.96 ml of 0.05g 
mPEG in 5 ml H2O stock  made up to 200 ml with H2O ) added  in a vessel of 2ml 
PSS. Therefore 3.7x10
-5
g of mPEG is needed for coating 1ml of AuNPs stock. The 
solution remained stable i.e. no colour change after addition of PSS. The pH of the 
solution was also measured and gave a pH  value of 7.3.   
 
 7.39x 10-6g/ml of mPEG coated on AuNPs was made up by  adding 0.5 ml of 
AuNPs to 0.25 ml of H2O and 0.125 ml of 1.478x10
-5
 g/ml mPEG (20 ml of 
1.478x10
-4
 g/ml mPEG stock in H2O (180 ml)). Therefore 3.7x10
-6
g of mPEG was 
needed for coating 1ml of AuNPs stock. The stability was then tested with 2 ml 
PSS after 15 min: there was no colour change.   
 
 1x10-7g/ml of mPEG coated on Au NPs was made up by adding 0.5 ml of AuNPs 
to 0.25ml of H2O and 0.125ml of  1x10
-6
 g/ml mPEG (0.68ml of 1.478x10
-5
 g/ml 
mPEG stock  in H2O (10ml)) was also added to the solution. Therefore 0.5x10
-7
g of 
mPEG was needed for coating 1ml of AuNPs stock. The stability was then tested 
with 2 ml PSS after 15 min and there was a colour change from pink to blue colour 
change. This demonstrated instability in PSS.  
2.3.6  Modification with Mecapto polyethylene glycol 
The concentration of 7.39x 10
-6 
g/ml of mPEG coated on 2ml gold NP stock was made up 
in and left stirring for 1 hour to allow attachment and 7.4x10
-8 
g/ml of the sample was used 
for cellular (20 µl) and for vascular (300 µl) function studies.  
2.3.7 Preparation of non thiol modified polyethylene glycol (PEG)  
Polyethylene glycol (0.001 g) was added to 500 ml distilled water (2x10-6 g in ml). An 
amount of 166 µl of the sample was added to 15 ml of PSS in the organ bath. 
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2.4 Characterisation of Nanoparticles 
2.4.1 Scanning electron microscopy 
Scanning electron microscopy (SEM) was used to confirm the size of the silica 
nanoparticles. A dilute droplet of nanoparticle (silica) solution was dried onto a clean 
silicon surface and imaged by scanning electron microscopy (Zeiss FEG SEM). The 
average nanoparticle size was determined by measuring the diameter of at least 10 NPs 
with reference to the typography scale found on the micrograph (Akbar et al, 2011). 
2.4.2 Transmission electron microscopy 
The sizes and morphology of the gold nanoparticles were confirmed using transmission 
electron microscopy (TEM, JEOL JEM-200). A dilute sample was dried on a clean copper 
grid and the sample was inserted under high vaccum into the microscope (Akbar et al, 
2011).  
2.4.3 Zeta Potential of  silica nanoparticles        
Using a Malvern Zetasizer Nano ZS instrument, the nanoparticle size of the SiNPs was 
determined by dynamic light scattering (DLS).  Zeta potential was also determined. 1ml of 
nanoparticle solution containing 0.02% weight was placed into a polystyrene cuvette and 
placed in to a slot on the a Malvern Zetasizer Nano ZS instrument (Malverin Instruments, 
UK). The particles were dispersed in water and PSS for their stability analysis. 
2.4.4 Analysing the rhodamine B isothiocyanate dye coated silica 
nanoparticles using fluorescence spectroscopy 
The dye molecules encapsulated in silica nanoparticles (TMNA 100nm and RH28) were 
placed in a Quartz cuvette and determined using fluorescence spectroscopy. The excitation 
wavelength of the dye was 540 nm and emission at 573 nm.  
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2.4.5 Determining the stability of the modified and non-modified 
gold nanoparticles 
2.4.5.1 Ultraviolet-visible spectroscopy   
To check the stability of the non-modified and modified  AuNPs in the presence of PSS, 
water and complete medium, samples were characterised with UV-vis. Firstly, the 
instrument was prepared and left for 3-4 minutes in order to set the UV lamp. Two quartz 
cuvettes were used, one was  filled with a solution ( H2O , cell media or  PSS) for reference 
and  the second was filled with 1:1 ratio of  NPs solution and  H2O, cell media or  PSS. 
The quartz cell was then placed on the sample holder and the sample was analysed. 
 
2.4.6 Assessment of functional groups on gold nanoparticles 
2.4.6.1 Energy-dispersive X-ray spectroscopy analysis   
EDAX analysis was performed using the Energy-dispersive X-ray spectroscopy analysis 
system attached to microscope JEOL 5600LV scanning electron microscopy. A droplet of 
NP samples was dried on a clean aluminium stub and was placed in a sample holder 
component in the instrument for analysis.  
2.4.6.2 Thermogravimetry analysis   
Briefly, a solution of PVP modified AuNPs were completely dried to give a pellet. 12 mg 
of the pellet held in a ceramic crucible was analysed on the thermogravimetry analyser 
(TGA) to show the number of PVP molecules attached on the AuNPs. A weight of the 
sample (12mg) was scanned in a temperature range of 0-1000 oC for TGA at a heating rate 
of 10
o
C/min under nitrogen purge. The process involves burning PVP molecules at a 
certain temperature from AuNPs. The longer it takes for all the PVP molecules to remove 
from the AuNPs indicates high quantities of PVP chains attached on AuNPs. PVP alone 
was also analysed as a control.  
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2.4.6.3 Surface Enhanced Raman Spectroscopy 
The functional groups attachted on the modified and non-modified AuNPs were analysed 
by Surface-enhanced Raman scattering (SERS). For sample preparation, 1ml of the NP 
solution was drop-coated on the glass slide and left to dry in the oven overnight at 60 
o
C, 
then the Raman spectra were recorded the following day. The spectra were obtained with a 
microscopic confocal Raman spectrometer (Reinshaw in via Raman microscope) operated 
with an argon laser (514 nm). The laser intensity was 50 mW.  
2.4.6.4 Diffuse reflectance infra-red Fourier transform spectroscopy 
DRIFTS were performed to determine the finger prints of the modified and non-modified 
AuNPs and their stabilisers. Briefly, DRIFTS  preparation involved  placing an analytic 
sample on the  salt plate (KBr), then another plate was placed on top of the first plate 
making a “sandwich”. The “sandwich” was then mounted on a sample holder. A 
background spectrum was  run using the OMNIC software before the sample was analysed 
on the system. 
 
2.4.7 Quantification of the relative amount of metal in the 
modified and non-modified gold Nanoparticles 
2.4.7.1 Inductively-coupled plasma mass spectrometry   
In order to determine the relative amount of metal in 300 µl of PVP and mPEG modified 
AuNPS and non-modified AuNPs, the samples were diluted in 5ml of distilled water and 
analysed using the Inductively coupled plasma mass spectrometry (ICP-MS; Perkin Elmer, 
UK). Furthermore, the presences of modified and non-modified AuNPs within the aortic 
vessels after 30 minutes incubation period from the vascular study (section 2.9) were also 
determined using this technique. Briefly, the vessel was firstly weighed before incubation 
with the experimental conditions. Afterwards, the concentration of AuNPs, AumPEG and 
AuPVP used in the organ bath and the double concentration, along with control vessels (in 
PSS) were incubated with 37 °C PSS under gas condition (95% O2 /5% CO2) then the 
weight of each of the vessels was recorded before being lysed. The amount of 0.5 ml of 
lysate buffer (containing 0.5g SDS, 0.2925g NaCl, 0.394g Tris, 0.030g tris 
PVP 
AuNPs 
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(hydroxylmethyl) aminomethane) was added to each tube and tubes were left for 48 hrs at 
room temperature to allow the tissue to dissolve in the buffer. Each tube was mixed with 
1ml of high-purity (70%) nitric acid to allow the vessel tissue to be fully dissolved. The 
glass tubes were placed in an oil bath at 200°C for 3 hrs. The tubes were then transferred 
into a 5 ml volumetric flask and the volume  made up to 5 ml with distilled water. 
Volumetric flasks containing the samples were placed within the ICP machine sample tray 
for analysis. 
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2.5 Cellular study of endothelial cells: Cell culture  
2.5.1 Preparation of cell culture medium  
The complete medium was prepared by filtering 450ml  of the Dulbecco’s Modified Eagle 
medium (DMEM)) containing 4.5 g/l glucose in a 500ml sterile bottle, along with 50ml of 
10% foetal bovine serum (FBS) and 5ml of 1% antibiotics (100 U/ml penicillin and 100 
g/ml streptomycin) and  finally 5ml of glutamine.  
 
2.5.2 Culture of bovine aortic endothelial cells  
Bovine aortic endothelial cells (BAEC) were isolated as previously described (Sattar et al, 
1994) and seeded in 75-cm
2
 flasks pre-coated with 0.1% gelatine and cultured in 
Dulbecco’s Modified Eagle Medium (Lonza, Cambridge, UK) supplemented with 20% 
foetal bovine serum (Cambrex, Hertfordshire, UK), 2 mM glutamine and 1% antibiotics 
(100 µg/mL  streptomycin, 100 U/ml penicillin), defined as complete medium. The cells 
were incubated at 37°C in a saturated air humidity with 5% CO2 incubator, passaged every 
2-3 days, using enzymatic digestion with 0.05% trypsin / 0.02% EDTA and split at a ratio 
of 1:2 or 1:3. At confluence, ECs were identified by their typical cobblestone morphology. 
The cells were used throughout the study between passages 4 and 9.  
2.5.3 Trypsinization of cells  
Once the incubated cells reached 80-90% confluence (80% of surface of flask covered by 
cells) they were trypsinized. It is important to avoid over confluence as this will cause cell 
death. The medium from the flask was discarded and the cells were rinsed three times with 
10 ml sterile phosphate buffer saline (PBS). Afterwards, 5ml of 0.05% trypsin and 0.02% 
EDTA was added to the flask containing the cells; the flask was gently rolled to ensure 
trypsin contact with all cells and incubated for cell detachment for 2-3 min. The cells were 
monitored under the microscope to prevent over-trypsinization which can severely damage 
the cells. As soon as the  cells detached the flask was removed from the incubator and 
gently tapped to detach all the cells.  The cells were then collected in the centrifuge tubes 
together with the complete medium to inactivate the trypsin. The cells were then 
centrifuged (HERMILE Z400K) at 1300 RPM for 5 min. The supernatant was discarded 
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and the cell pellets were re-suspended in fresh complete medium for subculture, (also 
known as passaging) or in serum poor medium SPM (2.5% FBS). 
2.5.4 Process for freezing the cells 
The cells were detached from a single T-25 flask with the trypsin and centrifuged at 1300 
RPM. The cell pellet was collected and re-suspended by a gentle pipetting with 25 % 
complete medium and 75% freezing medium made up from 10 % DMSO and 90% FBS. 
The amount of 1.5 ml was taken from the suspension containing the cells and then 
transferred to each cryotubes. The cells were first frozen at  – 20º C for 30 min then placed 
in the freezer at  -80 ºC for 24 hrs then finally stored in liquid nitrogen (– 196 ºC). 
2.5.5 Thawing of cells  
The frozen cryotube containing the BAECs was taken from either the liquid nitrogen or the 
-80 ºC freezer. The cryotube were then disinfected with 70% ethanol spray and were 
defrosted at 37 
o
C under aseptic condition. The cells were gently poured into a T-25 flask 
containing roughly 3 ml of complete medium and finally, the flask was incubated at 37 ºC 
in an humidified incubator (5% CO2; 95% air) changing medium each time, until 
confluent.  
      2.5.6 Cell proliferation and Cell viability 
Cells were seeded at 2.5x10
4
 cells/ml with 500µl of DMEM supplemented in a 24 well 
plate and were incubated to allow seeding  for 4 hrs. The medium was then changed for the 
experimental conditions (AuNPs, PVP, AuPVP, AumPEG and mPEG). Cells were further 
incubated at 37
o
C in humidified 5% CO2 atmosphere and assessed for morphology and 
proliferation at periods of 24 and 48 hrs. After incubation period the cells were quantified 
for the number of cells in a single cell suspension using Coulter counter (Z Series Coulter 
Counter from Beckman Coulter). At this stage 50 µl of cells were suspended in 10 ml 
isotonic solution and the reading on the Coulter counter was taken three times. Finally, cell 
concentration was calculated as following: 
Cell concentration/ ml = cell count X dilution factor  
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Viability of cells was determined using  two  methods: Trypan blue exclusion method and 
flow cytometer. This is described in details in section 2.5.8. 
2.5.7 Cell morphology  
Cells were viewed under the light microscope to detect any signs of contamination early 
on. Furthermore, detachment of the cells from the substrate were also inspected under the 
microscope, to identify any deterioration of cells which will require a change of medium to 
further prevent deterioration. The cells were imaged after 24 and 48 hours incubation with 
modified and non modified AuNPs to show any changes in the morphology such as cell 
elongation. 
2.5.8 Cell Viability 
Cell viability was performed based on two methods: Trypan blue exclusion method using 
Haemocytometer (a) and automated cell counter (b), and propidium iodide (PI) staining 
using the FACs flow cytometer. The following sections ( 2.5.8.1, 2.5.8.2  and 2.5.8.3) give 
more details on the methods used for performing cell viability. 
2.5.8.1 Haemocytometer chamber  
The cell viability was determined  using the haemocytometer chamber and  counting the 
viable cell by a Coulter counter. Proliferation was carried out as described previously. 
Briefly, the cells were seeded and were added to 24 well plate along with 2 ml complete 
medium (10 % FBS). The cells were then incubated for 4 hours to allow cell attachment. 
After 4 hours complete medium was replaced with SPM (2.5% FBS) along with the 
different experimental conditions: AuNPs (2.9µg/mL ), AuPVP (2.9µg/mL ),  PVP 
(5.9x10
-7 
µM), AumPEG (2.9 µg/mL ) and mPEG (9.25x10
-9
) was added to each well. The 
cells were then washed with 10 ml of sterile PBS  and 150 µl of 1x trypsin was added to 
each well. A 25 µl volume of the suspension of the cells was mixed with 25 µl volume of 
trypan blue. Half of the mixture was then placed on the chamber. Finally the chamber was 
placed in the cell counter  to display the results of the viable cells in percentage. 
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2.5.8.2 Automated cell counter 
Cell viability was also determined using TC20 automated cell counter (Bio-rad, UK). 
Briefly, trypsinized cell suspensions in each well chamber were mixed with trypan blue in 
a 1:1 ratio. A 25 µl amount of the sample were inserted in a counting slide and placed in a 
slot on the TC20 cell counter. The cell counter provided a total cell count (with or without 
trypan blue staining) and cell viability was assessed via trypan blue exclusion method. 
  
2.5.8.3 Determining cell viability with propidium iodide (PI) staining using 
FACs flow cytometer 
A concentration of 1 x 10
6
/ml cells incubated in SPM or with the experimental conditions, 
was washed twice using 2 ml of PBS and centrifuged at 400 x g for 5 min in a 50 ml 
centrifuge tube. The buffer was then decanted and the pelleted cells were resuspended in 
500µL of PBS and placed in a FACs tube. The flow cytometer was then adjusted for the PI 
setting. Each tube containing the cells after SPM (positive control) or experimental 
condition was mixed with 5 µl of PI staining solution and left in the dark for 1 minute.  
Unstained cells were also used as negative control. The samples for the positive control 
were then determined for PI staining using the FL-2 or FL-3 channel on a FACScan
™
 
instrument. The data for unstained cells were also acquired. The viable cells for the PI 
stained samples prior to analysis were then set on stop count and examined on a forward 
scatter versus FL3( PI) dot plot staining. 
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    2.5.9 Confocal analysis of nanoparticle uptake via cells 
2.5.9.1 Cell membrane labelling  
BAEC membranes were labelled with a fluorescent cell linker kit PKH26 (red dye). 
Briefly, 2 x 10
6
 cells were washed with basal medium (without serum) and centrifuged at 
400 g for 5 min at room temperature. After discarding all the supernatant, the cells were 
gently re-suspended in 100 l of diluents. Immediately prior to staining, the dye working 
solution (2x) was added to 100 l of diluents and the dye mixture was added to the cells. 
After 5 min with periodic mixing of the cells in the dye solution, the staining was stopped 
by an equal volume of FBS and left for 1 min. Then, the fluorescent cells in complete 
medium were centrifuged at 400 g for 10 min. To minimize carryover of residual dye, the 
cells were transferred into a new sterile conical tube for further centrifugation at 400 g for 
5 min. Thus BAECs were ready to be used for confocal microscopy analysis after NP 
treatment. 
2.5.9.2 Cell Nuclei labelling 
PKH26 labelled BAEC were seeded at 1x10
5
 cells/ml in endothelial cell growth medium 
on chamber slides previously coated with 0.1% gelatine. Cells were incubated to allow 
seeding  for 4 hrs. The medium was then changed for the experimental conditions (AuNPs, 
PVP, AuPVP). Cells were further incubated at 37
o
C in humidified 5% CO2 for a period of  
30 min, 1hr and 18 hrs. After incubation each well was washed  with PBS 2x and fixed 
with 4% Paraformaldehyde for 10 min. The chambers were washed again with PBS and 
then mounted using DAPI mounting medium. An amount of 300 µl of the diluted DAPI 
solution (sigma) (1 µl DAPI in 5 ml of PBS) was added to each well, and incubated for 5 
min at room temperature. The coverslips where then washed again with PBS. The  
coverslips were then removed from the wells using fine tweezers and  mounted on a 
microscope slide. AuNP localization was visualised  with a  Zeiss fluorescent microscope. 
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2.6 Analysis of Cellular signalling pathways   
      2.6.1 Protein estimation for western blotting 
Determination of the amount of protein extracted from the cell lines for loading in western 
blotting technique was carried out using a Bradford-based assay. Bio-Rad protein dye was 
diluted according to the ratio of 1:5 in distilled water (2 ml). Stock 1% BSA was made up 
at 1 mg/ml (µg/µl) in distilled water as a standard protein and dilution were prepared as 
shown on Table 2.4. The amount of 10 µl protein lyses from each sample was added with 
90 µl of distilled water. The absorbance was measured at 580 nm. The standard curve 
(Figure 2.1) was calculated to determine the amount of the protein needed to be added.  
 
  
 
 
 
 
 
 
    
    
  
Stock 1% BSA (µg/µl)  in 
distilled water: Distilled 
water (µl) 
0:100 
10:90 
20:80 
40:60 
Table 2.4:  Dilution of BSA 
used for protein estimation 
 
Figure 2.1: The standard curve used to work out protein 
estimation 
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2.6.2 Western blotting 
BAECs were seeded in complete medium in a 24-well plate at a cell concentration of 
10
5
/ml/well. After 48 hrs incubation, the medium was renewed with serum poor medium 
(SPM; medium supplemented with 2.5% FBS) for further 24 hrs incubation, and then NPs 
were added for 30 min stimulation at 37°C. After fast washing in cold PBS, cells were 
lysed with 120 µl/well of ice-cold radioimmunoprecipitation (RIPA) buffer (pH 7.5) 
containing 25 mM Tris-HCl, 150 mM NaCl, 0.5% sodium deoxycholate, 0.5% SDS, 1 mM 
EDTA, 1 mM sodium orthovanadate (EGTA), 1 mM phenylmethylsulfonyl fluoride 
(PMSF), 1% Triton X100 and 1 µM leupeptin. Thirty µg of proteins were mixed with 2x 
Laemmli sample buffer, denatured by boiling in a water bath for 15 min then centrifuged. 
Samples were separated along with pre-stained molecular weight markers by 12% SDS-
PAGE. Proteins were electroblotted onto nitrocellulose filters (1 hr) and the filters were 
blocked for 1 hr at room temperature in TBS-Tween (pH 7.4) containing 1% BSA. Filters 
were stained with the following primary antibodies diluted in the blocking buffer, 
overnight at 4°C on a rotating shaker: rabbit polyclonal antibodies to total extracellular 
signal-regulated kinase 1/2 (t-ERK1/2), goat polyclonal antibodies to total Akt (t-Akt, 
1:1000) mouse monoclonal antibodies to phopsho-ERK1/2 (p-ERK1/2, Tyr204 of ERK1, 
1:1000) and rabbit polyclonal antibodies to p-Akt-1/2/3 (Thr308, 1:500) from Santa Cruz 
Biotechnology. After washing (5x10 min in TBS-Tween at room temperature), the filters  
were  stained  with either goat anti-rabbit, rabbit anti-goat or rabbit anti-mouse horse-
radish peroxidase-conjugated secondary antibodies diluted in TBS-Tween containing 5% 
de-fatted milk (1:1000, 1 hr, room temperature) with continuous mixing. After a further 5 
washes in TBS-Tween, proteins were visualised using ECL chemiluminescent detection 
(Geneflow Ltd, Staffordshire, UK) then analysed using GeneSnap software (Syngene, 
Cambridge, UK). 
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2.7 Analysis of Cell death 
2.7.1 Induction of Apoptosis and  quantification using Annexin V-FITC  
detection kit 
Apoptosis was induced by the use of staurosporinse, a potent inhibitor (Sigma Aldrich, 
UK).  Briefly, in bijoux, 2 µl of staurosporine was mixed with 2 ml of DMSO and was 
later incubated with the BAEC for 2 hrs. This negative control was conducted to determine 
whether cells underwent apoptosis after exposure to modified and non-modified AuNPs 
along with their stabilisers after 2 and 24 hrs. The cells were stained as described in the 
Annexin V FITC Apoptosis Detection Kit (Sigma Aldritch, UK). The percentage of 
apoptotic cells per sample was determined using the FACs analysis. The samples were 
analysed in triplicate. 
2.8 Cellular uptake of AuNPs 
The fate of internalized particles in BAECs was determined by TEM. TEM preparation 
was as follows. BAECs were incubated with 2.9 µg/mL  modified and non-modified 13 nm 
AuNPs for 30 mins, 2 hrs, 24 hrs and 48 hrs and afterwards were fixed in a solution of 
 5 ml of 2% paraformaldehyde in 0.1 M PBS (5 ml). The cells were then taken to EM 
Wellcome Trust facility at the University of Manchester, for  ultrathin sectioning  and 
TEM imaging. 
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2.9 Vascular function study of rat aortic rings using organ bath system 
The adult male rat’s heart and associated vessels were placed in a dissecting dish 
containing gassed PSS to keep the tissue viable.  The aorta was then isolated from the heart 
and carefully the tissue surrounding the vessel was removed under a dissecting 
microscope,  3-4 mm  length segments of aortic ring were then cut, and suspended between 
2 fine steel wires, connected to a Harvard isometric transducer in an oxygenated bath 
chamber (Figure 2.1 and Figure 2.2) containing PSS. The segment was then loaded 
passively to 2g tension for 1hr to equilibrate. The vessel was then preconstricted with 
KPSS and subsequently dilated with both the endothelium-dependent dilator ACh, and 
independent dilator SNP. Data were recorded on a computer using the software lab chart 7 
(Powerlab system, AD Instruments, UK) (Figure 2.3).  Endothelium dependent relaxation: 
Aortic rings were constricted in high potassium solution then dilated at 5 different 
cummulative concentrations of ACh 10
-2
 to 10
-5 
mol, then incubated with NPs (30 min) and 
procedures were repeated after NP washout. 
 
 
 
         
 
 
 
 
 
  
 
 
 
 
   Figure 2.2: Dissection of an aortic ring mounted in an oxygenated organ bath chamber 
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Endothelium independent dilation: The same protocol as ACh was followed. However 
vasodilator SNP (10
-1
to 10
-5
 mol) was studied, before and after NPs. The concentration of 
NPs was calculated (see table 2.4). 
 Figure 2.3: Schematic image of organ bath setup 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: An example of data recorded on a computer using the software lab chart 7 (Powerlab system, 
AD Instruments, UK). 
Key : 
A) 2g tenstion  B) Kpss C) PSS D) ACh Dose resonse E) 30 minutes Incubation  
     E 
 B 
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   D 
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D 
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Table 2.5:  Calculated surface area and mass of nanoparticles and stabilisers to be 
added to each experiments  
Type of Nanoparticles / 
Stabilisers  
Surface 
area /unit 
mass (m
2
) 
No of particles in organ 
bath (particles/ml) 
Mass of NPs 
added (µg/mL 
) 
Silica NPs (TMNA, 100nm) 
 
3.09X10
-14
 1.1 x 10
11
  200ug/ml 
PVP- and mPEG-modified 
and non- modified AuNPs  
 
4.52x10
-12
 
 
 
 
1.698x10
11
 2.9ug/mL 
 
Double concentration of 
mPEG  modified AuNPs 
 
4.52x10
-12
 
 
 
3.396x10
11
 5.8ug/mL 
 
PVP alone: 
Maximum concentration  
used to modify AuNPs 
 
Minimum concentration used 
to modify AuNPs 
 
 
- 
 
 
 
 
- 
 
 
76ug/mL 
 (9.5x10
-6
uM) 
 
4.75ug/mL 
(5.9X10
-7
uM) 
PEG alone   
 
mPEG alone  
 
- - 0. 0011 ug/mL 
(1.84x10
-10
 uM) 
0.074ug/mL 
(9.25x10
-9
 uM) 
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2.10 Tissue fixation and transmission electron microscopy analysis of 
nanoparticle uptake 
TEM was performed to characterise the physical properties of AuNPs and to determine 
particle sizes, and also to visualise the uptake of AuNPs by the whole aortic vessel. After 
each aortic functional study, the vessels were fixed in solution containing 2.5% 
glutaraldehyde in 0.1M sodium cacodylate buffer, pH 7.3 and were allowed to stand in 
solution for 30 min at 22
o
C, and were then washed in buffer. The samples were postfixed 
with reduced osmium (1% OsO4 + 1.5% K4Fe(CN)6) for 1 hour, then dehydrated in a series 
of alcohols (ethanol), infiltrated with TAAB LV resin and polymerised for 24 hours at 
60˚C. Ultrathin 70nm sections were cut with Leica ‘Ultracut S’ ultramicrotome and placed 
on copper grids. The grids were observed in Tecnai 12 Biotwin TEM at 80kV.TEM 
sectioning was carried out at Manchester University  
2.11 Statistical analysis 
Results for both cellular and vascular studies are expressed as mean ±S.E.M (standard 
error mean). One way anova with Bonferroni correction was used to test for statistical 
significance (p<0.05 taken as significant). The calculation for percentage dilation response 
of ACh and SNP are calculated as: 
(Maximum tension after constriction) – (tension after relaxation) x100 
                             (Maximum tension after constriction) 
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  3. Chemical characteristics of synthesised nanoparticles 
3.1 Characteristics of synthesised nanoparticles  
A number of nanoparticles (NPs) were fabricated (silica, gold), and surface modified. The 
NPs were characterized (stability, size, charge) using Ultraviolet-visible (UV-vis) 
spectroscopy, Malvern’s Zetasizer, transmission (TEM) and scanning electron microscopy 
(SEM). The structures of the functionalised NPs were also determined by infra-red Fourier 
transform spectroscopy (DRIFTS), Surface Enhanced Raman Spectroscopy (SERs) and 
Thermogravimetric analysis (TGA). The energy dispersive X-ray spectroscopy (EDAX) 
was employed to determine the sample’s composition. This chapter will describe the 
results obtained from the NPs analysis. 
 
3.2 Characteristics of synthesised Silica nanoparticles 
Silica NPs were firstly fabricated using methods from previous studies (See Appendix A: 
Table 2).  The methods were then further modified, and attempts were performed twice to 
show repeatability. These methods were conducted to show the influence of modifying 
certain parameters during the NP synthesis. 
 
The attempt of Geishe method for fabricating non-dye doped (100 nm) NPs at 60
o
C 
resulted in particles double the expected sizes (200.65±35.65 nm). van Bladdern and Viraj 
(1992) method for the synthesis of 110 nm NP resulted in the formation of NP 
hydrodynamic size of 618±45.8 nm. While, van Bladdern et al (1992) method resulted in 
the formation of 371.7±10.3 nm. Then dye doped silica NPs were fabricated using the 
same methods (van Bladdern and Viraj, 1992; van Bladdern et al, 1992) for synthesising 
non-dye doped silica NPs, with the inclusion of 3-aminopropyltrimethoxysiliane (APS) 
attached rhodamine B isothiocyanate (RH) dye. Result shows an increase in diameter when 
RH dye was included. This is due to the APS molecules that are coupled to the dye, as they 
contain silane groups. The dye doped silica NPs synthesised using van Bladdern and Viraj 
method gave particles with hydrodynamic diameter of 913.7±52.7, while van Bladdern et 
al method produced particles >1000 nm. Overall, obtaining small size of particles as 
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demonstrated by van Bladdern et al (1992) was difficult. Obtaining small particle sizes is 
difficult but can be achieved more easily using the microemulsion method. 
 
NPs were synthesised using the Stöber method; furthermore, during synthesis a number of 
factors were manipulated, including the molar ratio of reagents, pHs, surface charge and 
temperature. NPs were then characterised in water and PSS, to show the influence on the 
particle diameter. The following section illustrates the results obtained (See Appendix A: 
Table 3).  
 
3.2.1 The influence of surface charge on the hydrodynamic diameter and zeta 
potential of Silica nanoparticles 
The influence of surface charge on the hydrodynamic diameter and zeta potential of 
nanoparticles in H2O and physiological salt solution was determined. The seeded growth of 
the NPs used excessive water and ethanol during synthesis. The following result was 
obtained: 
 
The TEM images of the SiNPs (sample TMRHSI),  showed spherical monodispersed NPs, 
of 113±12 nm in diameter (Figure 3.1 (B)). The hydrodynamic size, determined by DLS, 
was slightly larger at  125 nm in diameter. When the sample was dispersed in PSS, the 
DLS size increased further to 145 nm  diameter. Result shows that the zeta potential did 
not change dramatically compared to NPs dispersed in water. However, the APS surface 
modified sample of TMRHSI aggregated in both water and ionic salt solution (PSS) (the 
zeta potential was 9.23 and 5.42 mV,  respectively)  (See Appendix A: Table 3). This 
observation shows that surface charge can influence stability of particles.    
3.2.2 Effect of pH alteration on Silica particle size   
It was necessary to investigate the effect of pH alteration on NP size and stability. The 
results show that altering the pH had an influence on the stability of the NPs (See Appendix 
A: Table 3). The zeta potentials of both dye and non-dye doped 100 nm silica NPs either 
modified or non-modified with APS, were determined in water and physiological salt 
solution (PSS). The results show that there is a difference in stability for non APS surface 
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modified dye doped  particles (TMRHSI-) in water suspension after pH alteration from 
8.64  to 7.4 (zeta potential values before -49.8 and -30.2 after). A similar observation was 
detected, when dispersed in PSS (zeta potential values before was -37.8 and after it was -
23.6 mV) (Appendix A: Table 3). At this range, particles remained stable. Once the dye 
doped NPs were functionalized with APS, the TMRHSI+ characteristic were altered. The 
hydrodynamic diameter of the NPs were affected, giving a size of 187 nm compared to non 
APS functionalised NPs at 125 nm in water. Whereas in PSS, the APS modified NPs 
doubled in size giving a diameter of 256 nm, compared to non-APS modified NPs (145 
nm). This shows an increase diameter by a 100 nm. On the other hand, altering the pH did 
not  affect the stability of the APS modified dye doped  NPs. Similar observations were 
seen for  the APS modified silica NPs (TMNA 100+ and TMNA 200+) after 
characterisation in PSS (340.1 nm and 712.8 nm respectively) (Table 3.1). 
 
3.2.3 Production of 100nm silica NPs from a minimum amount of ammonia    
and H2O   
A method was adapted from Stöber to produce 100 nm SiNPs. The NPs were produced 
from a reaction of ETOH and concentrated ammonia without H2O added in the process. 
These samples were named RH28. The hydrodynamic size and zeta potential of the NPs in 
H2O and PSS was also recorded and the effect of adding ethanol and ammonia alone 
during NPs synthesis was determined. The size of NPs obtained (Figure 3.1 D) by SEM 
indicated that the particles were 100 ±7 nm. Hence this method was the most desirable of 
all methods for producing 100 nm.  
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3.2.4 Determining the nanoparticles sizes using DLS  vs. Microscopy  
The dimension of NPs can be observed using different techniques; here the size and 
hydrodynamic diameter was investigated with SEM and DLS respectively.  
 
 
Table 3.1: Determination of nanoparticles sizes using DLS vs. Microscopy and the effect of 
surface modification on the hydrodynamic diameter and zeta potential of silica nanoparticles 
(Akbar et al, 2011). (Key: -With out APS, + With APS). 
 
 
 
 
 
Nanoparticles 
 
 
Nanoparticles Size   (nm) 
 
 
 
Zeta potential (mV) 
 
Microscope 
(SEM) 
 
Hydrodynamic diameter  
(DLS) 
 
 
TMNA 100- 
 
TMNA 100+ 
 
TMNA 200- 
 
TMNA 200+ 
 
RH28 
 
 
 
97±7.60 
 
         - 
 
197±7.50 
 
- 
 
 
100 ±7 nm 
 
In H2O 
 
103.0 
 
135.6 
 
201.6 
 
259.4 
 
110.0 
In PSS 
 
106.0 
 
340.1 
 
194.0 
 
712.8 
 
127 
In H2O 
 
-44.50 
 
66.90 
 
-50.00 
 
25.50 
 
-48.2 
In PSS 
 
-28.80 
 
5.45 
 
-21.50 
 
1.90 
 
  -29.5 
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3.2.5 Scanning electron microscopy to clarify the sizes of silica nanoparticles   
The silica NPs were fabricated according to the Stöber method. Some silica NPs were 
doped with RH and others without. Particle sizes were determined using SEM images and 
the Malvern’s Zetasizer. The SEM indicated that the APS molecules coupled to RH caused 
the particle size to increase. Silica particles without dye gave a size <100 nm
 
(83±7 nm) 
whereas with dye the size increased to 113±12 nm (Figure 3.1 A & B). The SEM also 
identifies the sizes of NPs from modified methods to produce 100-200 nm with dyes 
(Figure 3.1 C-E). The APS molecules are used to covalently attach the dye molecules to 
the silica NPs. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Scanning electron microscopy image of  silica nanoparticles of (A) TMSI (100nm) non-dye 
and (B) TMRHSI (100 nm) with dye, (C) TMNA ( 100nm)  with dye (D) RH28 with dye and  (E) TMNA 
(200 nm) with dye 
B 
C 
A 
E D 
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The SEM images in Figure 3.1 confirm the fabrication of colloidal monodispersed SiNPs 
of close size distribution. The SEM images of silica NPs shows the sample of TMSI non-
dye with size distribution of 83±5 nm (Figure 3.1A), the TMRHSI with dye of size 
distribution of 113.6 ±12 nm (Figure 3.1B); the TMNA (100 nm) sample with the size  
distribution of 97.9 ±9 nm (Figure 3.1C) and RH28 with dye with the size  distribution of 
100 ±7 nm (Figure3.1D). Lastly TMNA (200 nm) have a  size distribution of 194±9 nm 
(Figure 3.1E). 
  
Comparing the sizes of the particles obtained from the SEM to those obtained by DLS, it 
was interesting to observe that sizes were larger by DLS. The particles (TMSI) sample 
without the dye, gave a reading of 103 nm. However, the size was less when characterised 
with the SEM 83±5 nm (Figure 1.3A). When the silica NPs were doped with RH dye the 
size distribution shifted, indicating that the particle sizes increased. Similarly, the DLS 
reading also indicated that the particles increased to 125 nm for TMRHSI sample. The zeta 
potential measurement for particles in Figure 3.1A and Figure 3.1B were proven to be 
stable  in H2O (-80.1 and -49.8 mV, respectively) (see Appendix A: Table 3). 
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3.2.6 Determination of dye present using fluorescence spectroscopy  
The fluorescence spectroscopy of the samples prepared with dye (TMNA and RH28) 
indicates that RH dye is present. Absorption of light at 500-600 nm wavelengths renders 
the colour of the substance red. Thus, our absorption spectra show a peak obtained at its 
expected wavelength, indicating that the dye is present (Figure 3.2).   
 
  
 
Figure 3.2: The fluorescence spectroscopy indicating the presence of rhodamine B isothioscyanate dye in 
samples (A) RH28 and (B) TMNA 
 
A) 
B) 
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3.3 Characteristics of synthesised gold nanoparticles  
3.3.1 Transmission electron microscopy of modified and non-modified 
AuNPs 
TEM was used to verify the size of the particles. The following images obtained confirm 
the spherical shape of non- modified AuNPs (Figure 3.3 A) synthesised using Turkevich 
method. The particles were surface modified with PVP (Figure 3.3 B) and mPEG (Figure 
3.3 B). Both polymers caused a wider distribution of particles when compared to non-
modified AuNPs. Furthermore, the image shows that the polymer did not affect the 
spherical structure of AuNPs. The scale bar on the image was used to calculate the 
particles size, where the individual particles were < 15 nm.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.3:  TEMs shows the distribution of monodispersed black dots which are the non-modified 
AuNPs, modified AuNPs with b) PVP and c) mPEG 
 
B 
C 
A 
20 nm 
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3.3.2 Determining the stability of modified and non- modified AuNPs in 
H2O, complete media and PSS   
UV-vis spectra (Figure 3.4A) demonstrated that AuNPs are stable in the presence of H2O. 
The surface Plasmon absorption spectra (SPR) trace existed at ~500 to 600 nm wavelength. 
This is present only for particle size of <50 nm. However, when exposed to PSS media the 
peak shifted, therefore indicating particle aggregation. When AuNPs were modified with  
both PVP (Figure 3.4 (B) and Figure 3.5 (C)) and mPEG (Figure 3.6 (1)) the absorption 
spectra gave the surface Plasmon resonance (SPR) band at ~500-600nm wavelength in 
water and in PSS, whereby the peak did not shift. Indeed, analysis indicates that AuNPs are 
very stable after being coated with polymers. After showing that gold alone aggregated in 
PSS, both PVP (Figure 3.4 C) and mPEG (Figure 3.6 (1) and (2)) stabilizers and 
demonstrated reduce aggregation of the gold particles in PSS as well as complete media. 
The polymers PVP and mPEG were used in this study because research has shown that 
these polymers have favourable properties i.e. preventing aggregation and are also 
biocompatible. 
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Figure 3.5:  Image of AuNPs in solution (A) non-modified AuNPs in water ( B) non-modified AuNPs  in 
physiological salt solution showing colour change due to aggregation, (C) PVP modified AuNPs in water 
and (D)PVP modified AuNPs  in PSS. 
 
A 
 
B C D 
A B 
C 
Figure 3.4: (A) Absorption of AuNPs in PSS and H2O (B) Absorption of Au (PVP) NPs in PSS and 
H2O (C) Absorption of Au (PVP) NPs in PSS and H2O and complete media 
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Figure 3.6: 1) Spectra of AuNPs, AuPVP, in H2O DMEM complete  medium and PSS 2) Image of gold 
nanoparticles in solution (A) mPEG  modified in complete media, (B) PEG  modified in PSS media, (C) 
non-modified AuNPs showing a colour change ( aggregation) in physiological salt solution. 
 
 
 
(1) 
(2) 
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3.3.3 Quantification of the relative amount of metal in the 
modified and non-gold Nanoparticles 
3.3.3.1 Energy-dispersive X-ray spectroscopy analysis   
EDAX analysis was used to determine the elemental composition of the AuNPs sample 
(Figure 3.7). The EDAX instrument is attached to an SEM that is not able to visualise the 
small AuNPs due to magnification limits. The result confirms presence of elemental gold 
within the sample, hence confirms reliability of AuNPs synthesised. The element Au 
defines gold, Na and Cl from the stabiliser sodium chloride and the Al observation peak is 
from the aluminium stub used to place the sample on for analysis.  
 
 
   Figure 3.7: Energy-dispersive X-ray spectra of AuNPs 
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3.3.3.2 Inductively-coupled plasma mass spectrometry 
The ICP indicated that the relative amount of gold contained within a 300 µL AuNPs 
sample was 48.46 ppm, while 600 µL AuNPs sample contained 88.60 ppm. These results 
were used to quantify the actual concentration of AuNPs within the physiological solution. 
The actual concentration of AuNPs within the organ-bath was calculated (ppm/ mL) by 
considering the dilution factor. Furthermore, the uptake concentrations were expressed as 
percentage. The detail explanation of the vascular uptake of AuNPs is expressed in Chapter 
5 Section 5.5 (Figure 3.8, see Appendix A: Table 4). 
 
 
Figure 3.8: Cellular uptake of modified and non-modified gold nanoparticles (N=3) as determined by 
ICP-MS. Control is calculated as total PPM per mL  
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3.3.4 Assessments of functional groups on Gold Nanoparticles 
3.3.4.1 Thermogravimetric analysis 
Thermogravimetric analysis (TGA) was used to determine the presence of PVP on AuNPs 
by their thermal decomposition. The figure below provides the TGA for PVP modified 
AuNPs and PVP alone (Figure 3.9). Samples were heated at the rate of 10 °C per min from 
room temperature to 990°C under nitrogen flow. The initial weight loss observed is due to 
oligomers that have lower molecular weight, the most common is the loss of water from 
the moisture absorbed on the sample. Furthermore, residual solvents may be present within 
the sample. The second weight loss that occurred in PVP alone in the region of 200 to  
430 °C is suggestive of the degradation of pure PVP polymer. In the PVP modified AuNPs 
sample, there was an initial weight loss of -40 % from 150 to 180°C due to water 
evaporation. The weight loss at approximately 280 to 460 °C and further at 460 to 560 °C 
may be due to the decomposition of PVP molecules that are attached on the AuNPs. One 
can notice a different behaviour between the PVP alone and PVP modified AuNPs. PVP 
alone degraded at a faster rate as compared to PVP modified AuNPs. This higher 
temperature for polymer decomposition suggest that gold has improved its thermal 
stability. The weight loss above 800 °C is due to the gold decomposition.  
 
 
 
 
 
 
 
 
 
 
Figure 3.9: TGA analysis of PVP modified AuNPs and PVP alone. Samples were heated at 10 °C heating 
rate from room temperature to 1000 °C under nitrogen flow 
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3.3.4.2 Surface Enhanced Raman Spectroscopy 
The spectra (Figure 3.10) show  the vibration frequency (cm
-1
) of the functional groups on 
AuNPs. It identifies the peaks of the groups present within the AuPVP and Au mPEG,  and 
the types of bonds present.This shows that  the AuNPs are functionalised, as the 
wavelength of the functional groups are identified and demonstrated to be present.The 
results indicate the shifting of C=O peak from 1521 cm
-1
 in the citrate stabilized Au NPs to 
1649 cm
-1
, which is  attributed to the hydrogen bonding between the mPEG and the citrate 
ligands.  The peak  was shifted  to 1609 cm-1 after the surface was stablised with PVP. 
 
 
Figure 3.10: The SERs spectra showing  the vibration frequency (cm
-1
) of the functional groups on (A)   
AuNPs, (B) AumPEG and (C) AuPVP 
A 
B 
C 
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3.3.4.3 Diffuse reflectance infra-red Fourier transform spectroscopy        
analysis of the functional groups within the gold nanoparticles. 
 DRIFTS analysis was carried out to determine the successful attachment of the polymer 
stabilisers PVP and mPEG on the AuNPs. This analysis is crucial to determine the 
functional groups present on the modified AuNPs. Appendix A: Figure 12 shows the 
DRIFTS spectra of (i) PVP (ii) PVP modified AuNPs (iii) mPEG and (iv)  mPEG modified 
AuNPs. These signatures may be recognized as C=O (1660 cm
−1
) and C\N (1200 cm
−1
) in 
PVP, mPEG are recognised by the thiol groups (-SH). The spectrum (see Appendix A&B: 
Figure 12) illustrates the functionalization of citrate reduced gold NPs with PVP in the 
form of shift of C=O stretching from 1650 cm
−1
 to 1641 cm
−1
. This may be attributed to 
the formation of intermolecular hydrogen bonding. Interestingly, analysing the AuNPs 
complex a distinct absorption bands at 3342.47, 2109.78 and 1634.55cm
-1
 were observed. 
The C=O peak from 1637 cm-1 is due to the citrate stabilized AuNPs. This stretch 
indicates the presence of sodium citrate (see table below). The evidence of  PVP and 
mPEG functionalised on AuNPs is also supported by SERs (Section3.44.2) and UV–vis 
spectroscopy (section 3.3.2). 
 Table 3.2 : the peaks representing the groups contained within the modified and non-
modified AuNPs .  PVP and PVP modified AuNPs show similar peaks and mPEG  and  
AumPEG represent similar peaks. 
 
 
 
 
 
 
 
 
 
PVP  AuPVP mPEG AumPEG AuNPs 
Wavelength 
(cm-1) 
Bond Wavelength 
(cm-1) 
Bond Wavelength 
(cm-1) 
Bond Wavelength 
(cm-1) 
Bond Wavelength 
(cm-1) 
Bond 
1650 C=O 1600 C=O 2882 -SH 2924 CH2 3342 O-H 
2950 CH2 2924 CH2 2860 CH2  
 
1100-1600 C-
O/C-
C 
1634 C=O 
3409 N-H 3370 O-H 1100-1466 C-O/ 
C-C 
3370 O-H 2109 CH2 
1200-1433 C-N/C-
C 
1200-14720 C-N/C-C - - 1641.1 C=O - - 
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4. Influence of modified and non-modified gold 
nanoparticles on cellular function 
4.1 Influence of  Gold Nanoparticles on Cell proliferation  
In order to optimize and examine the effect of modified and non- modified NPs 
on BAEC proliferation, the cell growth was reduced by exposing the cells to 
serum-poor medium (SPM). The cell number was determined using an 
automated Coulter counter (Beckman-Coulter). 
 
In the absence of NPs, there was no significant change in cell proliferation after 
48 hrs incubation, as compared with the control (untreated condition) obtained 
after 24hrs. The addition of unmodified AuNPs (2.92 µg/mL ) to SPM, 
decreased the cell proliferation after both 24hrs and 48hrs significantly 
(p<0.001 and  p=0.01, respectively). When the  BAECs were exposed to  PVP 
modified AuNPs (2.920 µg/mL ) after 24hrs and 48 hrs, a significant inhibition 
was observed (p<0.01 and p<0.001, respectively (N=3)(Figure4.1). 
 
Similarly, there was a significant inhibition in cell proliferation when BAEC 
were exposed to PVP (2.04x10
-7
 g/ml)(p<0.01), PEG (4µg/mL )(p=0.01), 
mPEG (7.4X10-8g/ml)(p<0.001) and  AumPEG (2.920 µg/mL ), (p<0.001) 
after 24hrs (Fig 5.1). There was a significant decrease in cell proliferation after 
48 hrs cell treatment with AuPVP (p<0.001), PVP (p<0.01),  PEG (p<0.05), 
mPEG (p<0.01) and AumPEG ( p<0.001), when compared to the untreated 
cells after 48 hrs (See Appendix B: Table 1). 
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Figure 4.1: The cell proliferation after exposure to modified and non-modified AuNPs and their 
stabilisers after 24 hours and 48 hours incubation The results are presented as the mean ± SD. 
Differences at *p<0.05,**p<0.01 and ***p<0.001 are considered statistically significant. 
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4.2 Determining the Cell viability after incubation with modified 
and non-modified gold nanoparticles 
 
Determination of the cell viability was based on 2 methods: Trypan blue 
exclusion method using Haemocytometer (a) and Automated cell counter (b) 
and  propidium iodide (PI) (1 μL of the 100 μg/mL) staining using the  FACs 
flow cytometer. 
 
Cell viability, expressed in percentage, indicates the number of living cells 
(unstained cells) out of the total cell number (living and dead cells).  The 
addition of modified and non-modifed AuNPs to SPM for 24 hrs did not 
significantly change cell viability, except PVP and AumPEG which decreased 
viability by 20% and 10% respsectively, compared with the control. At the end 
of 48 hrs. cell treatment, AuPVP and PEG decreased viability by 20% and 25% 
when compared to control (Figure 4. 2A, see Appendix B:Table 2).   
  
  
 
 134 
    4.2.1 Determination of Cell viability using the Haemocytometer   
 
 
 
 
   
 
Figure 4.2A: The viability of cells after exposure to modified and non-modified AuNPs and their 
stabilisers at 24 hours and 48 hours incubation using haemocytometer. The results are presented as the 
mean ± SD. Differences at *p<0.05, **p<0.01 and ***p<0.001 are considered statistically significant. 
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4.2.2 Determination of Cell viability using the Automated Cell Counter  
In the absence of NPs, no change in cell viability was observed after 48 hrs 
incubation in SPM, compared with the control (obtained after 24 hrs 
incubation). Among modified and non-modified NPs, the addition of AuPVP to 
SPM for 24 hrs significantly decreased cell viability by 15%, compared with 
the control. At the end of 48 hrs of cell treatment, AuPVP and PEG 
significantly decreased viability by 40% and 25%, compared with the control, 
respectively(Figure 4.2B, see Appendix B:Table 3). 
 
    * 
Figure 4. 2B: The viability of cells after exposure to modified and non-modified AuNPs and their 
stabilisers after 24 hours and 48 hours incubation using automated counter. The results are 
presented as the mean ± SD. Differences at *p<0.05,**p<0.01and ***p<0.001 are considered 
statistically significant. 
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4.2.3 Determination of Cell viability using Fluorescence-activated 
cell sorting (FACS) flow cytometer 
We determined the viability of the BAEC by Fluorescence-activated cell 
sorting (FACS)    after cell treatment with modified and non-modified NPs 
along with their stabilisers for 30 min, 2 hrs, 24 hrs and 48 hrs In the absence 
of NPs, short (30 min and 2 hrs) and long (24 hrs and 48 hrs) time exposure did 
not have a significant effect on cell viability, compared to control (untreated 
cells). The addition of non-modified and modified NPs to SPM for 24 hrs 
significantly decreased cell viability by about 20%, compared to the control 
(untreated cells after 30 min incubation and 24 hrs incubation). In addition, at 
the end of 48 hrs treatment, the addition of NPs did not change cell viability, 
except AuPVP which induced 14% and  13% decrease in cell viability, as 
compared to both controls (Untreated cells after 30 min and 24 hrs 
incubation)(Figure 4.2C, see Appendix B: Table 4). 
 
 
 
Figure 4.2C: The viability of cells after exposure to modified and non-modified AuNPs and their 
stabilisers at 24 hours and 48 hours incubation using FACs flow cytometer. The results are presented 
as the mean ± SD. Differences at *p<0.05,**p<0.01 and***P<0.0001 are considered statistically 
significant. 
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4.3 Determination of Apoptosis and necrosis 
The apoptotic and necrotic status of BAEC was determined by flow cytometric 
analysis through fluorescein Annexin V-FITC and PI double staining. 
Untreated cells were established as a negative control and staurosporine, a 
protein kinase inhibitor, was used as a positive control for  induction of 
apoptosis. The four quadrants plot were analysed as follows: cells in the lower 
left quadrant (Annexin-negative/PI-negative) indicate relative amount of living 
cells (Figure 4.3a and Figure 4.4a). Cells in the lower right quadrant (Annexin-
positive/PI- negative) indicate early apoptotic cells and the cells in the upper 
right quadrant (Annexin-positive/PI-positive) indicate late apoptotic and 
necrotic cells (Figure 4.3b & Figure 4.4b Figure 4.4c). The cell treatment with 
staurosporine after 2 hours induced early apoptosis by 59.30% of BAEC 
population and necrosis by 39.68% (Figure 4.4c), as compared to the negative 
control (defined by 3% early apoptotic cells and by 15.90% necrotic cells 
(Figure 4.3a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NEGATIVE CONTROL 
 
 
Figure 4.3: Flow analysis of non-induced BAEC cells after incubation 
with cell media (negative control)    stained with a) Annexin-negative/PI-
negative and b) Annexin-positive/PI-positive  
 
a                                                           b 
Figure 4.4: Flow analysis of Staurosporine (1µg/ml) (Positive control) induced BAEC cells 
and stained with a) Annexin-negative/PI-negative, b) Annexin-positive/PI-negative and c) 
Annexin- positive /PI-positive  
   a                                               b                                                         c 
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4.3.1 Induction of BAEC apoptosis and necrosis after incubation 
with modified and non-modified AuNPs and their stabilizers 
The flow cytometer determined the viability, apoptosis and necrosis of BAEC 
after 2 hrs and 24 hrs cell treatment with different NPs. In this experiment the 
non-treated cells were established as a negative control, at both 2 hrs and 24 
hrs incubation. The four –quadrant plots are output data obtained from the flow 
cytometer analysis software (Figure 4.5). 
 
Figure 4.5: Flow analysis of untreated (control) and treated 
BAEC cells with modified and non-modified and their 
stabilizers at 2 hrs and 24 hrs. The cells are stained with 
Annexin- positive /PI-positive 
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      4.3.2 Apoptotic Cells 
The percentage of apoptotic cells was measured 2 hrs and 24 hrs after NP 
incubation, (N=3). The results show that there is a significant difference in the 
percentage of apoptic cells between the untreated and treated cells with all 
formulations. However, AuNPs, PVP and mPEG treatment led to greater 
percentage of apoptotic cells (41.17± 15.82(p<0.01), 41.62±6.06 (P<0.001) and 
35.05±7.9% (p<0.001) respectively, after 2 hrs incubation. Interestingly, a 
significant difference in percentage of apoptosis after incubation in modified 
and non modified AuNPs and their stabilisers was observed when compared to 
24 hrs control. Furthermore, AuPVP had a greater increase in percentage 
number of apoptotic cells (37.47±14.14% (p<0.001) (Figure 5.6). There was a 
reduction in the % number of apoptotic cells after 24 hrs incubation with non-
modified AuNPs when compared with 2 hrs incubation but this was not 
significant (p=NS). Moreover, no overall significant difference in the degree of 
apoptosis was observed between 2 hrs and 24 hrs incubation (Figure 4.6).  
 
Figure 4.6: Effect of modified, non-modified and their stabilizers on the progressive of 
apoptosis of BAEC after 2 hrs. and 24 hrs. The results are presented as the mean ± SD. 
Differences at *p<0.05, **p<0.01 and ***p<0.001 are considered statistically significant. 
 
  
 
 140 
4.3.3 Necrotic Cells 
From the four –quadrant plots (Figure 5.3) the percentage of necrotic cells was 
determined 2 hrs and 24 hrs after cell treatment. There was  a difference  in 
terms of  percentage of necrotic cells between the untreated and treated cells 
with AuNPs, AuPVP and AumPEG at either 2 hrs or 24hrs incubation but this 
was not significant. However, the exposure of the cells to PVP for 2 hrs 
resulted in an increase in necrotic cells by 3.0-fold (p<0.01), while PVP pro-
necrotic effect was reduced at the end of 24 hrs incubation, when compared to 
the PVP treated cells after 2hrs incubation (p<0.05). At the end of 24 hrs of cell 
treatment AuPVP, PVP and mPEG significantly increased necrotic cells by 
28.35±2.97% (p<0.05), 23.81±1.42 % (p<0.05) and 35.33±3.79% (p=0.01) 
respectively, compared with the control after 24 hrs (Figure 4.7). 
 
 
 
Figure 4.7: Effect of modified, non-modified and their stabilizers on the progressive of necrosis of 
BAEC after 2 hrs and 24 hrs. The results are presented as the mean ± SD. Differences at *p<0.05 
and **p<0.01 are considered statistically significant. 
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4.4 Influence of Nanoparticles on Cell morphology  
BAEC morphology was analysed after 24 hrs and 48 hrs cell treatment with 
modified and non-modified NPs. The cells treated with most of the NPs did not 
change the standard polygonal shape of the cells, as observed in untreated cells. 
However, the cells treated with PVP displayed an elongated shape after 24 hrs 
(Figure 4.8A) and 48 hrs incubation (Figure 4.8B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8A: Photomicrograph representing modified and non-modified 
AuNPs and their stabilisers on BAEC morphology after 24 hours 
exposure,  where: (A) control cells,  (B) 2.920 µg/mL  AuNPs, (C) 2.920 
µg/mL  AuPVP,  (D) PVP ( 5.9X10
-13
M), (E) PEG and (F) AumPEG 
(100x magnification). PVP, but not PEG, caused elongation of the cells 
(inset). 
 
 
  
B A 
D  
F E 
) PVP C) AuPVP 
   ) AumPEG ) PEG 
) Control ) AuNP 
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Figure 4.8B: Photomicrograph representing modified and non-modified 
AuNPs  on BAEC cell morphology after 48 hours exposure,  where: (A) 
control cells, (B) 2.920 µg/mL  AuNPs, (C) 2.920 µg/mL  AuPVP, (D) 
PVP (5.9X10
-13
M) E) PEG and (F) AumPEG (100x magnification). 
PVP, but not PEG, caused elongation of the cells (inset). 
 
 
E 
 
F 
A B ) AuNP 
) PEG 
D) PVP C) AuPVP 
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4.5 Visualisation of AuNPs using Fluorescence microscopy 
AuNPs were examined using fluorescence microscopy (13nm) (Figure 5.9A) to 
determine whether the AuNPs can be observed under the fluorescence 
microscope, as this will provide the next step in identifying the AuNPs which 
are taken up by BAEC cells. Also 50nm AuNPs were also examined for 
comparison (Figure 4.9B). The image below indicates that 13nm gold 
nanoparticles were difficult to visualise under a fluorescence microscope due to 
the small size. The few bright spots are due to NP aggregation in PSS. The 
larger sizes gave a higher intensity than the smaller size NPs. 
 
                    
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
200nm 
200nm 
 
A 
Figure 4.9: Fluorescent imaging of AuNPs prepared in PSS 
 (2.9 µg/ml) for A) 13nm and B) 50nm AuNPs, visualised under a 
fluorescence microscope (AuNPs are represented by arrows). 
NPs were invisible due to their flurescence (as bright spots) 
although size measurements were not possible. In A) Only a few 
bright spots were identified due to NPs aggregation, in B) many 
more bright spots are evident. Determination of NP size was 
confirmed using TEM. 
A 
B 
1µm 
1µm 
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The cellular localization of AuNPs after uptake was investigated using 
fluorescence microscopy. The image below illustrates uptake after 1 hr and 
18hrs incubation. There was a greater number of NP uptake of non-modified 
AuNPs after 18 hours incubation as compared to the modified AuPVP. Overall, 
it was difficult to visualise the uptake of 13nm AuNP due to their small sizes. 
Therefore the localisation of larger non modified AuNPs were investigated for 
comparison (Figure 4.10).  
€
4.5.1 Cellular localization of 13 nm gold nanoparticles 
                        
 
A B 
D  E 
Figure 4.10: Images of BAECs under the fluorescence microscope, after a 1 hour (A-C) and 18 hour (D 
and E) stimulation with 13 nm AuNPs. Cells were counterstained using DAPI (4’, 6-diamidino-2-
phenylindole) to identify the nuclei (blue) and the cell membrane fluorescent dye PKH26 (red stain). (A 
and D) CONTROL; B, C, and E) black spots evident within the nuclear and membrane regions, 
respectively, suggestive of AuNP uptake (arrows). 
 
C 
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 4.5.2 Cellular localization of 50 nm AuNPs particles 
Localization of 50nm AuNPs could be observed more easily by fluorescent 
microscopy compared to AuNPs sized 13nm, after 18 hrs. of incubation. The 
50 nm AuNPs (Figure 4.11 C) were taken up by the cells and mostly 
accumulated in the membrane compared to cells treated with small sized 13 nm 
AuNPs. In addition, using fluorescence microscopy we can also observe that 
timing also influences uptake of the NPs. We found that after 18hrs, the NPs 
were particles localised inside the cells, whereas at 30 min and 1 hr, the 
particles remained outside the nucleus.  
 
 
 
 
 
 
 
 
 
 
 
 
               AuNPs 30 min           AuNPs 1 hr AuNPs 18 hrs  
A B C 
Figure 4.11: Image demonstrates BAEC uptake of 50nm AuNPs after stimulation at  (A) 30 min  
stimulation (B) 1 hr and (C) 18 hrs, black spots evident within the nuclear and membrane regions, 
respectively, suggestive of AuNP uptake (arrows). 
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4.6. Determining the membrane integrity of BAECs using 
confocal microscopy  
 
The influence of modified and non-modified AuNPs on cellular function and 
integrity of BAEC was determined at 1 time point (24 hrs). The BAECs were 
stained by red fluorescent dye to determine the integrity of the cell membrane 
as well as the nucleus. The intensity of the fluorescence illustrates  that the 
control  illuminated more than the cells loaded with the AuNPs, PVP AuPVP 
AumPEG mPEG and PEG. (Figure 4.12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: Confocal imaging of BAEC after exposure to (A) Control (no 
nanoparticles exposure) (B) AuNPs (C) AumPEG (D) AuPVP (E) mPEG and 
(F) PVP. BAEC are stained by the fluroscent dye (PHKH26) (red). Reduced 
fluorescence intensity is seen after incubation in PVP and mPEG modified 
AuNPs (C and D). 
  
B 
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Figure 4.13: Integrity of cells after exposure to SPM (control), (A) AuNPS (B) AumPEG 
(C) AuPVP (D) mPEG (E) and to PVP (F) 
 
 
The reduced intensity of the cell fluorescence suggests that that the uptake of 
NPs may have led to disruption of membrane integrity after application with 
AuNPs, AumPEG, AuPVP, mPEG and PVP (Figure 4.13).  
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4.7 Cellular uptake of Modified and non-modified NPs 
Transmission electron microscopy (TEM) images clearly show uptake of both 
non modified and modified AuNPs by BAEC in cell culture and that uptake is 
influenced by surface modification (Figure 4.14). The result shows that after 30 
min exposure there was an indication of AuNPs uptake by the cells (5 
particles), although this was not the case for the modified particles. After 2hrs 
exposure there was clearly an increase of AuNPs uptake (32±5.2 particles). 
Interestingly, there was a greater number of AuNPs and AuPVP by the cells 
after 24 hrs incubation (NP number 638±156.12 and 233±91.73 respectively). 
However, after 48 hrs there was a reverse effect with high uptake of  AuPVP 
(700±91.73 NPs). On the other hand, there seem to be very little uptake of 
AumPEG but a few particle numbers (16±3.52 NPs) after 48 hrs. Both 
modified and non-modified NPs were shown to be localised in endosomes, 
within the cytoplasm, suggestingnthat modified and non-modified NP uptake 
maybe through endocytosis pathways.  
 
Table 4.1: Number of nanoparticles (AuNPs, AumPEG and AuPVP) 
taken up by BAEC after incubation at different times (30 min, 2hrs, 
24 hrs and 48 hrs). 
 
 
 
 
 
 
 
 
 
 
  
 
Incubation time 
No of Nanoparticles / cell 
AuNP AumPEG AuPVP 
30 min  5±0 0 0 
2 hours 32±5.2 0 55±9.8 
24 hours 638±156.12 8±0 234±71.52 
48 hours 344±48.52 16±3.52 700±91.73 
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Figure 4.14: TEM images of BAEC uptake of AuNPs AumPEG and AuPVP at different incubation 
time (30 minutes, 2hrs, 24hrs and 48 hrs) (Arrows represents NPs). 
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  4.8Analysis of Cellular signalling pathways 
          4.8.1 Influence of ACh on ERK expression  
The effect of different concentrations of ACh (1, 10 and 100 µM) on p-ERK1/2 
expression was assessed by Western blot analysis. When compared to control, 
all the ACh concentrations caused an increase in expression of ERK1/2, with 
10 µM having the strongest inducer effect on phosphorylation (Figure 4.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15: ACh activated ERK in BAEC in a concentration dependent 
manner. A), Western blot showing the effect of 1, 10 and 100 µM ACh on 
phosphorylation of ERK (p-ERK) in BAEC. Total ERK protein levels were used 
as a loading control (20µg of protein samples added /well). B, quantitative 
analysis of the blot shown in A. (ERK-1 [black bars], ERK-2[grey bars]) n=2. 
 
 
B 
A 
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4.8.2 Influence of modified and non-modified AuNPs on ACh-
induced                 p-ERK1/2 expression 
Nanomaterials influence cell proliferation and have been suggested to play a 
role  in the phosphorylation or de-phosphorylation of certain regulatory 
proteins involved in vascular contraction and/or relaxation. Here we stimulated 
BAEC with Ach in the presence of modified and non-modified AuNPs and 
examined whether the AuNPs will have any effect on the ERK expression.  
The expression of ERK was increased after ACh stimulation, however both 
non- modified and  modified AuNPs as well as the polymers alone caused a 
reduction in expression when compared to ACh control(Figure 4.16). A 
significant reduction in expression was observed after AuPVP, PVP and 
AumPEG incubation (p <0.05). Furthermore, modified NPs caused less 
reduction of p-ERK2 expression than p-ERK1 expression, compared to non-
modified NPs.  
 
Figure 4.16: Effect of NPs on ACh-induced ERK1/2 phosphorylation in BAEC. A), Western blot 
showing the effect of AuNPs, AuPVP PVP AumPEG and mPEG after stimulated with 10 µM ACh 
on phosphorylation of ERK1/2 (p-ERK1/2) in BAEC. Total ERK1/2 protein levels were used as a 
loading control (20 µg of protein samples added /well). B, quantitative analysis of the blot shown in 
A. (p-ERK-1 [black bars], p-ERK-2[grey bars] n=3). The results are presented as the mean ± SD. 
Where differences at *p<0.05 is considered statistically significant. 
B 
A 
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4.8.3 Influence of ACh on Akt expression  
At 10 µM of ACh concentration the p-Akt expression was increased by over 3 
fold, (Figure 4.17).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17: ACh activated Akt in BAEC in a concentration manner. A), 
Western blot showing the effect of 1, 10 and 100 µM ACh on 
phosphorylation of Akt (p-Akt) in BAEC. Total Akt protein levels were used 
as a loading control (20 µg of protein samples added /well). Experiments 
were performed at least twice and a representative example is shown.  B, 
quantitative analysis of the blot shown in A. (Akt-1 [black bars]) n=2. 
 
  
 B 
A 
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B 
A 
4.8.4 Influence of modified and non-modified AuNPs on ACh-
induced p-Akt expression  
The overexpression of p-Akt induced by 10 M ACh shown in the previous 
section (section 4.8.3) was again observed. The addition of AuNPs did not alter 
the positive effect of ACh on p-Akt expression. Both PVP and mPEG modified 
AuNPs slightly decreased ACh-induced pAkt overexpression, compared with 
ACh effect alone ( Figure 4.18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18: Effect of NPs on ACh induced Akt phosphorylation in BAEC. A), Western 
blot showing the effect of AuNPs, AuPVP, PVP AumPEG and mPEG after stimulation 
with 10 µM ACh on phosphorylation of Akt (p-Akt) in BAEC. Total Akt protein levels were 
used as a loading control (20 µg of protein samples added /well).  B, quantitative analysis 
of the blot shown in A (Akt-1 [black bars]) n=2. 
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5. Vascular function studies   
All vessels constricted to high potassium solution (KPSS). There was no 
overall difference in the degree of constriction, before and after AuNP 
incubation (modified and non- modified) or their stabilisers (Figure 5.1). 
Vessels that constricted by less than 1g tension, after the equilibration period, 
were considered non-viable and discarded. 
 
Figure 5.1:  The influence of high potassium solution (KPSS) on aortic vessels before 
and after incubation, where ‘n’ is the number of vessels  
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5.1 Control experiments  
5.1.1 Repeatability of Acetylcholine responses  
To assess repeatability of the dilator responses, two ACh dose responses were 
carried out on the same vessel, before and after a thirty minute incubation 
period in PSS. This will determine whether second responses are significantly 
different from 1
st
 responses and hence inform statistical analysis. The results 
indicate that there is a difference before and after incubation without any NPs 
present. A cumulative increase in ACh concentration caused an increased 
dilation for both 1
st
 and 2
nd
 responses, whereby at the 100µM maximum 
concentration of ACh, vessel dilation was at 80.29±9.36 % and 68.33±7.86%, 
before and after PSS incubation, respectively (n=6; NS)   Results show some 
attenuation of dilator responses after incubation in PSS at 3 ACh 
concentrations only (0.1 µM, 1 µM and 10 µM (Figure 5.2) (See Appendix 
C:Table 1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Average percentage response of vessels to ACh, before and after incubation in 
PSS  (*P<0.05). 
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5.1.2 Repeatability of Sodium nitroprusside responses  
The effect of the endothelial independent dilator SNP was assessed before and 
after a 30 minute incubation period in PSS. Results show that incubation in 
PSS has no overall effect on dilator responses except for 1 dose at 0.01 µM 
SNP concentration (p<0.05).  At 0.1 µM SNP maximum concentration, vessel 
relaxation was only slightly reduced (95.26±3.80 % and 86.50±7.79 % before 
and after PSS incubation (n=7; NS), (Figure 5.3) (see Appendix C:Table 2). 
 
 
 
 
 
 
 
 
 
 
Figure 5. 3: Average percentage dilator response of vessels to SNP, before and after 
incubation in PSS (*p<0.05). 
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5.2 Effect of non-modified gold nanoparticles on 
dilator responses 
      5.2.1 ACh response after non-modified AuNP incubation 
In order to investigate the effect of AuNPs on endothelium-dependent 
relaxation, aortic vessels were treated with a cumulative concentration of ACh  
ranging from 0.1-100µM, before and after incubation with AuNPs at 1.68X10
11
 
NP/mL. The results demonstrated that incubation in AuNPs had no overall 
effect on dilator responses (n=5) (Figure 5.4; see Appendix C:Table 3). 
 
 
 
Figure 5.4: Average percentage dilator response of vessels to ACh, after incubation with 
non-modified AuNPs. 
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5.2.2 SNP response after non-modified AuNP incubation 
There was a significant reduction in dilator response after incubation with 
AuNPs at all SNP concentrations. This indicates that NPs are inhibiting the 
effect of SNP (Figure 5.5), (see Appendix C:Table 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Figure 5.5: Responses of vessels to SNP after incubation with non-modified AuNPs   
  (**P<0.01). 
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5.3 Effect of Polyvinilpirrolidine modified gold nanoparticles 
on dilator responses 
5.3.1 Initial studies on the influence of Polyvinylpyrrolidone polymer on 
dilator function 
AuNPs were initially coated with 9.5 X10
-12 
M PVP. These NPs were shown to 
have an effect on the dilation of the aortic vessels. When compared to control 
vessels, there was a significant reduction in dilator response at 3 ACh 
concentrations (Figure 5.6),(see Appendix C:Table 5). 
 
 
Figure 5.6: Responses of vessels to ACh after incubation with PVP modified AuNPs 
(*p<0.05) 
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SNP responses were also assessed. When compared to control SNP responses 
there was no significant attenuation in dilation (NS) (Figure 5.7). 
(See Appendix C: Table 6). 
 
 
  Figure 5.7: Responses of vessels to SNP after incubation with PVP modified AuNPs 
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5.3.2 Minimum concentration of Polyvinylpyrrolidone needed to 
stabilize Gold Nanoparticles 
To determine the minimum concentration of PVP needed to stabilise the 
AuNPs, serial dilutions of PVP were used to coat AuNPs. Observation of the 
colour change from reddish to blueish gave an indication that the NPs had  
aggregated; no colour change in the solution verified that the NPs were stable. 
Results demonstrated that a minimum PVP concentration of 5.9x10
-7
µM was 
necessary to prevent aggregation of the AuNPs. 
 
Once the minimum concentration required to prevent aggregation had been 
verified, the effect of PVP alone on vessel function was assessed to identify a 
concentration of PVP with minimal detrimental effects on ACh induced 
dilation. Vessel incubation in PVP alone, at 1.47x10
-7 
µM  to 3.68x10
-8 
µM led 
to a significant attenuation of ACh dilator responses, while at the lowest 
concentration examined (1.84X10
-8
µM) no overall attenuation in dilation was 
observed  (Figure 5.8).  
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Figure 5.8: Responses to 0.1 µM ACh concentration before and after incubation in serial 
dilutions of PVP. Where * (p<0.05) and ** (p<0.01) 
5.3.3 ACh responses 
The effect of PVP alone and PVP modified AuNPs, on ACh dilator responses 
were compared to the control (PSS). The results show that PVP alone caused a 
significant reduction in ACh dilator responses at 10 to 100µM [ACh] (p<0.05), 
when compared to PSS incubation (See Appendix C:Table 9). PVP modified 
AuNPs caused a reduction in dilator response, but not significantly 
(NS)(Figure 5.9), (See Appendix C:Table 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9:  Responses of vessels to Ach after minimum concentration of PVP modified 
AuNPs and PVP alone(* p<0.05).  
 
 
 
 
-10
0
10
20
30
40
50
60
70
80
90
-8 -7.4 -6.5 -5.9 -5.3 -4.7 -4.1 -3.8 -3.5
%
 r
e
la
xa
ti
o
n
 
log [ACh]M 
ACh response after incubation with AuPVP 
and PVP alone (minimum concentration) 
Control (n=6)
AuPVP (n=5)
PVP alone (n=4)
* 
* 
* 
  
 
 164 
5.3.4 SNP responses 
Vessel incubation in AuPVP affected SNP dilator responses (see Appendix C: 
Table 9). A significant reduction in dilator response was obtained at 0.001 µM  
to 0.01 µM [SNP] (p<0.001) with a further reduction at 0.10 µM (P<0.01). 
Incubation in PVP alone led to a small reduction in response, (NS) (Figure 
5.10), (see Appendix C: Table 10). 
 
 
 
 
Figure 5.10:  responses of vessels to  SNP after minimum concentration of PVP modified 
AuNPs and PVP   alone(* p<0.05, ** p<0.0 1 and *** p<0.00 1 ) 
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5.4 Effect of polyethylene glycol modified gold 
nanoparticles on dilator responses 
5.4.1 Minimum concentration of polyethylene glycol needed to stabilize 
Gold Nanoparticles  
The results of the PVP effect on vessel function suggests that it attenuates 
dilator function. Consequently, this study investigated whether other stabilisers 
had similar effects on dilator responses. Serial dilutions were carried out on 
mPEG to determine the minimum concentration needed to stabilise AuNPs. 
Once the minimum concentration required to prevent aggregation had been 
verified, ACh and SNP responses after incubation with mPEG modified 
AuNPs were determined (Table 5.1).  
 
Table 5.1:  Determining the minimal concentration of mPEG needed to 
stabilise AuNPs, through colour observation of the solution in physiological 
salt solution  
Concentration of mPEG(g) Colour observation  
3.7x10
-5
g Clear red -no colour change. 
3.7x10
-6
g Clear red -no colour change.   
0.5x10
-7
g Clear red -blue colour 
 
Findings demonstrated that mPEG coated AuNPs were stable after 
modification with both concentration of 3.7x10
-5
g and 3.7x10
-6
g (no colour 
change, indicating that the NPs were stable). Hence, AuNPs were coated with 
3.7x10
-6
g of mPEG as the minimal concentration that is necessary to prevent 
AuNP aggregation.  
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5.4.2 ACh responses 
There was no significant attenuation in ACh responses after incubation with 
mPEG modified AuNPs (2.9 µg/mL ) (See Appendix C: Table 11) To 
determine whether concentration can have an influence on responses, the 
concentration of the mPEG  modified AuNPs was increased (5.8 µg/mL ). At 
this concentration, the dilator responses were significantly reduced (p<0.001) 
compared to PSS control at most ACh concentrations (See Appendix C: Table 
12). Incubation in PEG alone caused a slight non-significant reduction in ACh 
dilator responses (Figure 5.11) (see Appendix C: Table 12).  
 
 
 
Figure 5.11: Responses to ACh after incubation with mPEG modified AuNPs at low and 
high concentration and PEG alone. *P<0.05  
 
**P<0.01 and ***P<0.001  
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5.4.3  SNP responses 
Interestingly, SNP dose responses were affected after incubation in PEG alone 
at the higher SNP concentrations (Figure 5.12)(See Appendix C:Table 15). 
Vessel incubation in mPEG alone (thiol modified PEG) led to a reduction in 
dilation, only at the highest SNP concentration (p<0.05) (Figure 5.13) (See 
Appendix C: Table 14). Vessel incubation in mPEG modified AuNPs at 2.9 
µg/mL  led to a small non-significant reduction in SNP dilator responses (NS) 
(See Appendix C: Table 13). 
 
Figure 5.12:  responses of vessels to SNP after incubation with PSS, mPEG 
modified and PEG alone (*p<0.05) 
 
 
 
 
 
 
 
 
 
 
Figure  5.13:  responses of vessels to SNP after incubation with mPEG alone(* p<0.05) 
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5.5 Modified and non-modified gold nanoparticle uptake into vasculature 
The uptake of NPs into the vessel wall of aortic vessels after 0.5 hour of 
vascular lumen exposure was examined using TEM and ICP. The TEM images 
indicated  that the non-modified AuNPs had aggregated and were identified 
within the lumen of the vessel.  They were seen close to the surface of ECs. 
There was no evidence that the AuNPs had entered the cell (Figure 5.14A). On 
the other hand, PVP modified NPs were identified within ECs. They were 
identified within endosomal structures, but not freely within the cytoplasm, 
suggesting that uptake is by the process of endocytosis (Figure 5.14B). Very 
few mPEG modified AuNPs were identified in ECs when added at 2.9 µg/mL , 
(Figure 5.14C). However, once the NP concentration was increased, greater 
uptake was detected (Figure 5.14D).  
 
ICP analysis indicated a high degree of uptake of non-modifed AuNPs 
(0.45ppm;13.95%), compared to PVP (0.14ppm;4.4%) and mPEG modified 
NPs at 2.9 µg /ml. At 5.8µg/mL  both uptake of PVP (0.38ppm; 6.46 %) and 
mPEG (0.35ppm;6.07%) modified AuNPs increased, but was nonetheless still 
lower than that of the non-modified AuNPs (highest uptake at  
0.74ppm;23.95%). The results shown in the chemistry section (section 3.3.3.2 ) 
. 
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5.5.1 Transmission electron microscopy images of 
nanoparticle uptake by aortic vessels  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 5.14: Representative TEMs illustrating AuNP uptake by the ECs lining of  
the vessel wall (A) non-modified AuNPs, (B) PVP modified AuNPs, (C) Low 
concentration of mPEG modified AuNPs and ( D) High concentration of mPEG 
modified AuNPs, (Arrow represents NPs.) 
C 
B 
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6. Overall Summary of results   
6.1 Synthesis and characterisation of Nanoparticles (silica and gold) 
NPs of various material compositions (silica and gold), size, charge and 
stabilisers were fabricated and characterised. The results are summarised as 
follows: 
1. Silica NPs (SiNPs,100 nm and 200 nm, with and without rhodamine dye) were 
synthesised and their sizes were determined by dynamic light scattering (DLS) 
and scanning electron microscopy (SEM).  
2. Zeta potential measurements demonstrated that  the SiNPs were stable in H2O,  
physiological pH and ionic strength conditions including physiological salt 
solution (PSS). 
3. SiNPs (both dye and non-dye doped) were functionalised with 3-
aminopropyltrimethoxysilian (APS). This led to an increase in the 
hydrodynamic diameter in water and caused aggregation in PSS. Furthermore, 
Zeta potential value demonstrated the reduced stability of these NPs after APS 
functionalisation. 
4. AuNPs (12±3nm) were fabricated according to the Turkevich method. Size and 
dispersion of these AuNPs was determined by Transmission Electron 
Microscopy (TEM). Energy dispersive X-ray spectroscopy (EDAX) identified 
the presence of gold elements in AuNPs. Inductively  coupled  plasma mass 
spectroscopy (ICP-MS) gave the relative amount of gold element present in 
300 µl and 600 µl AuNPs samples. 
5. AuNPs were surface-modified using the polymers PVP and mPEG. Both 
diffuse reflectance infra-red Fourier transform spectroscopy (DRIFTS) and 
Surface Enhanced Raman Spectroscopy (SERS), identified the functional 
groups on the modified AuNPs. Thermogravimetric analysis (TGA) 
determined the presence of PVP on AuNPs by studying their thermal 
decomposition profile. 
6. UV spectra demonstrated that non-modified AuNPs  were  stable  in cell 
culture medium but not in PSS. Once the AuNPs were modified in PVP and 
mPEG, the AuNPs were stable in both DMEM cell culture media and PSS. 
  
 
 172 
6.2 Influence of gold nanoparticles on cellular function  
Cellular study results indicate that: 
1. All AuNPs (modified and non- modified) reduced proliferation after 24 hrs 
incubation. Cell viability (using propidium iodide (PI) flow cytometric assay) 
was unaffected after short incubation times with AuNPs (30 min and 2 hrs). At 
longer incubation times, cell viability was reduced significantly, after 24 hrs 
incubation in all conditions, and after 48 hrs for AuNPs and AuPVP. 
2. Different methods (Haemocytometer chamber, automated cell counter and 
propidium iodide (PI) flow cytometric assay) used to test cell viability, gave 
different results suggesting that NPs may have interfered with cell viability 
assays.  
3. The degree of uptake of AuNPs by BAECs was dependent on incubation time 
and type of polymer stabilisers used. A greater degree of uptake was observed 
at a shorter incubation time (30min) with non-modified AuNPs, whereas 
uptake of AuNPs after PVP modification was highest after longer incubation 
periods (48 hrs). 
4. There was a significant increase in the percentage number of apoptotic cells in 
all conditions after 2hrs and 24 hrs incubation. AuNPs, PVP and mPEG 
treatment led to a higher significant increase in percentage number of apoptotic 
cells after 2 hrs incubation. Furthermore, AuPVP induced a greater increase in 
percentage number of apoptotic cells after 24 hrs incubation, than AumPEG. 
5. PVP resulted in an increase in necrotic cells by 3.0-fold at both 2 hrs and 24 
hrs incubation. mPEG also significantly increased necrotic cells by 2-fold, after 
24 hrs incubation. 
6.  Both modified and non-modified AuNPs reduced p-ERK expression, while 
non- modified AuNPs promoted the Akt signalling pathway. However, AuPVP 
and AumPEG reduced AKT signalling pathways. 
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6.3 Influence of gold nanoparticles on vascular function  
Vascular study demonstrates that: 
1. Non-modified AuNPs had no overall effect on acetylcholine (ACh) responses, 
however, they significantly reduced responses to sodium nitroprusside (SNP).  
2. PVP modified AuNPs (modified using 9.5 X10-12M PVP corresponding to the 
maximum concentration used to stabilise AuNPs) were shown to attenuate the 
responses to both  ACh (significant at 3 dose responses)  and SNP (NS) PVP 
modified AuNPs (at the Least PVP concentration of 5.9X10
-13
M, which was 
required to stabilise AuNPs) caused a small reduction in ACh induced dilator 
responses. SNP responses were, however, significantly attenuated. 
3. PVP alone (at the minimal concentration of 5.9X10-13M) caused a significant 
reduction in ACh dilator responses (at the 3 maximal ACh doses) However, for 
SNP responses, only a small reduction in dilation was evident. 
4. Using serial dilutions, the concentration of PVP that caused minimal attenuated 
effect on ACh dilator function was determined as 1.84X10
-8 
µM, however, this 
concentration was insufficient to prevent aggregation of the AuNPs. 
5. AumPEG  at  2.9µg/mL  had no overall significant effect on either ACh or 
SNP responses. 
6. Vessel incubation in double the concentration of AumPEG(5.8µg/mL )  led to a 
significant reduction in the ACh dilator response at most ACh concentrations 
examined.  
7. Incubation in mPEG or PEG alone, had no effect on ACh induced dilator 
responses, but attenuated SNP induced dilation. 
8. AuNP uptake by cells within the aortic vessel wall was verified by TEM and 
ICP. TEM sections had shown the presence of aggregated AuNPs in the lumen 
of the vessel, but none were identified in the vascular wall. Uptake of PVP 
modified AuNP was evident by ECs lining the vessel wall. The NPs were seen 
within endosomes. There was no evidence of AumPEG modified AuNPs at low 
concentration, however, at high concentration, the occasional NP was seen in 
the cytoplasm of ECs. 
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9. ICP analysis indicated a high degree of uptake of non-modifed AuNPs 
(0.45ppm;13.95%), compared to PVP (0.14ppm;4.4%) and mPEG modified 
particles at 2.9ug/ml. At 5.8ug/ml both uptake of AuPVP (0.38ppm; 6.46%) 
and AumPEG (0.35ppm;6.07%), but was  nonetheless still lower than that of 
the non-modified AuNPs (highest uptake at (0.74ppm; 23.95%). 
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7. Discussion  
In the present study, NPs of different material composition (Gold and silica) and surface 
modifications were fabricated and characterised. PVP, thiol modified PEG (mPEG), and 
PEG polymer stabilisers were investigated, however, both PVP and mPEG polymers 
were chosen to modify AuNPs due to their suggested biocompatibility and assembling 
abilities on the surface of the NPs. Cell culture and western blotting techniques were 
employed to determine the effect of modified and non-modified AuNPs on endothelial 
cell proliferation, viability, apoptosis and signalling pathways. Furthermore, the 
influence of NPs on the vasodilator function of aortic vessels was also investigated. Our 
findings demonstrate that the effect on AuNPs on EC function (proliferation, viability 
and apoptosis) and vasodilator responses of whole aortic vessels, ex vivo, was 
influenced by the type of polymer used to modify the surface of AuNPs. A greater 
degree of biocompatibility is identified using mPEG modified AuNP, rather than PVP 
modified AuNPs. However, vascular responses were, nonetheless, dependent to the 
overall NP concentration used. Our study represents the first description of the influence 
of 13 nm gold nanoparticles, modified with two different polymers (PVP and mPEG), 
on EC and vasodilator function of aortic vessels ex vivo. Our findings are directly 
relevant to the current clinical use of AuNPs in imaging diagnostics and will inform the 
appropriate dosages and surface modifications that will minimise any detrimental effect 
on cellular and vasodilator function. 
7.1 Characteristics of Nanoparticles (Silica and Gold) 
NPs of various material composition (silica and gold), size, charge and stabilisers were 
fabricated and characterised within our laboratories. Both the DLS and SEM techniques 
were used to verify the size of the silica nanoparticles, while TEM was employed to 
verify the size of gold nanoparticles due to their small sizes. The stability of SiNPs was 
also determined using zeta potential measurements. Our results show that the zeta 
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potential of the SiNPs (with and without rhodamine dye) in H2O were stable. 
Interestingly, the sizes of the SiNPs analysed using  DLS with the Malvern’s Zetasizer  
gave a slightly larger diameter compared to SEM.  Furthermore, the SiNPs were also 
characterised in PSS to show that they were stable at physiological pH and ionic 
strength. In addition, the pH of NPs in solution was also examined to show the stability 
of NPs in various pH conditions. The NPs were stable once the pH were altered to pH 
7.4, thus indicating that pH had no effect on the stability of the NPs. When the SiNPs 
were dispersed in water, the water molecules surrounded the NPs and produced a stern 
layer, also known as the inner and outer Helmholtz (HL) plane. The other ions which 
are not directly bound to the particles are also attracted to the negatively charged 
particles. Repulsion from the stern layer and the counter ions produces a diffuse layer. 
The point at which these layers meet results in a zeta potential. Once PSS solution is 
introduced, the ions cause a reduction in the number of water molecules. Both the 
surface of the silica and the PSS ions compete for the water molecules, resulting in less 
formation of the hydration layer. Furthermore, a closer interaction of the positively 
charged ions of the PSS and the water molecules at the surface of the silica results in the 
reduction of the shorter range of repulsive forces between the silica and the hydration 
layer. A reduction of zeta potential is therefore achieved.  
 
The APS modified nanoparticles displayed an overall net positive surface charge. 
However, this caused both the dye and non- dye doped particles to be unstable in PSS 
solution. We further demonstrated that APS caused the SiNPs to grow larger (Van 
Blaaderen and Vrij, 1992). Moreover,  the DLS analysis also indicated that the  
rhodamine b isothiocyanate (RH) dye influences the NPs size. An excessive 
concentration of ammonia and water during the synthesis of the NPs also increases the 
SiNP size. The seeding growth of the RH28 sample (DLS=110 nm) used less ammonia 
compared to TMRHSI sample (DLS=125 nm) (2ml vs. 6.04ml of ammonia, 
respectively) therefore we observed a smaller NP size with RH28. Similarly, Van 
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Blaaderen et al (1992) also demonstrated that NPs increased in size due to excessive 
concentration of ammonia and water. Ammonia in the reaction is known to act as a 
catalyst for the hydrolysis and condensation process of the silica precursor (Stöber et al, 
1968). Furthermore, an increase in the amount of the ammonia resulted in an increase of 
silanol groups on the surface of the nanoparticles and therefore caused the NP size to 
increase. Recently, studies have shown that sizes of silica NPs can further be influenced 
by other parameters besides ammonia. For instance, the optimization of the 
concentration of silica source (TEOS) and NH3 as well as the type of solvent (H2O and 
ethanol) and the reaction temperature can control the size distribution of SiNPs (Davies 
et al, 2009; Park et al, 2002). Indeed, we observed this in our study. 
 
Fabrication of the non-modified AuNPs involved a simple method from Turkevich and 
particles obtained were 12±3 nm when characterised with TEM. However, AuNPs 
characterisation with the Malvern Zetasizer was not possible to conduct, as the system 
in our laboratory was not inbuilt with the laser red HeNe source. This laser source is 
necessary for detecting  the AuNPs samples at the wavelength maxima of 500-600 nm. 
Nevertheless, substitutes were used for size (TEM), and stability (UV-vis), 
measurements. Using TEM the non-modified AuNPs were shown to be in aggregates. 
This aggregation of the non-modified AuNPs was not possible to detect by the naked 
eyes. Polymer coatings have been developed and have shown advantageous properties 
in preventing aggregation (Zhang et al, 2009). Thus, PVP, and thiol modified PEG 
(mPEG), polymers stabilisers were employed in our study. Interestingly, PEG 
molecules have no open bonding on the end of their chain structure, therefore are 
unlikely to covalently bond to AuNPs; thus PEG molecules are expected to be 
physically adsorbed on the gold surfaces  (Soel et al, 2013) whereas, modified PEG 
(mPEG), assembles on the surface of the particles with ease. Therefore, PVP and mPEG 
polymers were chosen for AuNPs surface modification in the present investigation. A 
recent study by Wang et al (2013), revealed that non thiol PEG exhibited the maximum 
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coagulation concentration, whereas thiol-PEG stabilizer accelerated AuNPs 
aggregation. Indeed this was the case for our mPEG modified AuNPs, therefore fresh 
mPEG modified AuNPs were made for every cellular and vascular function study. 
Many studies on the fabrication of gold nanoparticles built with polymer coatings such 
as PEG, mPEG and PVP have proven that nanosized dispersion is enhanced; this was 
also observed from our TEM analysis. 
 
To further investigate the stability of the AuNPs, UV-vis was conducted.  The 
characterisation demonstrated that AuNPs aggregated in PSS solution. PSS caused 
destabilisation and induced a significant color change from red to blue which resulted in 
the shift in Surface plasmon resonance (SPR). Furthermore, destabilisation of AuNPs 
could be recognized by the naked eye, however, once the particles were modified with 
PVP and mPEG, the NPs were able to remain stable in physiological conditions, which 
was detected visibly as the solution remained red in colour. A slight change in the ionic 
strength of a medium is known to be the cause of aggregation. Once a capping agent is 
added to the solution it will result in higher stability (Nativo et al, 2008). It is 
considered that stability in high ionic strength media depends upon PEG length. 
According to the DLVO theory, greater stability for smaller nanoparticles is achieved 
through minimal van der Waals attraction energy (Liu et al, 2007). In our study, the 
mPEG used had the length of 5000MW, this length was able to overcome the ionic 
strength of media. It is has been acknowledged that citrate-stabilized gold nanoparticles 
prefer to aggregate and precipitate in saline solutions. Dominguez-Medina et al (2013) 
indicated that AuNPs developed a different characteristic in the conditions below the 
NaCl concentration of many bodily fluids and blood plasma. Furthermore, aggregation 
was reduced after BSA was introduced to AuNPs in harsh Na+ conditions.  Hence, our 
observation of  AuNPs aggregation in PSS are the result of  complexing of the citrate 
anions with Na+ cations in the salt solution. Furthmore, in our study, the non-modified 
AuNPs remained stable after addition to the cell culture medium. An assumption has 
  
 
 
180 
been made that the production of proteins by the cells in cell culture, together with the 
presence of FBS, are responsible for stabilizing AuNPs (Nativo et al, 2008). These 
proteins absorb on the surface of AuNPs; this in turn provides stability to the particles. 
Our UV-vis spectra observation do not show any significant red shift or broadening 
after exposure of the particles to the cell culture medium. AuNPs are considered to have 
optical scatterings at ranges of 550-600 nm wavelengths, because of the localized 
surface plasmon resonances (Wang et al, 2010). These ranges of  wavelengths were also 
detected in our AuNPs samples.  
 
7.1.2 Assessment of Polyvinilpirrolidine, and Polyethylene glycol 
attached on gold  Nanoparticles 
It was crucial to determine functional groups on the surface of the gold nanoparticles 
after modification. Hence, the diffuse reflectance infra-red Fourier transform 
spectroscopy analysis (DRIFT) was employed. The evidence forPVP and mPEG 
functionalisationon AuNPs was demonstrated by their signatures of certain functional 
groups which were recognized as C=O, C\N (1200 cm−1), in PVP (Gangwar et al, 
2012), and thiol group (-SH) in mPEG (Yeh et al, 2009). These intermolecular bondings 
are used to identify the functional groups present.  The C=O peak observation in citrate 
stabilized AuNPs was also detected in our study, a similar finding as that made by 
Wang et al (2010). Furthermore, analytical tools such as EDAX were successfully 
applied in the present study to indicate the presence of AuNPs, and demonstrated that 
the gold chemical element was present in the nanoparticles. Small traces of Na and Cl 
from the stabiliser sodium chloride were also detected. SERs analysis was able to 
identify the functional groups on AuNPs. We identified a slight shift in the peak of C=O 
peak at 1609cm
-
1 on PVP modified AuNPs. However, there is a discrepancy in the 
documented peak position of carbonyl group of PVP, according to some studies.  
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For instance, Behera and Ram (2014) identified a slight shift ranging from 1667 to 1662 
cm
-1  
 in PVP modified AuNPs, and determined that the shift effect was due to charge 
transfer interaction of PVP molecules with the Au surface. On the other hand, Grzelczak 
et al (2011) and Moran et al (2011), identified peaks in the range of 1750-1769 cm
-1
. 
However, we can still show that the functional groups on the AuNPs caused shifts in the 
peaks. 
SERs are further used as a tool for ultra-sensitive monitoring of the intracellular 
distribution of AuNPs (Strem chemicals, Inc. 2013). Furthermore, Hu et al (2007) 
indicated that different-shaped gold nanoparticles possessed different SERS properties.  
A small variation in the shape/surface of the particles in our study, due to the surface 
modification with different polymers, may also attribute to a variation in SERs 
properties. TGA demonstrated the presence of PVP in the PVP-modified AuNPs by 
their thermal decomposition. The spectra in our study demonstrated that PVP alone 
degraded above   300 ºC, and completely decomposes at 430
o
C. The PVP modified 
AuNPs,  demonstrated  that PVP on the AuNPs  degraded at 280 to 460 ºC and a  
further  weight loss was detected at 460
O
C to 560
O
C, this weight loss may also be 
attributed to the decomposition of PVP. Similarly, Gangwar et al (2012) shows a small 
weight loss at 550
O
C and indicated that this weight loss was due to to the decomposition 
of PVP:curcumin coating around the AuNPs. Furthemore, the AuNPs in the present 
study decomposed at higher temperatures. These findings were similar to those by 
Gasaymeh et al (2010). They found that the metal NPs (silver), started to decompose at 
higher temperatures. They also demonstrated that PVP alone degraded above 300 ºC, 
and completely decomposes at 500 ºC. 
7.1.3 Inductively coupled plasma Mass spectroscopy (ICP-MS) 
Compared to TEM, inductively coupled plasma and mass spectroscopy (ICP-MS), is a 
more sensitive and accurate technique to quantify small amounts of gold nanoparticles 
taken up within the rat murine aortic vessels. ICP-MS can detect differences in the 
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internalized gold concentrations in the order of parts per million (ppm). In our study we 
analysed the relative amount of metal in the 300µl and 600µl sample of modified and 
non modified AuNPs and detected the differences at levels of parts per million. Also, 
the uptake of modified and non-modified particles into cells was also analysed and 
expressed as percentage uptake. The use of ICP-MS for the detection of internalised 
nanomaterials within vessels has also been described in other studies. For example, 
Shukur et al (2013) studied the effect of quantum dots on the function of murine 
mesenteric arteries, and used ICP-MS to identify the relative amount of metal in the 
QDs samples. Additionally, they detected the QDs uptake by the vessels and expressed 
their findings as ppm. Our result effectively shows that the double concentration of the 
AuNPs samples, gave a detection of double relative amount of metal. 
.   
7. 2 Effect of gold nanoparticles and their stabilisers on 
cellular function 
7.2.1 Cellular uptake of modified and non-modified AuNPs 
In our cellular study using BAECs, we observed that modified and non-modified NP 
uptake is dependent on incubation time and type of stabiliser used; we found cellular 
uptake of AuNPs by BAEC within 30 min incubation. This may have been facilitated by 
the fact that non-modified AuNPs were stable in culture media and monodispersed. The 
greater degree of non- modified NPs uptake could be due to their increased surface area 
to volume ratio due to smaller NP size, as compared to the modified AuNPs. After 2 
hours, the degree of NP uptake increased further. Moreover, a further increased uptake 
of AuNPs after 24 hours was evident. It was associated with a small non significant 
decrease in cell proliferation at 24 hours. Freese et al (2012) made a similar observation 
in their study  using Human Dermal Microvascular Endothelial Cells (HDMEC). They 
determined that the cytotoxicity of AuNPs was down to the concentration of AuNPs 
exposed to the cells. Interestingly, cell viability was not affected significantly, rather it 
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was increased. Chithrani et al (2006) found that AuNP uptake increased in the first 2 hrs 
after incubation, and slowed down after 4-7 hrs of incubation. In our study, uptake of 
non-modified AuNPs was reduced over time (after 48hours incubation). This could be 
due to the distribution of AuNPs amongst dividing cells and/or due to expulsion of the 
AuNPs from the cells over time. Reduced NP number due to cell division has also been 
observed in dermal cells cultured in 13 nm AuNPs (Mironava et al, 2010). Cell 
membranes are more likely to take up the NPs by endocytosis if they are monodispersed 
and colloidal. Which was the case in our study when the non-modified AuNPs were 
suspended in culture medium 
 
There was a greater uptake of PVP coated AuNPs. According to Hu et al (2009) and 
Chithrani et al (2006), uptake of AuNPs by cells is size dependent; this may explain the 
greater degree of uptake of PVP modified AuNPs. Furthermore Hu et al (2009) 
explained that there are contradictions amongst studies on cellular uptake and stated that 
chemical and structural differences influenced uptake. Hence, this may explain the 
variation of uptake observed  amongst the modified and non-modified uptake  by cells 
in our study. Qiu et al,(2010) found that  aging PVP for surface modification resulted in 
the formation of branched hollow . Interestingly, after 1 and 4 days, their particle size 
increased to 90–160 nm and 210–490 nm. This indicates that the PVP polymer 
molecules gradually self-assemble into larger particles in a given solution. Hence, this 
suggests that during NP modification, PVP self-assembles resulting in larger structure 
and therefore increases uptake due to their large size. As previously mentioned, cells 
prefer uptake of larger particles than smaller particles.  This may explain our 
observation of greater uptake number of AuPVPs by the BAEC at longer incubation 
periods. 
 
There was less uptake of mPEG modified AuNPs, in comparison to PVP modified 
AuNPs. Uptake was evident after 24 hrs of incubation. In contrast, Nativo et al (2008); 
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suggested that there was no uptake of PEG coated AuNPs at all by (Helacyton gartleri) 
HeLa cells. Even after prolonged incubation for 24 hours or after an increase in 
concentration of particles.  Particles were also undetectable by TEM and AES. 
Interestingly, Huang et al (2009) found a greater concentration of PEG NPs 
accumulation in tumour cells, however, they used gamma radiation to promote uptake. 
The density and the length of PEG chains surrounding the modified AuNPs may 
influence uptake, as Lipka et al (2010), reported PEG (10000MW) prolonged the 
circulation of AuNPs, but not PEG (750MW). Freese et al (2013) also demonstrated that 
functionalization of AuNPs with poly(2-hydroxypropylmethacrylamide) can influence 
the uptake behaviour in different endothelial cell types , compared to PEG and 
glucosamine surface modification. Interestingly, Hu et al (2009) stated that a coating of 
PEG resulted in the reduction of cellular uptake by 1/3 as compared to another polymer 
coating (poly (N-vinyl caprolactam), which promoted the cellular uptake of NPs. 
Likewise, Liu et al (2007), showed that modified PEG AuNPs led to less cellular 
internalization of particles. In our study, mPEG modified AuNPs were internalized 
within the endosomes after uptake. According to Fu et al (2005), AuNPs modified with 
PEG was efficiently internalized by non-specific endocytosis. Moreover, observation 
shows that modified and non-modified AuNPs accumulated in endocytic vesicles. These 
findings were similar to Wang et al (2010) found that smaller NPs entered the cells 
through endocytosis and accumulated in the endocytic vesicles. They observed that 
AuNPs with size of 45 nm had greater interaction with cells compared to larger 70nm 
and 110nm NPs.  
 
Tsai et al (2013), stated that cell uptake of NPs via non-specific endocytosis, results in 
endocytic vesicles enclosing the NPs. Consequently, the chances of NPs penetrating 
into the nucleus are reduced. This is confirmed by the lack of visualisation of AuNPs in 
the nuclei in our study. NP modification may result in a change of particle morphology. 
Stabilisers may also have an effect on the detection of NPs by TEM. It is acknowledged 
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that the morphology of NPs may make them difficult to identify, due to the low contrast 
produced by the mass-thickness (density × thickness) of the modified NP compared to 
the surrounding organelles within the cell (Garcia et al, 2012). This may be a reason in 
the variation of detection of NP uptake in this study. 
7.2.2 Cell proliferation and viability  
Researches have stated that AuNPs are biocompatible and non-toxic for cell growth and 
other biochemical activities of the cell (Wang et al, 2012; Tsai et al, 2013). Cell 
proliferation, in this study, was determined by coulter counter measurement. This 
technique is considered as being   most sensitive in determining the decrease in cell 
number in AuNPs treated cells compared to control (Bancos et al, 2012). We show that 
proliferation was inhibited after incubation with modified and non-modified AuNPs. 
Similarly, Kalishwaralal et al (2011), found that gold nanoparticles significantly 
inhibited cell proliferation. However, this effect was seen at the concentration of 500 
nM (9. µg/mL ), whereas we used the dosage concentration of 2.9 µg/mL . 
 
In the present study, cell viability was obtained via haemocytometer, coulters counter 
and flow cytometer assays. Although we show that cell viability was not affected by 
AuNP incubation after short incubation times, longer incubation times reduced viability 
significantly. AuPVP, AumPEG and their stabilisers had similar effect on cell 
proliferation of BAEC and cell viability when evaluated with flow cytometer. Although 
it was interesting to observe that the non-modified PEG further inhibited proliferation 
after 48 hrs. Using the haemocytometer, there was no evidence of any effect of AuNPs 
on cell viability in our study. NPs have been reported to interfere with cell viability and 
proliferation assays, (Bancos et al, 2012). Using silica nanoparticles (0.001 µg/mL ), 
Bancos et al (2012), has shown that they had little interference with flow cytometer and 
coulter counter assays. NP dosages were less than those used in the present study. 
Aguilar (2010) reported that 10 µg/mL AuNPs are not toxic to cells in vitro. 
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Freese et al (2012), found that  cell viability and proliferation of Human Dermal 
Microvascular Endothelial Cells (HDMEC), was reduced and this profound effect was 
not due to NPs sizes, but rather due to the influence of  concentration of sodium citrate 
on the NPs surface. In a study on  PVP and PEG polymers, Xie et al (2012), 
demonstrated using ethidium bromide/fluorescein diacetate staining technique (for cell 
viability) that PVP(10000MW) reduced viability of islet cells by 63.4%, whereas, PEG 
5000MW and PEG (8000MW) both further reduced viability (58.1% and 60.7%, 
respectively) after 48 hrs incubation. Furthermore, Xie et al (2012) indicated that PVP 
polymer was a better cryoprotectant candidate as compared to PEG because PVP 
showed a fast dissolution rate in culture medium.  
 
Our viability observation with the automated cell counter shows that PVP and mPEG 
both further reduced viability Moreover; we found that incubation timing had an 
influence on cell viability. Using porcine brain endothelial cells (BPEC), Freese et al 
(2013) found that the cell viability was not affected after treatment with poly (2-
hydroxy-propyl-methacrylamide)-coated gold nanoparticles at different concentration. 
On the other hand, Xie  et al (2012), found that increasing concentration of the 
polymers significantly increased the islet viability. In a AuNP study, Ng et al (2010) 
specified that 20nm sized AuNPs led to oxidative stress in the embryonic lung 
fibroblasts and inhibited cell proliferation as well as alteration of the cell cycle gene. 
They proclaimed that their observation was more likely due to immune reactions. 
Oxidative stress induced by AuNPs may lead to cell death and consequently reduce 
viability. This may explain the reduction in cell viability reflected in our study. Soenen 
et al (2012), found in their study that poly (methacrylic acid),-coated AuNPs reduced 
cell proliferation and cellular differentiation. These studies further support our findings 
that the modified AuNPs had an influence on reducing cell function.  
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7.2.3 Cellular localization of gold nanoparticles  
Using confocal microscopy, NPs of 13nm and 50 nm sizes were visualised within the 
cytoplasm of ECs. Recently, it has been demonstrated that fluorescence intensity can be 
amplified by Plasmon particles (Dykman and Khlebstov, 2011). This explains the 
observation of the 13 nm and 50 nm non-fluorescent dyed AuNPs particles by 
fluorescence microscopy. Furthermore, we observed that 50nm had greater intensity as 
compared to smaller sized particles. Longer incubation indicated greater number of 
AuNPs in the membrane. As mentioned previously in the study, AuNPs are widely 
applicable in radiation research due to their high atomic number (Z). Subsequently, this 
results in a different mass energy absorption property. Thus the mass energy absorption 
property of gold is greater than that of the soft tissue. The high atomic number 
corresponds to large bound of electrons, which results in high mass absorption 
coefficient for X-ray. Hence AuNPs are described as being effective X-ray agents. 
 
 Our observations of the larger sized AuNPs being more easily visualized, may be due 
to the fact that 50 nm AuNPs had greater atomic number than the small AuNPs and 
have greater absorption energy than the small particles. We observed uptake of both 
PVP modified and non-modified 13 nm AuNPs by ECs, where non-modified NPs 
showed greater uptake within the cytoplasm. Zhang et al (2012) stated that 50nm NPs 
have stronger radiation sensitivity than 17 nm NPs. Chien and co-workers, (2012) 
justified that non-modified AuNPs provided high contrast which allowed them to detect  
small capillary species in vivo, whereas  modified  AuNPs with mercaptoundecanoid 
acid (MUA) gave less positive results in detection of small vessels. Wang et al (2013) 
reported that increasing the capping density of AuNPs can increase the detection 
sensitivity of AuNPs. Interestingly, using the confocal imaging, demonstrated that 
images of cells with modified AuNPs had low intensity compared to non-modified 
AuNPs. Indeed justification can be made that size of AuNPs and weight of polymer 
stabilisers can influence the contrast of imaging. 
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7.2.4 Cell apoptosis and necrosis 
Apoptosis can be triggered by physiological and pathological stimuli (Elmor, 2007; 
Alberts et al, 2002).  Flow cytometric analysis through fluorescein Annexin V-FITC 
and PI double staining in the present study, revealed that the gold nanoparticles exerted 
significant cytotoxicity to BAEC- cells in time-dependent manner and was influenced 
by  type of stabilisers used. Similarly, using MTT assay, Selim and Hendi (2012) found 
that gold NPs induced apoptosis in MCF-7 human breast cells via p53, bax/bcl-2 and 
caspase  pathways. However, they found that significant cytotoxicity was dose 
dependent, whereby at 200µg/mL , viability was 70% after 24 hrs. The dose used was 3 
fold higher as compared to the dose concentration used in the present study (2.9µg/mL 
). We show that modified AuNPs and their stabilisers significantly induced apoptosis, 
and after non- modified AuNPs. Similarly, several reviews have stated that 13nm 
AuNPs coated with PEG (5000MW), induced inflammation and apoptosis of mouse 
Kupffer cells and macrophages (Tsai et al, 2013; Tiwari et al, 2011).  Knop et al (2010) 
stated that not only does PEG have benefits, but they also have side effects and 
complications. We observed that mPEG alone significantly increased necrotic cells as 
well as PVP alone. A contradiction is made  by  Tsai et al (2013), using  Annexin V/PI 
double staining to analyse the effect of AuNPs on the cell death program of MG63 
Osteoblast-Like Cells. They found that AuNPs do not alter the cellular apoptosis rate 
during an eight day incubation period, even after high dose concentration. Likewise, 
using trypan blue method Soel et al (2013), found that PEG modified AuNPs did not 
have any detrimental effect on the cell viability of EMT-6 mouse mammary carcinoma 
cell line, therefore proclaimed that PEG-modified AuNPs are not toxic. This finding 
indicates that AuNPs may be inducing apoptosis in a cell type dependent manner. 
According to Mironava et al (2010), detrimental effects caused by AuNPs cannot be 
detected solely by proliferation or apoptosis assays, as AuNPs may be causing an 
interference with other specific functions within the cells. Therefore, this present study, 
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further looked at the effect of modified and non-modified particles on signalling 
pathways. 
7.2.5 Influence of gold nanoparticles on ERK and Akt pathways 
MAP kinase (ERK-1 and ERK-2), is necessary for induction of proliferation in BAEC 
and is known to accumulate significantly in the nucleus ( Roux and Blenis, 2004). Our 
western blotting study shows that ERK-1 and ERK-2 expression was reduced in all 
culture condition when compared to incubation in ACh alone.This is supported by our 
finding that both modified and non-modified AuNPs inhibited cell proliferation of 
BAEC. Roux and Blenis (2004) revealed that inhibitors of the ERK pathway are 
emerging in clinical trials as anticancer agents. Based on our findings, we can suggest 
that modified and non-modified AuNPs make great anticancer agents, due to their 
ability to inhibit proliferation. Rauch et al (2012) demonstrated that NPs can bind to 
surface membrane receptors and consequently, activate specific cellular signalling 
pathways. This maybe one mechanism whereby modified and non-modified AuNPs 
may influence signalling pathways. 
 
In the present study, we noted that non-modified AuNPs did not affect the Akt 
signalling pathway. However, modified AuNPs reduced Akt signalling pathways.  
Wang et al (2012), studied the metabolic effects of dietary AuNPs in Drosophila larvae, 
they interestingly found that dietary AuNPs promoted the Akt signalling pathway and 
altered lipid metabolism, an unexpected in vivo effect of nanomaterial on cellular 
metabolism. Rauch et al (2012), demonstrated  using superparamagnetic iron oxide NPs  
that stimulation of ERK and Akt signaling pathways by the NPs was also dependent on  
surface modification. On the other hand, the concentration used to stimulate the cells in 
our study may have influenced the outcome.   
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Furthermore, the study of Wang et al (2012) also indicted that endocytosis of AuNPs 
may promote Akt signalling. We observed greater uptake of non-modified AuNPs than 
modified AuNPs after 30 min incubation. In the present study Akt signalling was only 
examined after 30 min of incubation. It is expected that a longer incubation time of cells 
with NPs will lead to further Akt phosphorylation as we have shown a great degree of 
uptake of NPs after 24 hrs. 
 
7.3 Effect of stabilisers (Polyvinylpyrrolidone and 
polyethylene glycol), modified and non-modified particles on 
vascular function 
 
7.3.1 Gold nanoparticles uptake into vasculature 
Examination of EM sections of the aortic vessels,  demonstrated that there was no 
evidence of uptake of  non-modified AuNPs by cells of the vasculature after 30 min 
incubation. However, our ICP results indicated the uptake of gold elements within 
vessels after exposure to AuNPs at of both concentrations (2.9ug/ml (13%) and 
5.8ug/ml (23%)). Considering that the AuNPs aggregated in PSS, indicated that they 
had increased in size. Interestingly, De Jong et al (2010) examined the uptake of 10nm 
of 250nm AuNPs by tissues after intervenous administration into rats, using TEM. They 
found that even large particles of 250 nm were impossible to detect in a single TEM 
section, due to the amount of AuNPs administered  being to low; therefore it makes it 
almost impossible to detect the AuNPs present in one TEM preparation. De Jong et al 
(2010) have suggested that it is ideal to employ additional elemental analysis to 
positively indicate the presence of AuNPs. Indeed, we have shown using ICP the 
presence of gold metal. Whether this is due to the presence of AuNPs inside the 
cytoplasm or whether it is due to AuNPs aggregates attaching to the surface of the EC, 
cannot be confirmed. Nevertheless, AuNP uptake was detected by TEM once they were 
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modified with PVP (ICP=4%). However, fewer AuNPs were detected after modification 
with mPEG (ICP=3%). Our findings also indicated that a greater concentration of 
polymer monolayers (used to stabilise the NPs) led to a higher degree of PVP modified 
AuNPs uptake.  
 
An increase in the concentration of mPEG modified AuNP led to increased vascular 
uptake. They were located in the adventitial layers, as well as the cytoplasm of 
endothelial cells. None were located in the nucleus of cells, in the elastic lamina or 
within the smooth muscle cell layer. A number of studies have shown that pegylated 
particles reduced uptake of particles. For instant, Arnida et al (2010) found that 50nm 
non-polymer modified particles had highest uptake by cells compared to the  PEG 
modified particles. Similarly, Manson et al (2011) found less uptake of pegylation of 
particles by the reticular endothelial system. Nativo et al (2008) found no uptake of 
PEG coated AuNPs at all by by HeLa cells.  Terntyuk et al (2009) studied the in vivo 
organ and tissue distribution of functionalized nanoparticles in rats and after 24 hours 
administration of pegylation AuNPs intravenously, and found a maximal AuNPs 
accumulation in the liver and spleen as compared to 30min administration. Thus, both 
Terntyuk et al (2009) and Boyoglu et al (2013) indicated that uptake can be influence 
by the timing of incubation. Our findings indicated that AumPEG uptake was also 
concentration dependent.  At low concentration there was no uptake of the AumPEG 
into the vasculature. Swami et al (2012) found that PEG modification of the NPs 
reduced their accumulation in off-target organs such as liver and spleen.  
 
The length, shape, and density of PEG chains on the NPs’ surface have been shown to  
reduce the hydrophilicity and phagocytosis of the NPs (Swami et al, 2012). Also, an 
assumption can be made that modified AuNPs causes the diameter of particle to 
increase, hence, reducing the chance of uptake into the vasculature. Another plausible 
explanation for reduced uptake and inability to detect NPs by TEM, maybe due to the 
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fact that NPs are taken up actively by the cells via nonspecific endocytosis, and are 
leaving the cells via exocytosis if the particles are unable to be digested by lysosomes 
after they have been taken up (Tsai et al, 2013).   
 
 Oh et al (2011) identified in their study that the ultimate intracellular destination is 
further determined by the diameter of particles. Using AuNPs with the diameter ranging 
from 2.4 to 89 nm, they found that 2.4 nm AuNPs were localised in the nuclear, 
whereas, 5.5 and 8.2 nm particles were partially delivered into the cytoplasm and > 16 
nm AuNPs did not enter the cells and were located at the cellular periphery. This 
justifies the observation of low or no uptake of NPs into ECs in our study, as non-
modified particles aggregated in PSS, subsequently, the particle sizes increased.  
Takae et al (2005) observed an increase in nanoparticle diameter from 20 to33.3 nm 
after functionalization with 6,000 Mw PEG. This statement justifies that the 
modification AuNPs in our present study led to the increase in the NP diameter, 
consequently, affecting particle uptake. 
 
De Jong et al (2010) indicated in their study, that TEM analysis alone is not effective in 
detecting uptake. Indeed, using ICP-MS we have shown uptake of non-modified AuNPs 
into vessels, contrary to our TEM results.  The aggregation of our non-modified AuNPs 
may have given a greater reading in ICP-MS, due to the fact that aggregation of NPs 
involves a greater number of NPs attached. In contrast, our modified AuNPs were well 
dispersed, therefore less amount of uptake is evident by ICP-MS. 
 
Our ICP-MS results for uptake of modified AuNPs were similar to TEM observation in 
which we detected less uptake of polymer coated AuNPs, in particular AumPEG.  
Interestingly, when the concentration of AumPEG NPs was doubled, a higher amount of 
gold metal from the double amount concentration of AumPEG was detected using ICP-
MS. 
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7.3.2 Effects of gold nanoparticles on aortic dilation responses 
The influence of AuNPs on vascular function was studied using the organ bath 
system.Aortic vessels were incubated in AuNPs at 1.68X10
11
 NP/mL (2.9µg/mL ), over 
a 30 minute acute exposure time period. This concentration was also utilised in our cell 
culture experiments. This exposure time and NP concentration is commonly used in 
other studies which have identified NP uptake into tissues. For instance,   Kempson et al 
(2012), studied the fate of intravenously administered gold nanoparticles in hair 
follicles, after intravenous administration into  mice. After 30 min, the dermal papilla, 
bulge region, and root sheath all contained NPs. Hainfeld et al (2006) used 1.9 nm 
AuNPs as an x-ray CT contrast agent to detect tumours in mice, and found that AuNPs 
had accumulated in the organs after just 15 min of intravenous injection.  When 10 nm 
AuNPs were injected intravenously at 5.7 x 10
12
 NP/ml into rats, uptake into most 
tissues was evident at 24 hours after injection (De Jong et al, 2010). In another in vivo 
study, 13 nm PEGylated AuNPs were injected at the low dose of 1.76 x 10
11
 NPs/ml 
into mice. These NPs were seen to accumulate in tissues within 30 min after intravenous 
injection and were shown to induce acute inflammation and apoptosis (Cho et al, 2009). 
A study investigating the effect of coupling AuNPs to NO donors (Ruthenium complex) 
has demonstrated that NO released from the AuNP-ruthenium complex was lower than 
that released from the ruthenium complex alone (Silva et al, 2014).  
7.3.2.1 Influence of non- modified gold nanoparticles on  dilator 
responses  
In this study we observed that non-modified AuNPs had no overall effect on the 
endothelium-dependent (ACh) relaxation of the vessels. AuNP aggregation in PSS and 
lack of uptake as evidenced by TEM may explain the lack of any detrimental effect on 
ACh mediated dilation.  An important finding from the present study is that unmodified 
AuNPs significantly attenuated responses to SNP. This suggests that AuNPs may interact 
directly with the SNP drug. Such interaction has also been suggested for a number of 
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agonists (Nurkiewicz et al, 2009), and confirms the additional need for coating AuNPs 
before use. AuNPs are able to rapidly catalyse the decomposition of hydrogen peroxide 
(He et al, 2013), whereby, hydrogen peroxide (H2O2), is recognized to induce 
vasorelaxation (Cai, 2005). Another possible suggestion for the attenuated SNP responses 
is that non-modified AuNPs may reduce the sensitivity of the smooth muscle cells to SNP 
and interfere with the signalling pathway leading to vasodilation. AuNPs may block the 
inward rectifier potassium channels  (KIR), which therefore reduce the SNP effects on the 
vascular smooth muscle, (Schubert et al, 2004).  
7.3.2.2 Influence of Polyvinilpirrolidine- modified gold nanoparticles on 
dilator responses 
Our initial observation showed that non-modified AuNPs aggregated in PSS. 
Consequently, to overcome this effect and prevent aggregation, AuNPs were modified 
with the polymers, PVP and mPEG. PVP modification of the AUNPs increased their 
stability and monodispersion AuPVP NP uptake into the vessel was demonstrated, as 
individual NPs within the cytoplasm of ECs. Our initial studies demonstrated that when 
AuNPs were modified with a high concentration of PVP, their uptake induced a 
significant reduction in ACh dilator responses. Vessel incubation in AuNPs modified 
with a low concentration of PVP, had no significant effect on ACh dilator responses. The 
fact that incubation in PVP alone (at the low concentration), caused a significant 
reduction in ACh dependent dilator responses, suggests that it is the PVP itself which 
may be influencing dilation. PVP modified AuNPs (at high concentration) may be larger 
in size than those that were modified with a low PVP concentration, and hence may have 
interacted with cellular components leading to the attenuated dilation. Furtherrmore, PVP 
modified NPs may affect the ATP production in the mitochondria as it is acknowledged 
that the production of relaxant factor by endothelium is dependent on the mitochondrial 
oxidative phosphorylation (OXPHOS) (Marin-Garcia, 2013). Furthermore, the 
mitochondria are one of the major organelles targeted by NPs for inducing oxidative 
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stress (Manke et al, 2013). For example, Pan et al (2009) demonstrated that non-modified 
gold nanoparticles of diameter 1.4 nm triggered necrosis by oxidative stress and 
mitochondrial damage. 
 
Duffin et al (2007), has demonstrated, using human models, that NPs enter the 
circulation and can have direct effects on the endothelium, leading to endothelial 
dysfunction. They investigated the effects of diesel exhaust inhalation on vascular and 
endothelial function in humans. After 2 to 6 hrs exposure of the NPs, they found that 
the vasomotor responses to the vasodilator drugs (ACh, BK and SNP) were attenuated, 
whilst the responses to Verapamil were not affected, as this type of vasodilator causes 
relaxation by an endothelium-independent and NO-independent pathways, unlike the 
other vasodilators used in their study. Therefore in our present study, PVP maybe 
preventing the AuNPs from quenching NO that is released by the NO donor (SNP). 
When vessels were incubated in AuNPs modified with a high PVP concentration, they 
had no influence on SNP responses, however, incubation in AuNPs modified with a 
low PVP concentration, induced a significant reduction in SNP responses. When 
vessels were incubated in a low concentration of PVP alone, no effect on SNP 
responses were noted. This suggests that it is the AuNP itself which maybe interfering 
with the action of SNP. PVP modification of the AuNPs may thus prevent its 
interaction with SNP. At low PVP concentration, the polymer monolayer may have 
been insufficient to fully coat the AuNP and hence allow its interaction with SNP. The 
interaction of nanomaterials with the function of SNP have been demonstrated 
previously. For example, Shukur et al (2012) demonstrated the attenuation of SNP 
induced dilation in mesenteric vessels after incubation in quantum dots. 
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7.3.2.3 Influence of Mecapto polyethylene glycol - modified gold 
nanoparticles on dilator responses 
Polyethylene glycol (PEG) has been demonstrated to prevent cellular uptake of gold 
nanorods (Hauck et al, 2008).  Kim et al (2007), used PEG coated gold nanoparticles  
to extend their systemic circulation half-life, whereby nanoparticles injected 
intravenously into rats showed much longer blood circulation time (> 4 hrs). In our 
present study we determined the minimum concentration of mPEG required to prevent 
aggregation of the AuNPs in PSS. mPEG modified  AuNPs (at 2.9ug/ml), had no 
overall influence on endothelium dependent responses. When vessels were incubated 
at the higher 5.8ug/ml concentration of mPEG modified AuNPs, the dilatory responses 
were significantly reduced (p<0.001). Indeed, uptake of AumPEG by the endothelial 
cells was also shown to be concentration dependent.A high NP concentration  may 
result in passive transport into the vessels. This is supported by Treuel et al (2013); 
they stated that NPs may enter cells by passive penetration of the plasma membrane.  
 
Vessel incubation in AuNPs modified with mPEG led to a slight but non-significant 
influence on SNP dilator responses.  Since the thiol group on the mPEG is attached to 
the surface of the AuNPs and the PEG chain molecule is in direct contact with the 
surrounding tissue, we decided to investigate the effect of the non thiol PEG molecule 
alone on vascular function. ACh responses were not affected after incubation with non 
thiol modified PEG alone, however, SNP dose responses were affected at high doses, 
suggesting that PEG may be influencing the sensitivity of the smooth muscle cells to 
SNP, possibly through blocking the KIR channels(Schubert et al, 2004). On the other 
hand, thiol modified AuNP incubation affected SNP responses only at the highest 
dose. 
 
Size of the polymer chain may also affect the vascular responses. In our study, PEG 
(6000 MW) has a greater molecular weight than mPEG (5000MW); indeed, their 
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weight may contribute towards the influence on responses observed. Nanoparticle 
morphology may alter after uptake, therefore, this may explain the varied effects of 
modified particles compared to their stabilizers alone (Garcia et al, 2013). 
 
Intracellular degradation of NPs is considered an important factor which may lead to 
the alteration of the NPs’ behaviour, and subsequently, results in the varied biological 
functionality after interaction with cellular components. Indeed, degradation of 
modified NPs may lead to variation in effects on cellular function compared to those 
caused by their stabilisers alone. For instance, Soenen et al (2014) studied the effect of 
nanoparticle degradation on poly(methacrylic acid)-coated quantum dot toxicity and 
revealed that the quantum dots were partially degraded and released cadmium ions and 
consequently caused greater particle toxicity. This can explain our observation of the 
difference in attenuation effects between the modified AuNPs and their stabilisers in  
our present study. 
7.3.2.4 Mechanisms of attenuated vasodilation induced by AuNPs 
In order to elucidate mechanisms leading to attenuated vasodilation by AuNPs, 
cellular studies were conducted on ERK and Akt signalling pathways. Both pathways 
are reported to be responsible for inducing dilation of vessels, due to their role in 
stimulating the production of NO by activation of eNOS. For instance, the ERK 
signalling pathway has been implicated in vasodilator responses associated with retinal 
arterioles (Yuan et al, 2008). Stimulation of NO-mediated vasodilation is also linked 
with the activation of P1EK/Akt pathways (Guo et al, 2005). The release of NO results 
in the activation of guanylyl cyclase in the VSMC, and consequently elevating the 
cGMP. cGMP is considered an important messenger in inducing vasodilation, as it is 
involved in activating the K
+ 
channels which leads to the hyperpolarization and 
relaxation of the vessels.  
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When BAECs were stimulated with ACh, AKt and ERK, phosphorylation was 
maximal at 10µM ACh concentration. This confirms our vascular studies, whereby 
aortic vasodilation is evident at this concentration. When the BAEC were stimulated 
with ACh, in the presence of modified and non-modified AuNPs, a reduction in ERK 
and Akt phosphorylation was observed for PVP and mPEG modified, but not non-
modified AuNPs. These findings confirm our vascular function responses for the non-
modified AuNPs (no attenuation and PVP modified AuNPs (significant attenuation in 
dilation). It is not clear why reduced ERK and Akt phosphorylation is not mirrored by 
reduced dilation due to AumPEG. However, the degree of uptake of modified AuNP 
by cells in culture was higher than that in vessels and this may explain the difference. 
Also PVP modified AuNP may act as antagonists and inhibit ERK and AKt 
stimulation by the ACh receptors; thus reducing the NO production in the EC.  Vessel 
incubation in PVP alone, led to a significant reduction in ACh induced dilation. The 
reason for this is not clear. The surface chemistry of the polymers is, however, known 
to influence cell interaction and morphology (Saltzman, 2000). PVP surface groups 
could bind to protein such as the ACh receptors, acting as an antagonist (Jiang et al, 
2006). Although PVP has been used to modify NPs to reduce their cytotoxicity, such 
as grapheme oxides (Zhi et al, 2013) and iron oxide NPs (Zhang et al, 2010), there is 
evidence that when PVP is complexed with iodine, the product (PVP-I) can be 
cytotoxic to cells. For example, Sato et al (2014) found that PVP-I induced apoptosis 
of epithelial cells at 1x10
-2 µM concentration. 
 
The SNP responses were reduced after incubation with non-modified AuNPs, minimal 
PVP modified AuNPs and PEG stabilisers but not PVP stabilisers. Minimal PVP 
modification provided a weak stability of AuNPs, hence, justifies the similarity in 
effect on the SNP responses to non-modified AuNPs. Furthermore, the attenuation of 
SNP response indicates that non-modified AuNPs and minimal PVP modified AuNPs 
may similarly compete for the NO released by the NO donors, thus impairing the 
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vasodilator response as has been recently demonstrated using ruthenium complex as a 
NO donor. When complexed with AuNPs, NO release was reduced (Silva et al, 2014). 
7.3.3 Study limitations 
The results of our present study maybe have been affected by a number of  limitations 
discussed below. 
 
1. Nanoparticle uptake: NP uptake by vessels may have been affected by the 
incubation conditions. Using the organ bath system, vessels were constantly 
gassed in 95 % O2: 5 % CO2 within the organ chamber.  This could have 
disturbed the uptake of the AuNPs by the vessels, compared to the steady 
conditions of exposure in the cell culture environment. A pressure myograph 
system could be used in future applications, where the vessel is exposed to 
gassed PSS at source. Additionally, only a few sections were examined under 
TEM, per exposure condition. A more thorough quantification of serial 
sections could be done in the future. 
2. Cell culture studies were conducted using BAECs. Use of rat aortic endothelial 
cells would have allowed for a better comparison with rat aortic vascular function 
studies. Furthermore, the use of human cells and human vessels would allow the 
translation of the work which would represent an ideal model to determine the 
direct influence of AuNPs in man.  
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7.4 Conclusion   
In the present study NPs of 2 different material compositions were fabricated and 
characterised; Silica NPs (SiNPs) and gold NPs (AuNPs). The 13 nm AuNPs were 
modified using 2 polymers; PVP and mPEG. The SiNPs were successfully utilized as 
the NPs of choice for an alternative vascular function ex vivo study, and the findings 
were published (Akbar et al, 2011). The influence of both modified and non-modified 
AuNPs on cellular and vascular function ex vivo was examined in this study. 
 
Results demonstrate that AuNPs are rapidly internalised by endothelial cells and whole 
isolated aortic vessels ex vivo, after a 30 min incubation period. Uptake of modified 
AuNPs by cells was observed to be time dependent, where maximum incubation time 
(48hrs) resulted in greater uptake of AuPVP, compared to AumPEG. Incubation in 
polymers alone also affected cellular function. Polymer degradation of internalized 
polymer modified NPs may take place once inside the cell. In this case, both the AuNPs 
and their degraded stabilizers may induce different effects on cellular function after 
uptake compared to polymers alone. This was observed by the cell apoptosis, where 
PVP and mPEG alone had a greater apoptosis effect compared to AuPVP and AumPEG 
at 2 hours incubation. Both modified and non-modified AuNPs influenced cellular 
signalling differently and modulated physiological responses. In the vessel study, 
unmodified AuNPs attenuated endothelial-independent dilator responses. However, 
AuNPs aggregated in PSS preventing their uptake into the vasculature and hence did not 
influence endothelial-dependent dilator responses of murine aortic vessels. Coating of 
AuNPs with PVP and mPEG polymer (modified AuNPs), prevented aggregation in 
PSS, however, PVP modified AuNPs led to attenuated endothelial-dependent dilator 
responses. The mPEG polymer modified AuNPs had no overall influence on endothelial 
dependent dilator responses, although the influence was concentration dependent. Our 
findings have important implications for the development of new therapies, since 
AuNPs are used in therapy and in imaging diagnostics.  
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7.5 Future work  
The results from our study suggest that depending on the coatings and concentration 
used, AuNPs may affect cellular and vascular function. We have demonstrated that 
modified and non-modified AuNPs can influence  cellular and vascular function by 
affecting endothelial cell function and influencing cell signalling pathways. Therefore, 
future studies will involve: 
Additional Cell culture studies. Cellular behaviour is influenced by NP dosage; it 
would be of interest to determine the effect of modified and non-modified AuNPs on 
cellular function at different dosages. One interesting study indicated that the 
detrimental effects caused by AuNPs cannot be detected solely by proliferation or 
apoptosis assays, as AuNPs may be causing an interference of other specific functions 
within the cells (Mironava et al, 2010). Hence it would be of interest to examine the 
effect of modified and non-modified AuNPs on upregulation of inflammatory markers 
and also to further explore the cell signalling pathway, including eNOS upregulation 
and phosphorylation.   
Functional studies 1: In the present study, the AuNPs were found to influence 
endothelial-dependent and independent responses differently, depending on the type and 
concentration of polymers used to modify the AuNPs. It will be necessary to extend 
these findings to examine the detailed mechanisms involved in attenuated dilation. The 
influence of nanoparticle uptake on arterial function can be further investigated using 
pressure myography technique, which involves mounting vessels under more 
physiological conditions of pressure and flow. We have determined the type and 
concentration of stabilizers that will have a minimum cytotoxic effect on large vessels 
but not on small vessels. So such a study would be interesting, since diameter regulation 
of these vessels is more important in the control of blood perfusion into tissues. In the 
present study, non-targeted colloidal gold NPs were examined. It would be interesting to 
see what effect tagged AuNPs (eg. antibody labelled) may have on cellular and vascular 
function. Additionally, the effects of modified and non-modified AuNPs on whole 
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animals in vivo are yet to be determined. A detailed analysis and quantification of 
nanoparticle uptake can be verified by microscopy using thin (confocal) and ultrathin 
sections (electron microscopy). This will allow detailed quantification of NPs within 
cells. 
 
Functional studies 2: The influence of SiNPs synthesised in the present study, on 
vascular function was examined in another study (Akbar et al, 2011). The ex vivo 
studies demonstrated that acetylcholine (ACh) induced a concentration dependent 
dilator response in all pre-constricted vessels. Incubation in 100nm nanoparticles lead to 
a reduction in the magnitude of the dilator response at higher ACh concentrations, 
although this was not statistically significant (at 0.1 mM ACh, mean dilation was 
37.42±5.50% vs. 45.58±7.02% dilation after incubation in PSS, NS; at 1.0 mM ACh, 
mean dilation was 40.14±5.74% vs. 53.94±6.26% dilation after incubation in PSS, NS) 
ex vivo. SiNPs were injected into a male Wistar rat and sacrificed after 2 hours. The 
ACh-induced dilator responses were altered after NPs incubation in vivo. There was an 
improve dilatory response at every ACh dose response.  Hence, the degree of ACh 
dilation after incubation in 100 nm SiNPs in vivo was higher than that after incubation 
in 100 nm SiNPs exvivo, at the highest 1.0 mM ACh concentration (74.19% dilation vs. 
40.14±5.74%) dilation, after incubation 100nm nanoparticle incubation in vivo and ex 
vivo respectively. More in vivo experiments are required to confirm the findings. Aortic 
vessel incubation in 100 nm ex vivo had no effect on the endothelial-independent dilator 
responses (SNP) at any of the concentrations examined (NS). On the other hand, 
responses were reduced after NPs were incubated in vivo. However, overall n=1 of in 
vivo experiment was conducted therefore, more experiments are  needed  to clarify the 
in vivo results. 
 
  
 
 
203 
  
 
8.REFERENCES 
 
 
 
 
  
 
 
204 
     
8. REFERENCES  
Aderem, A. and Underhill, D.M. (1999) ‘Mechanisms of phagocytosis in macrophages.’ 
Annual Review of Immunology, 17, pp. 593-623. 
Adini I., Rabinovitz I., Sun J. F., Prendergast G. C. and Benjamin L.E. (2003) ‘RhoB controls 
Akt trafficking and stage-specific survival of endothelial cells during vascular development.’ 
Genes and Development, 17(21) pp. 2721–2732.   
Aguilar, Z. (ed.) (2010) ‘Nanomaterials for Medical Applications.’ 1st ed., Elsevier, pp. 1-544. 
Akbar, N., Mohamed, T., Whitehead, D., Azzawi, M. (2011) ‘Biocompatibility of amorphous 
silica nanoparticles: size and charge effect on vascular function, in vitro.’  Biotechnology and 
Applied Biochemistry, 58(5) pp. 353–362.  
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. and Walter, P. (ed.) (2002) 
‘Molecular Biology of the Cell.’ 4th ed., New York: Garland Science; pp.1-1616 
Alkilany, M.A. and Murphy, C.J. (2010) ‘Toxicity and cellular uptake of gold nanoparticles: 
what we have learned so far?’ Journal of Nanoparticle Research, 12(7) pp. 2313-2333. 
Arnida, A., Malugin, A. and Ghandehari, H. (2010) ‘Cellular uptake and toxicity of gold 
nanoparticles in prostate cancer cells: a comparative study of rods and spheres.’ Journal of 
Applied Toxicology, 30(3) pp. 212-217.  
Astruc, D., Lu, F. and Aranzaes, J.R. (2005) ‘Nanoparticles as Recyclable Catalysts: The 
Frontier between Homogeneous and Heterogeneous Catalysis.’ Angewandte Chemie 
International Edition, 44(48) pp. 7852–7872. 
Atomic World; Accessed on 15 January 2014. Available from: http://www.hk-
phy.org/atomic_world/tem/tem02_e.html. 
Aulton, M.E. and Taylor, K.M.G. (2013) ‘Disperse sytems.’(Chapter 5) In: Aulton’s 
Pharmaceutics: The Design and Manufacture of Medicines, pp. 63-92. 
Azzawi, M. (2012) ‘The nanotoxicological influence of nanoparticles with Special Reference 
to the Vasculature’ In M Slevin, Ed.: Current advances in the medical application of 
nanotechnology. Bentham Publications, pp. 73-84. 
 
Korzeniowska, B. Nooney, R. Wencel, D. and McDonagh, C. (2013) ‘Silica nanoparticles for 
cell imaging and intracellular sensing.’ Nanotechnology 24(44) Article ID: e442002. 
  
 
 
205 
Bancos, S., Tsai, D.-H., Hackley,V.,Weaver, J.L. and Tyner, K.M.(2012)‘Evaluation of 
Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles In Vitro 
via Plate-Based, Flow Cytometry, and Coulter Counter Assays.’ International Scholarly 
Research Notices (ISRN) Nanotechnology, 2012, pp.1-15. 
Barandeh, F., Nguyen, P.-L., Kumar, R., Iacobucci, G.J., Kuznicki, M.L., Kosterman,A., 
Bergey,E. J Prasad, P.N. and Gundawardena, S. (2012) ‘Organically Modified Silica 
Nanoparticles Are Biocompatible and Can Be Targeted to Neurons In Vivo.’ Plos one, 7(1), 
Article ID: e29424. 
Behera, M. and Ram, S. (2014) ‘Inquiring the mechanism of formation, encapsulation, and 
stabilization of gold nanoparticles by poly (vinyl pyrrolidone) molecules in 1-butanol.’ 
Applied Nanoscience, 4(2) pp. 247-254. 
Berg, J.M., Tymoczko, J.L.and Stryer, L. (ed.) (2002) Biochemistry. 5th ed., New York: W H 
Freeman. pp. 1-1026. 
Bergman, L., Rosenholm, J. and Öst, A. (2008) ‘On the Complexity of Electrostatic 
Suspension Stabilization of Functionalized Silica Nanoparticles for Biotargeting and Imaging 
Applications.’ Journal of Nanomaterials, pp. 1-9. 
Bernanke, D.H. and Velkey, J.M. (2002) ‘Development of the coronary blood supply: 
changing concepts and current ideas.’ The Anatomical Record, 269(4) pp.198-208. 
Bernardi, R.J., Lowery, A.R., Thompson, P.A., Blaney, S.M. and West, J.L. (2008) 
‘Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in 
vitro evaluation using human cell lines.’ Journal of Neuro-Oncology, 86(2) pp. 165-72. 
Bizi, M. (2012) ‘Stability and flocculation of nanosilica by conventional organic polymer.’ 
Natural Science, 4(6) pp. 372-385.  
Blanco-Andujar, C., Tung L.D and Thanh N.T.K. (2010) ‘Synthesis of nanoparticles for 
biomedical applications.’ Annual Reports on the Progress of Chemistry, Section A (Inorganic 
Chemistry), 106, pp. 553-568. 
Bogush, G. H., Tracy, M. A. and Zukoski Iv, C. F. (1988) ‘Preparation of monodisperse silica 
particles: control of size and mass fraction.’ Journal of Non-Crystalline Solids, 104 (1) pp. 95-
106. 
Böhm, F. and Pernow, J. (2007) ‘The importance of endothelin-1 for vascular dysfunction in 
cardiovascular disease.’  Cardiovascular Research, 76(1) pp. 8-18. 
  
 
 
206 
Bolotina, V. M., Najibi, S., Palacino, J. J., Pagano, P.J. and Cohen, R.A. (1994) ‘Nitric oxide 
directly activates calcium-dependent potassium channels in vascular smooth muscle.’ Nature, 
368(6474) pp. 850-853. 
Boonen and Roeven, (2011) ‘Synthesis and characterisation of silica-coated magnetite 
nanoparticles.’ Minor Disciplines Applied Science Course 47: Colloids. pp.1-23. 
Boulanger, C. M. and Vanhoutte, P.M. (1998) ‘The endothelium: a modulator of 
cardiovascular health and disease.’ Dialogues in Cardiovascular Medicine, 3(4) pp.187-1999. 
Boyoglu, C., He, Q., Willing, G., Boyoglu-Barnum, S., Dennis, V. A., Pillai, S. and  Singh S. 
R. (2013) ‘Microscopic Studies of Various Sizes of Gold Nanoparticles and Their Cellular 
Localizations.’ ISRN Nanotechnology, 2013, pp.1-13. 
BSI standards publication, PAS 71, pp.1-25. 
Buckley, A.M. and Greenblatt, M. J. (1994) ‘Sol-Gel Preparation of Silica Gels.’ Journal of 
Chemical Education, 71(7) pp. 599-602. 
Butterworth, K.T., McMahon, S. J., Taggart, L. E. and Prise, K. M. (2013) ‘Radiosensitization 
by gold nanoparticles: effective at megavoltage energies and potential role of oxidative stress.’ 
Translational Cancer Research, 2(4) pp. 269-279. 
Cai, H. (2005) ‘Hydrogen peroxide regulation of endothelial function:Origins, mechanisms, 
and consequences.’ Cardiovascular Research, 68(1) pp. 26-36. 
Canton, G., Riccò, R., Marinello, F., Carmignato, S. and Enrichi, F. (2011) ‘Modiﬁed Stöber 
synthesis of highly luminescent dye-doped Silica nanoparticles.’ Journal of Nanoparticles 
Research, 13(9) pp. 4349-4356. 
Casciaro, S., Conversano, F., Ragusa, A., Malvindi, M.A., Franchini, R., Greco, A., 
Pellegrino, T. and Gigli, G. (2010) ‘Optimal enhancement configuration of silica nanoparticles 
for ultrasound imaging and automatic detection at conventional diagnostic frequencies.’ 
Investigative Radiology, 45(11) pp.715-724. 
Celermajer, D.S. (1997) ‘Endothelial Dysfunction: Does It Matter? Is It Reversible?’ Journal 
of the American College of Cardiology, 30(2) pp.325-333. 
Chandra, P., Das, D. and Abdelwahab, A.A. (2010) ‘Gold Nanoparticles in Molecular 
Diagnostics and Therapeutic.’ Digest Journal of Nanomaterials and Biostructures, 5(2) pp. 
363 – 367. 
  
 
 
207 
 Chawla, S J. and Mansoor. M. (2003) ‘Cellular uptake and concentrations of tamoxifen upon 
administration in poly (ε-caprolactone) nanoparticles.’ American Association of 
Pharmaceutical Scientists, 5(1) pp. 28–34. 
Chien, C.-C., Chen, H.-H., Lai, S.-F., Hwu, Y., Petibois, C., Yang, C.S., Chu, Y. and 
Margaritondo G. (2012) ‘X-ray imaging of tumor growth in live mice by detecting gold-
nanoparticle-loaded cells.’ Scientific Reports, 2, pp.610-616. 
Chithrani, B.D, Ghazani, A.A., Warren, C.W. and Chan, W.C.W. (2006) ‘Determining the 
Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells.’ Nano 
letters, 6(6) pp.662-668. 
Cines, D.B. , Pollak, E. S., Buck C.A., Loscalzo, J., Zimmerman,  G.A. , McEver, R.P., Pober, 
J. S., Wick, T.M., Konkle, B.A., Schwartz, B.S., Barnathan, E.S., McCrae, K.R., Hug, B.A., 
Schmidt, A. and Stern, D.M. (1998) ‘Endothelial Cells in Physiology and in the 
Pathophysiology of Vascular Disorders.’ Blood, 9(10) pp. 3527-3561. 
Coats, P., Johnston, F., MacDonald, J., McMurray, J.J. and Hillier, C. (2001) ‘Endothelium-
derived hyperpolarizing factor: identification and mechanisms of action in human 
subcutaneous resistance arteries.’ Circulation, 103(12) pp. 1702-1708. 
Cooper, G.M. (ed.) (2000) ‘The Cell: A Molecular Approach.’ 2nd ed., Sunderland (MA): 
Sinauer Associates, Available on: http://www.ncbi.nlm.nih.gov/books/NBK9839/5March 
(Accessed: 4 December 2013). 
 
Cortadellas N, Fernández, E and Garcia A. (2012) ‘Biomedical and Biological Applications of 
SEM.’ Handbook of instrumental techniques from CCiTUB, pp. 1-9. 
 
  
  
 
 
208 
Crist, R.M., Grossman, J.H., Patri, A.K., Stern, S.T.,   Dobrovolskaia, M.A.,  Adiseshaiah, P. 
P.,   Clogston, J.  D. and    McNeill, S. E. (2013) ‘Common pitfalls in nanotechnology: lessons 
learned from NCI's Nanotechnology Characterization Laboratory.’  Integrative Biology, 5, pp. 
66-73. 
 
Davda, J. and Labhasetwar, V. (2002) ‘Characterisation of nanoparticles uptake by endothelial 
cells.’ International Journal of Pharmaceutics, 233(1-2) pp. 51-59.  
Davies, G.-L, Barry, A. Gun’ko, Y.K. (2009) ‘Preparation and size optimization of silica 
nanoparticles using statistical analyses.’ Chemical Physics Letters, 468 pp. 239–244. 
Doane, T. and Burda, C. (2013) ‘Nanoparticle mediated non-covalent drug delivery.’ 
Advanced Drug Delivery Review, 65(5) pp. 607-621. 
Dominguez-Medina, S., Blankenburg, J., Olson, J., Landes, C.F. and Link, S. (2013) 
‘Adsorption of a Protein Monolayer via Hydrophobic Interactions Prevents Nanoparticle 
Aggregation under Harsh Environmental Conditions.’ ACS Sustainable Chemistry and 
Engineering, 1(7) pp.833-842. 
Dragoni, S., Franco, G., Regoli, M., Bracciali, M., Morandi, V., Sgaragli, G., Bertelli, E. and 
Valoti, M.(2012 ) ‘Gold nanoparticles uptake and cytotoxicity assessed on rat liver precision-
cut slices.’ Toxicological sciences, 128(1) pp. 186–197. 
Duffin, R., Mills, L.N. and Donaldson, K. (2007) ‘Nanoparticles-A Thoracic Toxicology 
Perspective.’ Yonsei Medical Journal, 48(4) pp. 561–572. 
 Dukhin, A.S., Ulberg, Z.R., Karamushka, V.I. and Gruzina, T.G. (2010) ‘Peculiarities of live 
cells' interaction with micro- and nanoparticles.’ Advances in Colloid Interface Science, 
159(1) pp. 60-71. 
Dunlap, M. and Adaskaveg, J.E. (1997) ‘Introduction to the Scanning Electron 
Microscope: Theory, Practice, & Procedures.’ Facility for advanced instrumentation, 
U. C. Davis. pp. 1-50. 
Dykman, L.A. and Khlebtsov, N.G. (2011) ‘Gold Nanoparticles in Biology and Medicine: 
Recent Advances and Prospects.’ Acta Naturae, 3(2) pp. 34–55. 
Elmore, S. (2007) ‘Apoptosis: A Review of Programmed Cell Death.’ Journal of Toxicologic 
and Pathology, 35(4) pp. 495–516. 
  
  
 
 
209 
Estrela-Lopis, I., Romero, G., Rojas, E., Moya, S.E. and Donath, E. (2011) ‘Nanoparticle 
uptake and their co-localization with cell compartments – a confocal Raman Microscopy study 
at single cell level.’ Journal of Physics: Conference Series, 304: Article ID: e012017.  
Evan, S., Cihui, Z., Amir, N., Hamir, Agatha borne, C., Shea Thompson and Steven A (2011) 
‘Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor 
model.’ Nanotoxicology. 5(4) pp. 459-468. 
Falcone, S., Cocucci, E., Podini, P., Kirchhausen, T., Clementi, E.  and Hood, E., Simone, E., 
Wattamwar, P., Dziubla, T.,  and Muzykantov, V. (2011) ‘Nanocarriers  for vascular delivery 
of antioxidants.’ Nanomedicine, 6(7) pp. 1257-1272. 
Fang, R.H, Che-Ming Jack Hu C.-M.J. and Zhang L. (2012) ‘Nanoparticles disguised as red 
blood cells to evade the immunesystem.’ Expert Opinion on Biological Therapy, 12(4) pp. 
385-389. 
Farooq, A., Whitehead, D. and Azzawi, M. (2013) ‘Attenuation of endothelial dependent 
vasodilator responses, induced by dye encapsulated silica NPs, in-vitro.’ Nanomedicine 
(Lond). 9(3) pp. 413-425.  
Figueroa, E. R., Lin, A.Y., Yan, J., Luo, L., Foster, A. E. and Drezek, R. A.(2014) 
‘Optimization of PAMAM-gold nanoparticle conjugation for gene therapy.’Biomaterials. 
35(5) pp. 1725-1734. 
Freese, C., Uboldi, C., Gibson, M. I., Unger, R.E., Weksler, B.B., Romero, I.A., Couraud, P.-
O. and Kirkpatrick, C.J. (2012) ‘Uptake and cytotoxicity of citrate-coated gold nanospheres: 
Comparative studies on human endothelial and epithelial cells.’ Particle and Fibre 
Toxicology, 9(23) pp. 1-11.  
Freese, C., Unger, R. E., Deller,R. C., Gibson, M. I., Brochhausen, C., Klok, H.-A. and  
Kirkpatrick, C.J. (2013) ‘Uptake of poly(2-hydroxypropylmethacrylamide)-coated gold 
nanoparticles in microvascular endothelialcells and transport across the blood–brain barrier.’ 
Journal of Biomaterial Science, 1(8) pp. 824-833. 
Frens, G. (1973) ‘Controlled nucleation for the regulation of theparticle size in monodisperse 
gold suspensions.’ Nature Physical Science, 241, pp. 20–22. 
Fritz, G., Schädler, V., Willenbacher, N. and Wagner, N.J. (2002) ‘Electrosteric Stabilization 
of Colloidal Dispersions.’ Langmuir, 18(16) pp. 6381-6390. 
Fröhlich E. (2012) ‘The role of surface charge in cellular uptake and cytotoxicity of medical 
nanoparticles.’ International Journal of Nanomedicine, 7, pp. 5577-5591. 
  
 
 
210 
Fu, W., Shenoy, D., Li, J., Crasto. C., Jones. G., Dimarzio, C., Sridhar S. and Amiji, M. (2004) 
‘Biomedical Applications of Gold Nanoparticles Functionalized Using Hetero-Bifunctional 
Poly(ethylene glycol) Spacer.’ Material Research Society, 845,pp. 1-6.   
Fulton, D., Gratton, J.P., McCabe, T.J., Fontana, J., Fujio, Y., Walsh, K., Franke, T.F., 
Papapetropoulos, A. and Sessa, W.C. (1999) ‘Regulation of endothelium-derived nitric oxide 
production by the protein kinase Akt.’ Nature, 399(6736) pp. 597-601. 
García, G.P., Sumbayev, V., Gilliland, D., Yasinska, I.M.,  Gibbs, B.F., Mehn, D., Calzolai, L. 
and   Rossi, F. (2013) ‘Microscopic Analysis of the Interaction of Gold Nanoparticles with 
Cells of the Innate Immune System.’ Scientific reports, 1326 (3) pp. 1-7. 
Gasaymeh, S.S., Radiman S., Heng, L.Y. and Saion E. (2010) ‘Gamma Irradiation Synthesis 
and Influence the Optical and Thermal Properties of Cadmium Sulfide (CdS)/Poly (Vinyl 
Pyrolidone) Nanocomposites.’ American Journal of Applied Sciences, 7(4) pp. 500-508. 
Ghosh, P., Han, G., De, M., Kim, C. and Rotello, V. (2008) ‘Gold nanoparticles in delivery 
applications.’ Advanced Drug Delivery Reviews, 60(11) pp. 1307-1315. 
Giesche, H. (1994) ‘Synthesis of monodispersed silica powders I & particle properties and 
reaction kinetics. II. controlled growth reaction and continuous production process.’ Journal of 
the European Ceramic Society, 14, pp. 189-15.  
Glencross, H., Ahmed, N. and Wang, Q. (2011) ‘Biomedical science practice:  experimental 
and professional skills.’  Oxford University Press, 7, pp. 1-342. 
Gliga, A.R., Skoglund, R.., Wallinder, I. O., Fadeel, B. and Karlsson, H.L.(2014) ‘Size-
dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, 
agglomeration and Ag release.’ Particle and Fibre Toxicology, 11(11) pp.1-17. 
Green D.L., Lin J.S., Lam Y.F., Hu M. Z.-C., Schaefer D.W. and Harris, M.T. (2003)   ‘Size, 
volume fraction, and nucleation of Stöber silica nanoparticles.’ Journal of Colloid and 
Interface Science, 266(2) pp. 346–358. 
Grzelczak, M., Mezzasalma S.A., Ni, W., Herasimenka, Y., Feruglio, L., Montini, T., Perez-
Juste, J., Fornasiero P., Prato, M., and Liz-Marzan, L. M. (2012) ‘Antibonding Plasmon 
Modes in Colloidal Gold Nanorod Clusters.’ Langmuir, 28, pp. 8826–8833. 
Gu, H., Xu, K., Xu, C. and Xu, B. (2006) ‘Biofunctional magnetic nanoparticles for protein 
separation and pathogen detection.’ Chemical Communications (Cambridge, England), 7(9) 
pp. 941-949. 
  
 
 
211 
Guerrero, S., Herance, J.R., Rojas, S., Mena, J. F., Gispert, J. D., Acosta, G. A., Albericio, F. 
and Kogan, M. J. (2012) ‘Synthesis and in vivo evaluation of the biodistribution of an 18F-
labeled conjugate gold-nanoparticle-peptide with potential biomedical application.’ 
Bioconjugate Chemistry, 23(3) pp. 399-408. 
Guo, X., Razandi, M., Pedram, A., Kassab, G. and Levin, E.R. (2005) ‘Estrogen induces 
vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen 
receptors alpha and beta.’ The Journal of Biological Chemistry, 280(20) pp. 19704-19710.  
Hachani, R., Lowdell, M., Birchall, M. and Thanh, N. T. (2013) ‘Tracking stem cells in tissue-
engineered organs using magnetic nanoparticle.’ Nanoscale, 5(23) pp. 11362-11373. 
Haidekker, A.M., Boettcher, L.W., Suter, L.D., Rone, R. and Grant, S.A. (2006) ‘Influence of 
gold nanoparticles on collagen fibril morphology quantified using transmission electron 
microscopy and image analysis.’ BMC Medical Imaging, 6(4) pp. 1-7. 
Hainfeld, J.F., Slatkin, D.N., Focella, T.M. and Smilowitz, H.M. (2006) ‘Gold nanoparticles: a 
new X-ray contrast agent.’ British Journal of Radiology, 79(939) pp. 248–253.  
Haiss, W., Thanh, T.K.N., Aveyard, J. and Fernig, D.G. (2007) ‘Determination of Size and 
Concentration of GoldNanoparticles from UV-Vis Spectra.’ Analytical chemistry, 79(11) pp. 
4215-4221 
Hao, X., Wu, J., Shan,Y., Cai, M., Shang, X., Jiang, J. and  Wang H. (2012) ‘Caveolae-
mediated endocytosis of biocompatible gold nanoparticles in living Hela cells.’ Journal of 
Physics: Condensed Matter, 24(16) pp. 164207. 
Hartung, G.A. and Mansoori, G.A. (2013) ‘In vivo General Trends, Filtration and Toxicity of 
Nanoparticles.’ Journal of Nanomaterial and Molecular Nanotechnology, 2(3) pp.1-21. 
Harush-Frenkel, O., Debotton, N., Benita, S. and Altschuler, Y. (2007) ‘Targeting of 
nanoparticles to the clathrin-mediated endocytic pathway.’ Biochemical Biophysical Research 
Communications, 353(1) pp. 26-32.  
Hauck, T.S., Ghazan, A.A. and Chan, C.W. (2008) ‘Assessing the Effect of Surface Chemistry 
on Gold Nanorod Uptake, Toxicity, and Gene Expression in Mammalian Cells.’ Small, 4(1) 
pp. 153–159. 
Haynes, W. M. (2012) ‘CRC Handbook of Chemistry and Physics, 93rd Edition 2012-2013.’ 
Section 8: Analytic chemistry, Taylor and Francis group, CRC press, FL, pp.1-2664. 
  
 
 
212 
He, W., Zhou, Y.T., Wamer, W. G., Hu, X., Wu, X., Zheng, Z., Boudreau, M.D. and Yin, J.J. 
(2013) ‘Intrinsic catalytic activity of Au nanoparticles with respect to hydrogen peroxide 
decomposition and superoxide scavenging.’ Biomaterials, 34(3) pp.765-773.  
Hench, L.L. and West, J. K. (1990) ‘The Sol-Gel Process.’ Chemical Reviews, 90(1) pp. 33-
72. 
Hsiai, T.K, (2008) ‘Mechanosignal transduction coupling between endothelial and smooth 
muscle cells: role of hemodynamic forces.’ American journal of physiology-cell physiology, 
294(3) pp.659–661. 
Hu, J., Wang, Z. and Li, J. (2007) ‘Gold Nanoparticles with Special Shapes: Controlled 
Synthesis, Surface-enhanced Raman Scattering, and The Application in Biodetection.’ 
Sensors, 7(12) pp. 3299-3311. 
Hu, L., Mao, Z. and Gao, C. J. (2009) ‘Colloidal particles for cellular uptake and delivery.’ 
Journal of Materials Chemistry, 19(20) pp.3108–3115. 
Huang, S., Li, R., Qu, Y., Shen, J. and Liu, J. (2009) ‘Fluorescent Biological Label for 
Recognizing Human Ovarian Tumor Cells Based on Fluorescent.’ Journal of fluorescence. , 
19(6), 1095-101. 
Hubbard, A.T. (ed.) (2002) ‘Encyclopedia of Surface and Colloid Science: Por-Z.’ CRC Press,   
pp.1-5667. 
Huo, S., Jin, S., Ma, X., Xue,  X., Yang, ,K.,  Kumar, A., Wang, P.C. Zhang,  J.,  Hu, Z. and 
Liang,  X.-J. (2014) ‘Ultrasmall Gold Nanoparticles as Carriers for Nucleus-Based Gene 
Therapy Due to Size-Dependent  Nuclear Entry.’ ACS  Nano, 8 (6) pp.  5852–5862. 
Ignarro, L.J. (2000) ‘ Nitric oxide: biology and pathobiology.’ Academic Press, pp. 606-611.  
Jackson, T. and Zheng, X. (2010)’ A Cell-based Model of Endothelial Cell Migration, 
Proliferation and Maturation During Corneal Angiogenesis.’ Bulletin of Mathematical 
Biology, 72(4) pp. 830-868. 
Jain, S., Hirst, D.G. and O'Sullivan, J.M. (2012) ‘Gold nanoparticles as novel agents for 
cancer therapy.’ British Journal of Radiology, 85(1010) pp. 101–113. 
Jeffery, N.D., McBain, S.C., Dobson, J. and Chari, D.M. (2009) ‘Uptake of systemically 
administered magnetic nanoparticles (MNPs) in areas of experimental spinal cord injury 
(SCI)’, Journal of Tissue Engineering and Regenerative Medicine, 3(2), 153-160. 
Jeon, I.–Y. and Baek, J.-B. (2010) ‘Nanocomposites Derived from Polymers and Inorganic 
Nanoparticles.’ Materials, 3, pp. 3654-36. 
  
 
 
213 
Jiang, Y., Yan, Y.B., and Zhou, H.M. (2006) ‘Polyvinylpyrrolidone 40 assists the refolding of 
bovine carbonic anhydrase B by accelerating the refolding of the first molten globule 
intermediate.’ Journal of Biological Chemistry; 281, pp. 9058-65. 
Jong, W.H.D  and  Borm, P.J.A. (2008) ‘Drug delivery and nanoparticles: Applications and 
hazards.’ International Journal of Nanomedicine, 3(2) pp. 133–149. 
Jong,W.H.D., Burger, M.C.,  Verheijen, M.A. and  Geertsma, R. E. (2010) ‘Detection of the 
Presence of Gold Nanoparticles in Organs by Transmission Electron Microscopy.’ Materials, 
3(9) pp. 4681-4694. 
Jorgensen, T.D., Dissing, S. and Gromada, J. (1996) ‘Cyclic GMP potentiates phenylephrine 
but not cyclic ADP-ribose-evoked calcium release from rat lacrimal acinar cells.’ Elsevier 
Science B.V, 391(1-2) pp. 117-120.  
Kalishwaralal, K., Sheikpranbabu, S., BarathManiKanth, S., Haribalaganesh, R., 
Ramkumarpandian, S. and Gurunathan, S. (2011) ‘Gold nanoparticles inhibit vascular 
endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent 
pathway in retinal endothelial cells.’ Angiogenesis, 14(1) pp.29-45. 
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F.and Farokhzad, O. C. (2012) 
‘Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.’ 
Chemical Society Reviews, 41(7) pp. 2971-3010. 
Kasper, J., Hermanns, M.I., Bantz, C., Utech, S.,Koshkina, O., Maskos, M., Brochhausen, C.,  
Pohl, C., Fuchs, S.,Unger, R.E. and  Kirkpatrick, J. (2013) ‘Flotillin-involved uptake of silica 
nanoparticles and responses of an alveolar capillary barrier in vitro.’ European Journal of 
Pharmaceutics and Biopharmaceutics, 84(2), pp. 275-287.  
Kealey, D. and Haines, P. J. (2002) ‘Instant notes:  analytical chemistry.’ BIOS Scientific 
Publishers Limited, 7, pp. 1-342. 
Kempson, I. M., Chien, C.C., Chung, C.Y., Hwu, Y., Paterson, D., de Jonge, M.D. and 
Howard, D.L. (2012) ‘Fate of intravenously administered gold nanoparticles in hair follicles: 
follicular delivery, pharmacokinetic interpretation, and excretion.’ Advanced Healthcare 
Materials, 1(6) pp. 736-741. 
Khan, H.A., Abdelhalim, M.A.K., Al-Ayed, M.S. and Alhomida, A.S. (2012) ‘Effect of gold 
nanoparticles on glutathione and malondialdehyde levels in liver, lung and heart of rats.’ Saudi 
Journal of Biological Sciences, 19(4) pp. 461–464. 
  
 
 
214 
Kim, D., Park, S., Lee, J. H., Jeong, Y. Y., and Jon, S. (2007) ‘Antibiofouling polymer-coated 
gold nanoparticles as a contrast agentfor in vivo X-ray computed tomography imaging.’ 
Journal of the American Chemical Society, 129, pp. 7661–7665. 
Kim, E.-Y., Schulz, R., Swantek, P., Kunstman, K., Malim, M.H. and Wolinsky, S.M. (2012) 
‘Gold nanoparticle-mediated gene delivery induces widespread changes in the expression of 
innate immunity genes.’ Gene Therapy, 19, pp. 347-353. 
Kim, J. S., Yoon, T. J., Yu, K. N., Noh, M. S., Woo, M., Kim, B. G., Lee, K. H., Sohn, B. H., 
Park, S. B., Lee, J. K. and Cho, M. H. (2006) ‘Cellular uptake of magnetic nanoparticle is 
mediated through energy-dependent endocytosis in A549 cells.’ Journal of  Veterinary 
Science, 7(4) pp. 321-326. 
Kimling, J., Maier, M., Okenve, B., Kotaidis, V., Ballot, H. and Plech, A. (2006) ‘Turkevich 
Method for Gold Nanoparticle Synthesis Revisited.’ Journal of Physical Chemistry B, 110(32) 
pp. 15700–15707. 
Kirby, B.J and Hasselbrink E.F. (2004) ‘Zeta potential of microfluidic substrates:1.Theory, 
experimental techniques, and effects on separations.’ Electrophoresis, 25, pp. 187–202. 
Kirkham, M. and Parton, R.G. (2005) ‘Clathrin-independent endocytosis: New insights into 
caveolae and non-caveolar lipid raft carriers.’ Biochimica et Biophysica Acta (BBA) - 
Molecular Cell Research, 1746(3) pp.350–363. 
Kluger, M.S. (2004) ‘Vascular Endothelial Cell Adhesion and Signaling During Leukocyte 
Recruitment.’ Advances in Dermatology, 20, pp. 163-200. 
Klumpp, C., Kostarelos, K., Maurizio Prato., M. and Bianco, A. (2006) ‘Functionalized 
carbon nanotubes as emerging nanovectors for the delivery of therapeutics.’ Biochimica et 
Biophysica Acta (BBA) – Biomembranes, 1758(3) pp. 404–412. 
Knop, K., Hoogenboom, R., Fischer. D. and Schubert U.S. (2010) ‘Poly(ethylene glycol) in 
drug delivery: pros and cons as well as potential alternatives.’ Angewanted Chemie 
International Edition (English), 49(36) pp. 6288-6308. 
  
  
 
 
215 
Koffie, R.M., Farrar, C.T., Saidi, L.-S., William, C.M., Hyman, B.T. and Spires-Jones, T.L. 
(2011) ‘Nanoparticles enhance brain delivery of blood–brain barrier-impermeable probes for 
in vivo optical and magnetic resonance imaging.’ Proceedings of the National Academy of 
Sciences, 108(46) pp. 18837–18842. 
Kolluru G. K., Bir, S. C. and Kevil, C. G. (2012) ‘Endothelial Dysfunction and Diabetes: 
Effects on Angiogenesis, Vascular Remodeling, and Wound Healing.’ International Journal 
of Vascular Medicine, 2012, pp. 1-30. 
Krpetić. Z., Porta. F., Caneva, E., Dal Santo, V. and Scarì, G. (2010) ‘Phagocytosis of 
biocompatible gold nanoparticles.’ Langmuir, 26(18) pp. 14799-14805. 
Kumar, D. P., Subas, D., Subrata, C.  and Soumen, R. (2012) ‘Formulation and Evaluation of 
Solid Lipid Nanoparticles of a Poorly Water Soluble Model Drug, Ibuprofen.’ International 
Research Journal of Pharmacy, 3(12) pp. 132-137. 
Lake, C. L. (2004) ‘Pediatric cardiac anesthesia.’ 4th ed. Booker PD Lippincott Williams & 
Wilkins, pp. 1-786. 
Larese, F. F., D’Agostin, F., Crosera, M., Adami, G., Renzi, N., Bovenzi, M. and Maina, G. 
(2009) ‘Human skin penetration of silver nanoparticles through intact and damaged skin.’ 
Toxicology, 255, pp. 33-37. 
LeBlanc, A. J., Moseley, A. M., Chen, B. T., Frazer, D., Castranova, V. and Nurkiewicz, T. R. 
(2010) ‘Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive 
oxygen species-dependent mechanism.’ Cardiovascular Toxicology, 10, pp. 27-36. 
Lee, K., Cui, Y., Lee, L. P.,
. 
and  Irudayaraj, J.
 
(2014) ‘Quantitative imaging of single mRNA 
splice variants in living cells.’ Nature Nanotechnology, 9, pp. 474–480. 
LeRoy, C. and Wrana, L. (2005) ‘Clathrin mediated Endocytic Regulation of cell signalling.’ 
Nature Reviews Molecular Cell Biology, 6, pp. 112-126.  
Lewinski, N., Colvin, V. and Drezek, R. (2008) ‘Cytotoxicity of nanoparticles.’ Small, 4(1) 
pp. 26-49. 
Liao, L., Liu, J., Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Hammond, P. T. and  
Johnson. J. A. (2014) ‘A Convergent Synthetic Platform for Single-Nanoparticle Combination 
Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and 
Camptothecin.’ Journal of the American Chemical Society, 136(16) pp. 5896-5899. 
  
  
 
 
216 
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, Jr. W. E.,  Walker, M., 
Seidel, G. D.,Yuldasheva, N. and Tamarkin, L. (2010) ‘Phase I and Pharmacokinetic Studies 
of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF.’ Nanomedicine clinical cancer 
research, 16(21) pp. 6139-6149. 
Lim, J., Yeap, S.P., Che H.X. and Low, S.C. (2013) ‘Characterization of magnetic 
nanoparticle by dynamic light scattering.’ Nanoscale Research Letters, 8, pp. 381-425. 
Lin, A., Sabins, A., Kona, S., Nattama, S., Patel, H., Dong, J. F. and Nguyen, K. T. (2010) 
‘Shear regulated uptake of nanoparticles by endothelial cells and development of endothelial- 
targeting nanoparticles.’ Journal of Biomedical Materials Research Part A, 93(3) pp.833-842. 
Lin, I.-C., Liang, M., Liu, T.-Y., Monteiro, M.J. and Toth, I. (2012) ‘Cellular transport 
pathways of polymer coated gold nanoparticles.’ Nanomedicine: Nanotechnology, Biology and 
Medicine, 8(1) pp. 8–11. 
Liongm, M., Zinkm, J.I. and  Tamanoi, F. (2007) ‘Mesoporous silica nanoparticles as a 
delivery system for hydrophobic anticancer drugs.’ Small Journal, 3, pp. 1341-1346. 
Lipka, J., Semmler-Behnke, M., Sperling, R. A., Wenk, A., Takenaka, S., Schleh, C., Kissel, 
T., Parak, W.J.and Kreyling, W..G. (2010) ‘Biodistribution of PEG-modified gold 
nanoparticles following intratracheal instillation and intravenous injection.’ Biomaterials, 
31(25)  pp. 6574-81. 
Liu, C. and Zhang, N. (2011) ‘Nanoparticles in gene therapy principles, prospects, and 
challenges.’  Progress in molecular biology and translational science, 104, pp. 509-571. 
Liu, Q., Liu, H., Zhou, Q., Liang, Y., Yin, G. and Xu, Z. (2006) ‘Synthesis of nearly 
Monodispersive gold nanoparticles by a sodium diphenylamine sulfonate reduction process.’ 
Journal of Materials Science, 41, pp. 3657-3662. 
Liu, Y., Shipton, M.K., Ryan, J., Kaufman, E.D., Franzen, S. and Feldheim, D.L. (2007) 
‘Synthesis, Stability, and Cellular Internalization of Gold Nanoparticles Containing Mixed 
Peptide−Poly (ethylene glycol) Monolayers.’ Analytical Chemistry, 79(6) pp. 2221–2229. 
Lodish, H., Berk, A., Zipursky, S.L., Matsudaira, P., Baltimore, D. and Darnell, J. (2000) 
‘Molecular Cell Biology.’ 4th ed., New York: W.H. Freeman; Section 20.1, Overview of 
Extracellular Signaling. Available on: http://www.ncbi.nlm.nih.gov/books/NBK21475. 
Malvern; Available on: http://www.malvernstore.com/cnb/shop/malvern?productID=11&op       
=catalogue-product_info-null&prodCategoryID=7 (Accessed: 29 November 2013). 
  
 
 
217 
Manke, A., Wang, L. and Rojanasakul, Y. (2013) ‘Mechanisms of Nanoparticle-Induced 
Oxidative Stress and Toxicity.’ Biomedical Research International, 2013, pp. 1-15. 
Manson, J., Kumar, D., Meenan, B.J. and Dixon, D. 2011 ‘Polyethylene glycol functionalized 
gold nanoparticles: the influence of capping density on stability in various media.’ Gold 
Bulletin, 44(2) pp. 99-105.   
Marcelo, K.L., Goldie, L.C. and Hirschi, K.K. (2013) ‘Regulation of endothelial cell 
differentiation and specification.’ Circulation Research, 112(9) pp. 1272-1287. 
Marín-García, J. (2012) ‘Mitochondria and Their Role in Cardiovascular Disease.’ Springer, 
USA, pp.1-519.  
Martines, M.U, Yeung, E., Persin, M., Larbot, A., Voorhout, W.F., Kübel, C.K.U.,  Kooyman, 
P. and Prouzet, E. (2005) ‘Hexagonal mesoporous silica nanoparticles with large pores and a 
hierarchical porosity tested for HPLC.’ C. R. Chimie 8, pp. 627-634. 
McCarron, G.J., Bradely, K.N. and Muir, T.C. (2003) ‘Ca 2+ signalling and Ca 2+ activated K+ 
in smooth muscle’ in Chadwick, J. D. and Goodie, J. A. (e.ds.) Role of the Sarcoplasmic 
Reticulum in Smooth Muscle, Novartis Foundation Symposia: Devon, John Wiley & Sons, pp. 
52-64. 
McIntyre, M. and Dominiczak, A.F. (1997) ‘Nitric oxide and cardiovascular disease.’ 
Postgraduate Medical Journal, 73, pp. 630- 634. 
Meldolesi, J. (2006) Macropinocytosis: regulated coordination of endocytic and exocytic 
membrane traffic events.’ Journal of Cell Science, 119(22) pp. 4758-4769.  
Miao, B. and Degterev, A.  (2009) ‘Methods to analyze cellular necroptosis.’ Methods in 
Molecular Biology, 559, pp.79-93. 
Mironava, T., Hadjiargyrou, M., Simon, M., Jurukovsk, V. and Rafailovich, M.H. (2010) 
‘Gold nanoparticles cellular toxicity and recovery: Effect of size, concentration and exposure 
time.’ Nanotoxicology, 4 (1) pp. 120-137. 
Mody, V., Siwale, R.,  Singh, A. and Mody, H. R. (2010) ‘Introduction to metallic 
nanoparticles.’Journal of pharmacy & bioallied sciences, 2(4) pp. 282-289.  
Moran, C.H., Rycenga, M., Zhang, Q. and Xia, Y. (2011) ‘Replacement of Poly(vinyl 
pyrrolidone) by Thiols: A Systematic Study of Ag Nanocube Functionalization by Surface-
Enhanced Raman Scattering.’ Journal of physical chemistry. C, Nanomaterials and interfaces, 
115(44): 21852–21857. 
 
  
 
 
218 
Mukherjee, P., Bhattacharya, R., Bone, N., Yean, K., Lee, Y. K., Patra, C. R., Wang, S., Lu,   
L., Secreto, C., Banerjee, P.C., Yaszemski, M. J., Kay, N. E. and Mukhopadhyay, D. (2007) 
‘Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia 
(BCLL): enhancing apoptosis.’ Journal of Nanobiotechnology, 5(4) pp. 1-13. 
Mukherjee, P., Bhattacharya, R., Wang, P., Wang, L., Basu, S. and  Nagy, J. A. (2005) 
‘Antiangiogenic Properties of Gold Nanoparticles.’ Clinical Cancer Research, 11(9) pp. 3530-
3535.  
Mulvany M.J. and Aalkjaer, C. (1990) ‘Structure and function of small arteries.’ 
Physiological. Reviews, 70, pp. 921-961. 
Mulvany, M.J. (2002) ‘Small Artery Remodeling and Significance in the Development of 
Hypertension News in Physiological Sciences.’ News in physiological sciences, 17, pp.105-
109.  
Murawska, M., Skrzypczak A. and Kozak, M. (2012) ‘Structure and Morphology of Gold 
Nanoparticles in Solution Studied by TEM, SAXS and UV-Vis.’ Acta Physica Polonica A, 
121(4) pp. 888-892. 
Murphy, C.J., Gole, A. M., Stone, J.W., Sisco, P.N., Alkilany, A. M., Goldsmith, E. C. and 
Baxter, S. C. (2008) ‘Gold nanoparticles in biology: beyond toxicity to cellular imaging.’  
Accounts of chemical Research, 41, pp. 1721–1730. 
Nasser, T.K., Wilensky, R.L., Mehdi, K. and March, K.L. (1996) ‘Microparticle deposition in 
periarterial microvasculature and intramural dissections after porous balloon delivery into 
atherosclerotic vessels: quantitation and localization by confocal scanning laser microscopy.’ 
American Heart Journal, 131(5) pp. 892-898.  
Nativo, P., Prior, I.A. and Brust, M. (2008) ‘Uptake and Intracellular Fate of Surface-Modified 
Gold Nanoparticles.’ ACSNano, 2( 8) pp. 1639–1644. 
Ng, C.T., Li, J.J., Perumalsamy, R., Watt, F., Yung, L.Y.L. and Bay, B.H. (2010) ‘Localizing 
cellular uptake of nanomaterials in vitro by transmission electron microscopy’ in Microscopy: 
Science, Technology, Applications and Education Méndez-Vilas, A. and Díaz, J. Formatex, 
pp. 316-320. 
Ngadi, N., Abrahamson, J., Fee, C. and Morison, K. (2000) ‘QCM-D Study on Relationship of 
PEG CoatedStainless Steel Surfaces to Protein Resistance.’ International Journal of Chemical 
and Biological Engineering, 1(3) pp. 125-129. 
Nitta, S.K. and Numata, K. (2013) ‘Biopolymer-Based Nanoparticles for Drug/Gene Delivery 
and Tissue Engineering.’ International Journal of Molecular Sciences, 14(1) pp. 1629-1654. 
  
 
 
219 
Nitzsche, R. and Connah, M. (2012). The use of the Malvern Zetasizer for the measurement of 
Zeta Potential. Available on: http://www.silver-colloids.com/Tutorials/Intro/zetaintro.html 
(Accessed: 2
nd
 March 2014). 
Nune, S.K., Gunda, P., Thallapally, P.K., Lin. Y.-Y., Forrest, M.L. and Berkland, C. J. (2009) 
‘Nanoparticles for biomedical imaging.’ Expert Opinion on Drug Delivery, 6(11) pp. 1175–
1194.  
Nurkiewicz T.R., Porter, D.W., Hubbs, A.F., Stone, S., Chen, B.T., Frazer, D.G., Boegehold, 
M.A. and Castranova, V. (2009) ‘Pulmonary Nanoparticle Exposure Disrupts Systemic 
Microvascular Nitric Oxide Signaling.’ Toxicological Sciences, 110(1) pp. 191-203. 
O’Neal, D.P., Hirsch, L.R., Halas, N.J., Payne, J.D. and West, J.L. (2004) ‘Photo-thermal 
tumor ablation in mice using near infrared-absorbing nanoparticles.’ Cancer Letter, 209, pp. 
171–176. 
Oberdorster, G., Maynard, A., Donaldson, K., Castranova,  V., Fitzpatrick, J., Ausman, K., 
Carter, J., Karn, B., Kreyling, W., Lai, D., Olin, S., Monteiro-Riviere, N., Warheit, D. and 
Yang, H. (2005) ‘Principles for characterizing the potential human health effects from 
exposure to nanomaterials: elements of a screening strategy.’ Particle and Fibre Toxicology. 
2, pp. 8-21. 
Oh, E., Delehanty, J.B., Sapsford, K.E., Susumu, K., Goswami, R., Blanco-Canosa J.B., 
Dawson, P.E., Granek, J., Shoff, M., Zhang, Q., Goering, P.L., Huston, A. and Medintz, I.L. 
(2011) ‘Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-
penetration peptides and particle size.’ ACS Nano, 5(8)  pp. 6434-48. 
Ojea-Jiménez, I. and Campanera, J.M. (2012) ‘Molecular Modeling of the Reduction 
Mechanism in the Citrate-Mediated Synthesis of Gold Nanoparticles.’ Journal of Physical 
Chemistry C, 116(44) pp. 23682-23691. 
Ojea-Jiménez, I. and Puntes, V. (2009) ‘Instability of Cationic Gold Nanoparticle 
Bioconjugates: The Role of Citrate Ion.’ Journal of the American Chemical Society, 131(37) 
pp. 13320-13327. 
Panariti, A., Miserocchi, G. and Rivolta I. (2012) ‘The effect of nanoparticle uptake on 
cellular behavior: disrupting or enabling functions?’  Nanotechnology, Science and 
Applications, 5, pp. 87–100. 
Pandey, R., Sharma, S. and Khuller, G.K. (2006) ‘Oral poly(lactide-co-glycolide) nanoparticle 
based antituberculosis drug delivery:Toxicological and chemotherapeutic implications.’ Indian 
Journal of Experimental Biology, 44, pp. 459-467. 
  
 
 
220 
Panza, J.A., García, C.E., Kilcoyne, C.M., Quyyumi, A.A. and Cannon, R.O. (1995) ‘Impaired 
Endothelium-Dependent Vasodilation in Patients With Essential Hypertension Evidence That 
Nitric Oxide Abnormality Is Not Localized to a Single Signal Transduction Pathway.’ 
Circulation, 91, pp. 1732-1738. 
Papapetropoulos, A., Rudic, R.D. and Sessa W.C., (1999) ‘Molecular control of nitric oxide 
synthases in the cardiovascular system.’ Cardiovascular Research, 43(3) pp. 509-520. 
Park W and Borsa T. (2004) ‘Synthesis and Self-Assembly of Metal-Coated Nanoparticles.’ 
Materials Research Society Symposium Proceedings, 820, pp. 289-294. 
Park, E.J. and Park, K. (2009) ‘Oxidative stress and pro-inflammatory responses induced by 
silica nanoparticles in vivo and in vitro.’ Toxicology Letters, 84(1) pp. 18-25. 
Park, S.K., Kim K. D. and Kim H. T. (2007) ‘Preparation of silica nanoparticles: 
determination of the optimal synthesis conditions for small and uniform particles.’ Colloids 
and Surfaces A, 197, pp. 7–17. 
Pellach, M., Goldshtein, J., Ofra Ziv-Polat, O. and  Margel, S. (2012) ‘Functionalised, 
photostable, fluorescent polystyrene nanoparticles of narrow size-distribution.’ Journal of 
Photochemistry and Photobiology A: Chemistry, 228, pp. 60– 67. 
Pennycook, S.J. and Nellist, P.D. (2011) ‘Scanning transmission electron microscopy:  
imaging and analysis.’ Springer New York, pp. 1-762. 
Pérez-Martínez, F.C., Carrión, B. and Ceña, V. (2012) ‘The use of nanoparticles for gene    
therapy in the nervous system.’ Journal of Alzheimer's disease, 31(4), 697-710.  
Pleger, S.T., Harris, D.M., Shan, C., Vinge, L.E., Chuprun, J. K., Berzins, B., Pleger,W., 
Druckman, C., Volkers, M., Heierhorst, J., Øie, E., Remppis, A., Katus, H. A., Scalia, R., 
Eckhart, A. D., Koch, W.J and Most, P. (2008) ‘Endothelial S100A1 Modulates Vascular 
Function via Nitric Oxide.’ Circulation Research, 102, pp. 786-794. 
Qiu, P. and Mao, C. (2010) ‘Biomimetic branched hollow fibers templated by self-assembled 
fibrous polyvinylpyrrolidone structures in aqueous solution.’ ACS Nano, 4 (3) pp. 1573–1579. 
Rahman, I.A. and Padvettan, V. (2012) ‘Synthesis of silica nanoparticles by sol gel: size-
dependent properties, surface modification, and application in silica-polymer 
nanocomposities-a review.’ Journal of Nanomaterials, pp. 1-15. 
Rahman, M., Laurent, S., Tawil, N., Yahia, L., Mahmoudi, M. (2013) ‘Protein-Nanoparticle 
Interactions.’ Springer Series in Biophysics, 15, pp. 21-24.  
  
 
 
221 
Ranghar, S., Sirohi, P., Verma, P.  and Agarwal, V. (2014) ‘Nanoparticle-based Drug Delivery 
Systems: Promising Approaches Against Infections.’ Brazilian Archives Of Biology And 
Technology, 57(2)  pp. 209-222.  
Rauch, J.,  Kolch, W. and Mahmoudi, M. (2012) ‘Cell Type-Specific Activation of AKT and 
ERK Signaling Pathways by Small Negatively-Charged Magnetic Nanoparticles.’ Scientific 
Reports, 2, Article ID 868. 
Razink, J.J. and Schlotter, N.E. (2007) ‘Correction to ‘Preparation of monodisperse silica 
particles:  Control of size and mass fraction’ by G.H. Bogush, M.A. Tracy and C.F. Zukoski 
IV, Journal of Non-Crystalline Solids, 104, (1988) 95–106.’ Journal of Non-Crystalline 
Solids, 353, pp. 2932-2933. 
Robinson, B.V., Sullivan, F.M., Borzelleca, J.F. and Schwartz, S.L. (1990) ‘PVP: A Critical 
Review of the Kinetics and Toxicology of Polyvinylpyrrolidone (Povidone).’ Lewis 
Publishers, Chelsea, MI, pp. 1-209. 
Roesslein, M.,   Hirsch, C., Kaiser, J.-P., Krug, H.F. and Wick, P. ‘Comparability of in Vitro 
Tests for Bioactive Nanoparticles: A Common Assay to Detect Reactive Oxygen Species as an 
Example.’ International Journal of Molecular Sciences.2013, 14(12) pp. 24320-2433. 
Rosas-Hernandez, H., Jimenez-Badillo, S., Martinez- Cuevas, P.P., Gracia- Espino, E., 
Terrones, H., Terrones, M., Hussain, S.M., Ali, S.F. and Gonzalez, C. (2009) ‘Effects of 45-
nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings.’ Toxicology 
letters, 191(2-3) pp. 305-313. 
Ross, M.H. and Pawlina, W. (2010) Histology: A Text and Atlas. 6th e.d., Minnesota: 
Lippincott Williams & Wilkins. pp. 1-974. 
Rouse, J. G., Yang, J., Ryman-Rasmussen, J. P., Barron, A. R. and Monteiro-Riviere, N. A. 
(2007) ‘Effects of Mechanical flexion on the penetration of fullerene amino acid-derivatized 
peptide nanoparticles through skin.’ Nano Letters, 7, pp. 155-160. 
Roux, P. P. and Blenis, J. (2004) ‘ERK and p38 MAPK-Activated Protein Kinases: a Family of 
Protein Kinases with Diverse Biological Functions.’ Microbiology and Molecular Biology 
Reviews, 68(2) pp. 320-344. 
Saltzman, W.M. (2000) ‘Cell interactions with polymers In Textbook of Tissue Engineering.’ 2nd 
edition, Lanza, R.P., Langer, R. and Vacanti, J. (Ed.), Academic Press, NY, pp. 221-235.  
Saptarshi, S.R., Duschl, A. and Lopata, A.L. (2013) ‘Interaction of nanoparticles with proteins: 
relation to bio-reactivity of the nanoparticle.’ Journal of Nanobiotechnology, 11(26) pp. 1-12. 
  
 
 
222 
Sato, S., Miyake, M., Hazama, A. and Omori, K. (2014) ‘Povidone-iodine-induced cell death in 
cultured human epithelial HeLa cells and rat oral mucosal tissue.’ Drug and Chemical 
Toxicology, 37(3) pp. 268-275. 
Sattar, A., Rooney, P., Kumar, S., Pye, D., West, D.C., Scott, I. and Ledger, P. (1994) 
‘Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat 
skin.’ Journal of Investigative Dermatology, 103, pp. 576-579. 
Schaper, W. and Buschman, I. (1999) ‘Anteriogenesis, the good and bad of it.’ Cardiovascular 
Research, 43, pp. 835−837. 
Schiffrin E.L. (1998) ‘Remodeling of Resistance Arteries in Hypertensive Patients: Effects of 
Antihypertensive Therapy.’ Scandinavian cardiovascular journal, 32(2) pp. 15 – 21. 
Schneider, M., Stracke, F., Hansen, S. and Schaefer, U.F. (2009) ‘Nanoparticles and their 
interactions with the dermal barrier.’ Dermatology-Endocrinology, 1, pp. 197 – 206. 
Schroeder, A., Goldberg, M.S., Kastrup, C., Wang, Y., Jiang, S., Joseph, B.J., Levins, C.G., 
Kannan, S.T., Langer, R. and Anderson, D.G. (2012) ‘Remotely activated protein-producing 
nanoparticles.’ Nano Letters, 12(6) pp. 2685-2689.  
Schubert, R., Krien U., Wulfsen I., Schiemann, D., Lehmann, G., Ulfig, N., Veh, R.W., Schwarz, 
J.R. and Gago, H. (2004) ‘Nitric oxide donor sodium nitroprusside dilates rat small arteries by 
activation of inward rectifier potassium channels.’ Hypertension, 43(4) pp. 891-896.  
Seebergh J.E. and Berg, J.C. (1994) ‘Depletion flocculation of aqueous, electrosterically-
stabilized latex dispersions.’ Langmuir, 10(2) pp. 454–463.  
Selim, M.E. and Hendi, A.A. (2012) ‘Gold Nanoparticles Induce Apoptosis in MCF-7 Human 
Breast Cancer Cells.’ Asian Pacific Journal of Cancer Prevention, 13(4) pp. 1617-1620. 
Seol, S.K., Kim, D., Jung, S., Chang, W.S. and  Kim, J.T. (2013) ‘One-Step Synthesis of PEG-
Coated Gold Nanoparticles by Rapid Microwave Heating.’ Journal of Nanomaterials, (2013), 
Article ID 531760. 
Shah, V., Shah, S., Shah, H., Rispoli, F.J., McDonnell, K. T., Workeneh, S., Karakoti, A., Kumar, 
A. and Seal, S. (2012) ‘Antibacterial Activity of Polymer Coated Cerium OxideNanoparticles.’ 
Plos One, 7(10) pp. 47827-473. 
Sharma. M. and Yashonath, S. (2007) ‘Size Dependence of Solute Diffusivity and Stokes-
Einstein Relationship: Effect of van der Waals Interaction’, Diffusion Fundamentals, 6, pp. 1-15. 
Shaw, D. J. (1992) ‘Introduction to Colloid & Surface Chemistry.’ 4th ed, Butterworth 
Heinemann, pp. 1-306.  
  
 
 
223 
Shaw P.J. (2006) ‘Comparison of Widefield/Deconvolution and Confocal Microscopy for Three-
Dimensional Imaging, Chapter 23 1-467.’ Handbook of Biological Confocal Microscopy, 3rd ed, 
James B. Pawley, (E.d), SpringerScience and Business Media, New York. 
Shenoi, M. M., Shah, N.B., Griffin, R.J., Vercellotti, G.M. and Bischof, J.C. (2011) ‘Nanoparticle 
preconditioning for enhanced thermal therapies in cancer.’ Nanomedicine, 6(3) pp. 545-63. 
Shukur, A., Rizvi, S.B., Whitehead, D., Seifalian, A. and Azzawi, M. (2013) ‘Altered sensitivity 
to nitric oxide donors, induced by intravascular infusion of quantum dots, in murine mesenteric 
arteries.’ Nanomedicine: Nanotechnology, Biology, and Medicine, 9(4) pp. 532-539. 
Silva, B.R., Lunardi, C.N., Araki, K., Juliana, C., Silva, D., Lusiane, M. and Bendhack. (2014) 
‘Gold nanopartical modifies nitric oxide release and vasodilation in rat aorta.’ Journal of 
Biological Chemistry, 7, pp. 57-65. 
Singh, M., Kumar, M., Manikandan, S., Chandrasekaran, N., Mukherjee, A. and Kumaraguru, A. 
K. (2014) ‘ Drug Delivery System for Controlled Cancer Therapy Using Physico-Chemically 
Stabilized Bioconjugated Gold Nanoparticles Synthesized from Marine Macroalgae.’ Padina 
Gymnospora, Journal of Nanomedicine and Nanotechology, 5(2) pp.1-7. 
Singh, A.B. and Harris, R.C. (2005) ‘Autocrine, paracrine and juxtacrine signaling by 
EGFR ligands.’ Cellular Signaling, 17, pp. 1183-1193. 
Soenen, S.J., Manshian, B.B., Montenegro, J.-M., Amin, F., Meermann, B., Thiron, T.,  
Cornelissen, M., Vanhaecke, F., Doak, S., Para W.J., De Smedt, S.C.; Braeckmans, K. (2012) 
‘Cytotoxic Effects of Gold Nanoparticles: A Multiparametric Study.’ ACS Nano, 6(7) pp. 5767-
5783. 
Soenen S.J., Montenegro, J. -M., Abdelmonem, A.M., Manshiand, B.B., Doak, S.H.,Wolfgang J. 
P.,  De Smedt, S.C. and  Braeckmans, K. (2014) ‘The effect of nanoparticle degradation on poly 
(methacrylic acid)-coated quantum dot toxicity: The importance of particle functionality 
assessment in toxicology.’ Acta biomaterialia, 10(2) pp. 732-741. 
Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K.(2008) ‘In vitro permeation 
of gold nanoparticles through rat skin and rat intestine: effect of particle size.’ Colloids and 
Surfaces B: Bio interfaces, 65(1) pp. 1-10. 
Sokoya, E.M., Burns, A.R., Setiawan, C.T., Coleman, H.A, Parkington.C. and Tare, M. (2006) 
‘Evidence for the involvement of myoendothelial gap junctions in EDHF-mediated relaxation in 
the rat middle cerebral artery.’ American Journal of Physiology - Heart and Circulatory 
Physiology, 291, pp. 385-393.  
  
 
 
224 
Souza, G.R. and Miller, H. (2012) ‘Chapter 2: Elastic Light Scattering of Biopolymer/ Gold  
Nanoparticles Fractal Aggregates.’  Book es C.D. (ed.), Reviews in Plasmonics, Springer, pp. 39-
68. Available on: 
http://www.springer.com/cda/content/document/cda_downloaddocument/9781461408              
833-c1.pdf?SGWID=0-0-45-1252451-p174132423 (Accessed: 3 January 2014). 
Sterm chemicals, INC. (2013) ‘Medical and Pharmaceutical Applications for Nanomaterials and 
nanoparticles-supplier data by strem chemicals.’ Available on: 
www.azonano.com/article.aspx?ArticleID=1336 (Accessed: 20 January 2014). 
Stöber, W., Fink, A. and Bohn, E. (1968) ‘Controlled Growth of monodisperes silica spheres in 
the Micron size range.’ Journal of Colloid and Interface Science, 26, pp.62-69.  
Stoelting, R.K. and Hillier, S.C. (2005) ‘Pharmacology & Physiology in Anesthetic Practice.’ 4th 
ed., Philadelphia: Lippincott Williams and Wilkins, pp. 1-850. 
Suh, H., Jeong, B., Liu, F. and Kim, S.W. (1998) ‘Cellular uptake study of Biodegradable 
nanoparticles in vascular smooth muscle cells.’ Pharmaceutical Research, 15,  pp.1495-1498. 
Suh, W.H., Suslick, K. S., Stucky, G.D. and Suh, Y.H. (2009) ‘Nanotechnology, Nanotoxicology, 
and Neuroscience.’ Progress in Neurobiology, 87, pp. 133-170. 
Sumpio, B.E., Riley, J.T. and Dardik, A. (2002) ‘Cells in focus: endothelial cell.’ International 
Journal of Biochemistry and Cell Biology, 34(12) pp.1508-1512. 
Sun, C., Leeb, J. and Zhang, M. (2008) ‘Magnetic Nanoparticles in MR Imaging and Drug 
Delivery.’ Advanced Drug Delivery Reviews, 60, pp.1252–1265. 
Swami, S., Shi, J., Gadde, S., Votruba , A. R., Kolishetti, N. and Farokhzad O.C. (2012) 
‘Nanoparticles for Targeted and Temporally Controlled Drug Delivery. In Svenson S. and 
Prud'homme, R.K. Multifunctional Nanoparticles for Drug Delivery Applications  Nanostructure 
Science and Technology.’ US, Springer, pp. 9-29. 
Swapp, S. (2012) ‘Geochemical Instrumentation and Analysis: Scanning Electron Microscopy 
(SEM).’ University of Wyoming. Available at :http://serc.carleton.edu/18401 (Accessed: 8 July 
2014). 
Sykes, E.A., Chen, J., Zheng, G. and. Chan, W.C.W. (2014) ‘Investigating the Impact of 
Nanoparticle Size on Active and Passive Tumor Targeting Efficiency.’ACS Nano, 8(6 ) p.  5696–
5706. 
Swanson, J.A. and Watts, C. (1995) ‘Macropinocytosis.’ Trends in cell biology, 5(11) pp. 424-
428. 
  
 
 
225 
Taimeh, Z., Loughran, J., Birks, E.J. and Bolli R. (2013) ‘Vascular endothelial growth factor in 
heart failure.’ Nature Reviews Cardiology, 10, pp. 519-530.  
 
Takae, S., Akiyama, Y., Otsuka, H., Nakamura, T., Nagasaki, Y. and Kataoka, K. (2005) ‘Ligand 
density effect on biorecognition by PEGylated gold nanoparticles: regulated interaction of 
RCA120lectin with lactose installed to the distal end of tethered PEG strands on gold surface.’ 
Biomacromolecules, 6(2) pp. 818–824. 
Terentyuk, G., Akchurin, G., Maksimova, I., Shantrokha, A., Tuchin, V., Maslyakova, G., 
Suleymanova, L., Kogan, B., Khlebtsov, N. and Khlebtsov, B. (2009) ‘Tracking gold 
nanoparticles in the body Biomedical Optics & Medical Imaging.’  International society for 
optics and photonics (SPIE), (4). 
Tiwari, P.M., Vig, K., Dennis V.A. and Singh S. R. (2011) ‘Functionalized Gold Nanoparticles 
and Their Biomedical Applications.’ Nanomaterials, 1, pp. 31-63. 
Toma H.E., Zamarion, V.M., Toma, S.H. and Araki K. (2010) ‘The coordination chemistry at 
gold nanoparticles.’ Journal of the Brazilian Chemical Society, 21(7) pp.1158-1176. 
Tosi, G., Bortot, B., Ruozi, B., Dolcetta, D., Vandelli, M. A., Forni, F. and  Severini, G.M. (2013) 
‘Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.’ 
Current Medicinal Chemistry, 20(17)  pp. 2212-25. 
Treuel, L., Jiang, X. and Nienhaus, G. U. (2013) ‘New views on cellular uptake and trafficking of 
manufactured nanoparticles.’ Journal of the Royal Society Interface, 10(82), Article 20120939. 
Tsai  S.-W., Liaw, J.-W., Kao1 Y.-C., Huang, M.-Yu., Lee, C.-Y.,  Rau, R.,Huang,  C.Y., Wei, 
K.-C. and Ye, T.-C. (2013) ‘Internalized Gold Nanoparticles Do Not Affect theOsteogenesis and 
Apoptosis of MG63 Osteoblast-LikeCells: A Quantitative, In Vitro Study.’ Plos one, 8(10) pp. 
6545-6557. 
Tscharnuter, W. (2000) ‘Photon CorrelationSpectroscopy in Particle Sizing’ in Encyclopedia of 
Analytical Chemistry. R.A. Meyers , John Wiley & Sons Ltd, Chichester, (Ed.) pp.5469-5485. 
Tucknott, R. and  Yaliraki, S.N. (2002) ‘Aggregation properties of carbon nanotubes at 
interfaces.’Chemical Physics, 281, pp. 455–463. 
Turkevich, J., Stevenson, P. C. and Hillier, J. (1951) ‘A study of the nucleation and growth 
processes in the synthesis of colloidal gold.’ Discussions of the Faraday Society, 11, pp. 55-75. 
Van Blaaderen, A. and Vrij, A. (1992) ‘Synthesis and characterization of colloidal dispersions of 
fluorescent, monodisperse silica spheres.’ Langmuir, 8(12) pp.  2921–2931. 
  
 
 
226 
Van Blaaderin, A. and Vrij, A. (1993) ‘Synthesis and characterisation of monodisperese colloidal 
organo-silica spheres.’ Journal of colloid and interface science, 156, pp. 1-18. 
Van Blaadern, A., Van Geest, J., Vrij, A. (1992) ‘Monodisperese colloidal silica spheres from 
tetraalkoxysilanes particle formation and growth meachanism.’ Journal of colloid and interface 
science , 154 (2) pp. 481-501. 
Van Hove, C.E. Van der Donckt, C., Herman, A.G., Bult, H. and Fransen, P. (2009) ‘Vasodilator 
efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse 
aortic smooth muscle cell.’ British Journal of Pharmacology, 158(3) pp. 920–930. 
Vecchio, G., Galeone, A., Brunetti, V., Maiorano, G., Sabella, S., Cingolani, R. and Pompa, P. P. 
(2012) ‘Concentration-Dependent, Size-Independent Toxicity of Citrate Capped AuNPs in 
Drosophila melanogaster.’ Plos one, 7(1) e29980.  
Venkatathri, N. (2007) ‘Preparation of silica nanoparticle through coating with 
octyldecyltrimethoxy silane.’ Indian Journal of Chemistry, 46, pp. 1955-1958. 
Verhaegh, N.A.M. and Van Bladderen, A. (1994) ‘ Dispersions of rhodamine-labelled silica 
spheres - Synthesis, characterization, and fluorescence Confocal Scanning Laser Microscopy.’  
Langmuir, 10, pp. 1427-1438. 
Verrier, E.D. and Boyle, E.M. ‘Endothelial Cell Injury in Cardiovascular Surgery.’ Annals of 
Thoracic Surgery, 1996, 62, pp. 915-922. 
Visser, Taco D.; Wiersma, Sjoerd H. (1994) ‘Electromagnetic description of image formation in 
confocal fluorescence microscopy.’ Journal of the Optical Society of America A: Optics, Image 
Science, and Vision, 11(2) pp.599-608. 
Voliani, V., Signore, G., Nifosí, R., Ricci, F., Luin. S. and Beltram, F. (2012) ‘Smart Delivery 
and Controlled Drug Release with Gold Nanoparticles: NewFrontiers in Nanomedicine.’ Recent 
Patents on Nanomedicine, 2(1) pp. 34-44. 
 
Wang, F., Phonthammachai, N., Mya, K.Y., Tjiu, W. and He, C. (2011) ‘PEG-POSS Assisted 
Facile Preparation of Amphiphilic Gold Nanoparticles and Interface Formation Janus.’ Chemical 
Communications, 47(2) pp. 767-769. 
Wang, Y. and Zhao, S. (2010) ‘Vascular Biology of the Placenta.’ San Rafael (CA): Morgan & 
Claypool Life Sciences, Accessed 01 February 2014, Available from: 
http://www.ncbi.nlm.nih.gov/books/NBK53247. 
Webb, C,R. (2003) ‘Smooth muscle contraction and relaxation.’ Advances in Physiology 
Education, 27, pp. 201-206. 
  
 
 
227 
Xie, D., Jules, S., Weng,Y., Zhou, Y., Sidner, R.A. and  Pescovitz, M. (2012) ‘Poly(ethylene 
glycol) and poly(N-vinlypyrrolidone) for improved porcine islet cryopreservation.’ Journal of 
Biomedical Science and Engineering, 5, pp. 263-269. 
Yeh, J.-M., Huang, K.-Y., Lin, S.-Y., Wu, Y.-Y., Huang, C.-C. and Liou, S.-J. (2009), 
‘Noncovalent Interaction between Gold Nanoparticles and Multiwalled Carbon Nanotubes via an 
Intermediatory.’ Journal of Nanotechnology, 2009, pp. 1-7. 
Yuan, Z., Hein, T.W., Rosa, R. H. and Kuo, L. (2008) ‘Sildenafil (Viagra) Evokes Retinal 
Arteriolar Dilation: Dual Pathways via NOS Activation and Phosphodiesterase Inhibition.’ 
Investigative Ophthalmology & Visual Science, 49, pp. 720–725. 
Yung, Y.C., Chae, J., Buehler, M.J., Hunter, C.P. and Mooney, D.J. (2009) Cyclic tensile strain 
triggers a sequence of autocrine and paracrine signaling to regulate angiogenic sprouting in 
human vascular cells.’ Proceedings of the National Academy of Sciences of the United States of 
America, 106(36) pp. 5279-84. 
Zecchin, H.G., Priviero, F.B., Souza, C.T., Zecchin, K.G., Prada, P.O., Carvalheira, J.B., Velloso, 
L.A., Antunes, E. and Saad, M.J. (2007) ‘Defective insulin and acetylcholine induction of 
endothelial cell-nitric oxide synthase through insulin receptor substrate/Akt signaling pathway in 
aorta of obese rats.’ Diabetes, 56(4) pp.1014-24. 
Zhang X, Guo M, Wu H, Sun Y, Ding Y, Feng X, Zhang L. (2009) ‘Irradiation stability and 
cytotoxicity of gold nanoparticles for radiotherapy.’ International Journal of nanomedicine, 4, 
pp.165-73. 
Zhang, H. L., Wu, S. H., Tao, Y., Zang, L. and Su, Z. (2010) ‘Preparation and Characterization of 
Water-Soluble Chitosan Nanoparticles as Protein Delivery System.’ Journal of Nanomaterials, 
2010, Article ID 898910 pp. 1- 5.  
Zhang, X.-D., Di, Wu, D., Shen, X., Chen, J., Sun, Y.-M., Liu, P.-X. and Liang, X.-J. (2012) 
‘Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation 
therapy.’Biomaterials, 33(27) pp. 6408-6419. 
Zhi X,  Fang H, Bao C, Shen G, Zhang J, Wang K, Guo S, Wan T, Cui D. (2013) ‘The 
immunotoxicity of graphene oxides and the effect of PVP-coating.’ Biomaterials, 34(21) pp. 
5254-61.  
  
 
 
228 
 
 
 
 
 
 
  
 
9. Appendix 
 
  
 
 
229 
9.1 Appendix A-Chemistry 
1. Equation used for working out sphere of particles  
 
 
     
 
        [1] 
Equation 3.1:  Equation used to calculate the volume of a sphere 
 
 V is volume of sphere πis 3.14 and r is the radius of the nanoparticles in cm. 
  This equation is used to work out the number of particles per mL.    
 
                                               [2] 
Equation 3.2:  Equation used to work out mass of a nanoparticles sphere 
 
m is mass of a nanoparticles sphere, V is volume of a sphere and D is the density of 
material used to make the nanoparticles. 
 
 
     
 
 
       [3] 
Equation 3.3:  Equation used to work out the number of particles within a solution 
  
V is the volume of a sphere at a given diameter, m is the mass of dried nanoparticle 
product (1mL). 
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2. Working out total number of mPEG 5000MW and PVP (8000MW) molecules 
needed to cover area of the gold surface area  
 
Equation used   to working out  the surface area of a sphere : 
4∏r2=4x∏(6x10-7)2=4.52x10-12cm2 
 
Calculation for working out the area of 1 monolayer of mPEG or PVP: 
 
Assume to cover particles with 1 monolayer, mPEG or  PVP will take up 
 1 nm, therefore area of  1 monolayer is  L x h (1x10-7)
2 
=1x10
-14
cm
2
 
Chains of mPEG or PVP required to cover an area of a particle: 
 
4.52x10-12cm
2
 / 1x10
-14
cm
2 
=452 chains  
 
Calculation for working out the total chains  of mPEG orPVP required to cover an 
area of a particle: 
 
Working out weight of 1 molecule of mPEG:  
 
5000 RMM / 6.022 x 10^23. =8.303x10-21g 
8.303x10
-21
g x 452 chains=3.75 x10
-18
g of  mPEG required to cover an area of a 
particle. 
 
Working out weight of 1 molecule of PVP:  
8000 RMM / 6.022 x 10^23. =1.328 x 10-20 
1.328x10
-20
g X 452 chains=6.00 x10
-18
g of PVP required to cover an area of a 
particle. 
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3. Titration of NH4OH with HCl to determine the concentration of ammonia 
(NH3) in the bottle of NH4OH before synthesising nanoparticles 
 
1.5 ml of NH4OH unknown concentration was added in a 250ml volumetric flask, 
then made up to 250cm
3 
with water. The ( 25cm
3
) burette  is then filled up with  
25 ml of 0.1 HCl. Then 20ml of NH40H from the stock solution of 250ml was 
transferred into a 100ml conical flask using a glass pipette.  Methyl red indicator ( 
2 drops)  was added in the flask containing the 20ml of NH4OH. A magnetic 
stirrer was introduced in the NH4OH solution inorder  to  aid with the stirring of 
the solution. The flask was then place under the burette then 0.1M HCl was added 
in to the flask drop wise until the solution changes colour from yellow to pinkish. 
The value in which it took for the HCl to change the colour of the solution in the 
flask was recorded. The procedure was  repeated 3 times . The average was 
recorded to work out the % of NH3 and concentration of NH4OH (See Table 1). 
 
Table 1: Volume of HCl used in titrating of NH4OH for determining the % of 
ammonia  
 
Amount of NH4OH(cm
3)titrated  with 
HCl 
Volume of HCl used to titrate (cm3) 
20  17.5 
20 17.49 
20 17.4 
 AVERAGE :17.46 
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3.1 Working out the concentration of NH4OH and the %NH3 in the 1L bottle 
of NH4OH: 
 
NH4OH+HClNH4Cl +H2O 
(M X  mL ) NH4OH=(M X  mL)HCL 
M X 20mL=0.1x17.46 
Concentration of NH40H=0.0873 mol/l 
g/l= RMM X  n 
 35 X 0.0873  =3.0555g/l 
 
(M X  mL) NH4OH  (before)=(M x mL) NH4OH (after) 
Volume (1000mL ) x Density(0.9) =Mass (900g of NH4OH before ) 
Working out the mass of NH4OH 
M  X 1.5=0.0873x250cm
-3
 
Mass of NH4OH after (509.25g ) =14.55 X 35 
% of NH4OH =509.25/900 x100=56.65% 
Gram of NH3 : mass (g) =RMM X  n 
 Therefore 17x14.55=247g of NH3 
Working out the mass of NH4OH 
% of NH3 247g of NH3/900g x100 
 Therefore 27% of NH3 in the 1L bottle of NH4OH 
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                                   4. Silica NPs fabricated using methods from previous Studies 
USING METHOD FROM GIESCHE 1993 
Silica produced at the size of 100nm under the temperature of 60
O
C  
Material 
0.8M  NH3 
0.2M TEOS 
3M H2O 
USING METHOD FROM VAN BLAADEREN AND VRIJ 1992 
Silica produced at the size of 110nm under the temperature 20
O
C  
(Adapted by adding Rhodamine dye(0.001g ) 
Material 
0.07M  APS 
0.15M TEOS 
2.96M H2O 
1.10M NH3 
USING METHOD FROM VAN BLAADEREN, GEEST AND VRIJ (1992) Silica produced at 
the size of 35nm under the temperature of 20
O
C 
(Adapted by adding APS)  
Material 
1.2M  NH3 
0.0016M TEOS 
2.98M H2O 
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5. An example of the  calculation of the amount of APS needed to coat sphere 
with one monolayer 
Area of Sio2 sphere particle with the diameter of  103nm 
 2.7X1013 for 1ml  3.33x10-6 X 2.7X1013 cm2  = 8998.87cm2 molecules 
8998.87cm
2
/40X10
-16  
=
 
2.24x10
18
molecules 
Mass of an APS molecule=RMM/Avogadro’s number  
 222/6.0221x1023 =3.69x10-22 g 
Mass of APS needed=Number of APS molecules x Mass of an APS molecule 
2.24x10
18
X3.69X10
-22 
8X10
-4
g/222=3.7X10
-7
moles 
C = 3.7X10
-7
/0.0230dm
3
 
1.61x10
-4
M = n/100ml=0.0161g of APS=16uL 
0.001XV1=2.76x10
-5
MX23.06 
V1=3.72mL of ethanol 
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Table 2: Hydrodynamic size of silica nanoparticles, in water from adapted 
method which were  repeated n=2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Method 
NH4
OH 
(mL
) 
H20 
(mL) 
ETOH 
(mL) 
TEOS 
(mL) 
Rhodam
ine dye 
(g) 
APS 
( 
uL) 
TEMP 
0
C 
PARTICLE SIZE nm (DLS) DURATION 
OF 
REACTION 
NH4OH 
WITH 
DYE 
 
WITHOUT 
Geische 
100nm 
4.53
3 
1.722 69.28 20 - - 
 
60
o
C - 200.65 
± 
35.65 
24 hr 
Bladder
n and 
viraj 
(1992) 
6.23
3 
0.272 55.96
9 
 
3.35l 0.001g 189 20
o
C 913.7±5
2.7 
618 
± 
45.8 
 
24 hr 
Bladder
n et al 
(1992) 
 
8.39
4 
0.151 57.13
4 
0.033 0.001g 9.4
6 
20
o
C Aggregat
-ed to 
large 
sizes 
>1000n
m 
 
371.7 
± 
10.3 
24hr 
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Table 3: The effect of surface charge on the hydrodynamic and potential of 
nanoparticles in H2O and potassium physiological salt solution using Stöber  
method 
 Hydrodynamic diameter  (DLS)  
Charge 
 
pH of 
sample 
Zeta potential (mV) 
SAMPLE 
NUMBE
R 
SAMPLE  Size in 
H2O 
Size in 
H2O 
(pH 
7.4) 
Size 
in 
PSS 
Size in 
PSS 
(pH 
7.4) 
Zeta 
potential 
in  water 
Zeta 
potential 
in PSS 
Zeta 
potential 
in water 
(pH 7.4) 
Zeta 
potent
ial in  
PSS 
(pH 
7.4) 
1 TMSI-
(WITHOUT 
DYE) 
103.3 133  275.1 - 8.30 -80.1 -10.7 -59.7 -29.8 
2 TMSI+ 
(WITHOUT 
DYE) 
137 - 222  + 6.63 18.2 5.82 18.97 -4.99 
3 TMRHSI- 
(WITH 
DYE) 
125 - 145  - 8.64 -49.8 -37.8 -30.2 -23.6 
4 TMRHSI+(
WITH DYE) 
187  256  + 6.80 9.23 5.42 -7.18 -6.91 
 
 
 
  
_ 
Without APS 
+ 
With APS 
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Figure 1:  The photon correlation spectroscopy analysis (A and B)showing the  hydrodynamic 
diameter of GEISHE (1993) METHOD for 100nm silica nanoparticles in H2O.  
 
 
 
 
 
Figure 2: The photon correlation spectroscopy analysis showing the  hydrodynamic diameter of 
Van Bladdern and Viraj (1993) METHOD for 110nm silica nanoparticles in H2O. Sample  A 
and B with dye  
 
 
 
 
A B 
A B 
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Figure 3:  The photon correlation spectroscopy analysis showing the  hydrodynamic diameter of  
Van Bladdern et al (1992) METHOD A) and B )with dye C) and D) without dye 
  
A B 
C D 
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Figure 4:  The photon correlation spectroscopy analysis showing the  hydrodynamic diameter  
and stability of TMSI-(WITHOUT DYE) in A) H2O B)PSS) C ) Zeta  potential in H2O D) Zeta  
potential pss E) Zeta potential in water (pH 7.4)  and F) Zeta potential inPSS (pH 7.4) 
  
A B 
C D 
E F 
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Figure 5:  The photon correlation spectroscopy analysis showing the  hydrodynamic 
diameter  and stability of TMSI+(WITHOUT DYE) in A) H2O B) PSS) C ) Zeta  potential in 
H2O D)  Zeta  potential pss E) Zeta potential in water (pH 7.4) and F) Zeta potential in PSS 
(pH 7.4) 
  
A B 
C D 
E F 
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Figure 6:  The photon correlation spectroscopy analysis showing the  hydrodynamic diameter  
and stability of TMRHSI-(WITH DYE) in A) H2O B) PSS, C ) Zeta  potential in H2O,  D ) Zeta  
potential pss, E) Zeta potential in water (pH 7.4) and F) Zeta potential inPSS (pH 7.4) 
  
A B 
C D 
E F 
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Figure 7:  The photon correlation spectroscopy analysis showing the  hydrodynamic diameter  
and stability of TMRHSI+(WITH DYE) in A) H2O B)PSS) C ) Zeta  potential in H2O)D Zeta  
potential pss)E) Zeta potential in water (pH 7.4)F) Zeta potential inPSS(pH 7.4) 
  
E F 
C D 
A B 
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Figure 8:  The photon correlation spectroscopy analysis showing the  hydrodynamic diameter  
and stability of RH28) in A) H2O,  B) PSS , C ) Zeta  potential in H2O and D) Zeta  potential in 
PSS) 
 
 
 
 
 
 
A B 
C D 
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Figure 9 :  The photon correlation spectroscopy analysis showing the  hydrodynamic diameter  
and stability of TMNA- 100nm  in A) H2O and B) PSS  
 
 
 
 
 
 
 
Figure 10 :  The photon correlation spectroscopy analysis showing the  hydrodynamic diameter  
and stability of TMNA+ 100nm  in A) H2O and B) PSS 
  
A B 
A B 
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Figure 11 :  The photon correlation spectroscopy analysis showing the  hydrodynamic diameter  
and stability of TMNA- 200nm  in A) H2O and B) PSS 
 
 
 
 
 
 
 
 
Figure 12 :  The photon correlation spectroscopy analysis showing the  hydrodynamic diameter  
and stability of TMNA+ 200nm  in A) H2O and B) PSS  
  
A B 
A B 
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Figure 12:  DRIFTS OF A)PVP ALONE and B)PVP modified AuNPs 
 C)mPEG ALONE D) mPEG modified AuNP  and E) AuNPs  
 
E 
D 
C 
A 
B 
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Table 4: Determining the relative amount of AuNPs in both 300ul, 600ul 
sample and uptake by aortic vessels   
   *AuNPs in aortic vessels 
      
Sample Name Average concentration of 
AuNPs (ppm) 
 Percentage of AuNPs  uptake (%)  
Control  0.024 0.004 
300ul of AuNPs  3.231 100.000 
600 ul of AuNPs 5.907 100.000 
AuNPs(2.9ug/mL)* 0.451 13.957 
AuNPs(5.8ug/mL)* 0.747 23.121 
Aupvp(2.9ug/mL)* 0.143 4.426 
Aupvp (5.8ug/mL)* 0.382 6.466 
AuMPEG(2.9ug/mL)* 0.123 3.811 
AuMPEG 
(5.8ug/mL)* 
0.359 6.070 
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       9.2 Appendix B-Cellular study  
 Table1: The cell proliferation after incubation with modified and non-modified 
AuNPs and their stabilisers at 24 hrs. and 48hrs using Coulter Counter, Where 
*p<0.05, **p<0.01 and *** p<0.001 
 
 
24 hours control AuNPs AuPVP PVP PEG mPEG AumPEG 
Average 50327 31430 33504 36936 30861 27307 26778 
PAIRED 
TTEST 
   
     - 
8.85E-05*** 0.00184** 0.008746** 0.012335** 0.00146** 0.0003** 
48 hours control AuNPs AuPVP PVP PEG mPEG AumPEG 
Average 47391 28216 32494 28256 33606 32366 34216 
   PAIRED 
TTEST 
 
- 
0.012392997** 0.00419** 0.000901*** 0.031656* 0.00289** 0.000580*** 
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 Table 2:  The viability of cells after incubation with modified and non-
modified AuNPs and their stabilisers at 24 hrs. and 48hrs using 
haemocytometer, Where *p<0.05 and  ***p<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 Table3: The viability of cells after incubation with modified and non-modified 
AuNPs and their stabilisers at 24 hrs. and 48hrs using automated Cell Counter , 
Where *p<0.05, **p<0.01 and *** p<0.001 
 
 
 
 
 
 
 
    
      Condition 
Viability of cells after 
incubation (%) 
P-Value 
24 hrs. 48 hrs. 24 hrs. 
(Control 
vs.) 
48 hrs. 
(Control vs.) 
24 hrs. vs. 48 hrs. 
CONTROL 96.53±2.11 95.14±2.50 - - 0.693 
AuNPs 82.15±7.06 87.50±3.60 0.123 0.157 0.537 
AuPVP 85.42±5.51 73.61±6.05 0.133 0.030* 0.223 
PVP 77.08±5.51 81.60±10.62 0.030* 0.283 0.725 
AuMPEG 88.19±0.69 89.58±2.75 0.030* 0.210 0.651 
mPEG 89.24±8.76 71.53±3.47  0.464 0.346 0.801 
PEG 85.42±2.08 91.67±2.08 0.020* 0.005*** 0.027* 
Condition Viability of cells after 
incubation (%) 
P value 
24 hrs. 48hrs   24 hrs. 
(Control vs.) 
48 hrs. 
(Control vs.) 
p-value (24hrs 
Vs. 48hrs) 
CONTROL 97.75±1.31 96.75±1.97 - - 0.688 
AuNPs 90.75±3.22 96.5±1.50 0.091 0.923 0.157 
AuPVP 83.25±2.95 56.5±2.62 0.004** 1.81E-05**** 0.001*** 
PVP 93±2.48 83.75±5.89 0.142 0.081 0.198 
AumPEG 86.25±4.40 92.5±1.50 0.046* 0.200 0.228 
Mpeg 91.5±2.32 91.75±3.54 0.058 0.264 0.955 
PEG 83.75±6.66 72.25±7.08 0.084 0.016* 0.282 
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Table 4:  The analysis of  FACs flow cytometer used to determine the viability of 
cells after incubation with modified and non-modified AuNPs and their 
stabilisers at 24 hrs. and 48hrs Where *p<0.05, *p<0.01, *** p<0.001  
 
 
 
  
 
  
 
 
Condition 
 
Incubation time 
 
p-value 
30min 2 hrs 24  hrs 48  hrs 30min 
Control 
vs. 24 
hrs 
30min 
Control 
vs. 48 
hrs  
24 hrs 
Control vs. 
24 hrs 
24 hrs 
Control 
vs. 48 
hrs 
control no 
stain 
99.72 
± 
0.03 
99.75 
± 
0.10 
99.76 
± 
0.067 
96.87 
± 
1.85 
0.057 0.705 - 0.289 
control stain 94.65 
± 
2.61 
94.44 
± 
2.67 
92.81 
± 
3.54 
95.40 
± 
1.64 
0.002** 0.819 0.119 
(CONTROL
no stain 
V.S 
CONTROL 
Stain ) 
0.473 
Aumpeg 95.95 
± 
0.22 
90.36 
± 
0.27 
75.12 
± 
0.57 
93.09 
± 
1.65 
0.003** 0.641 0.003** 0.344 
AuNPS 95.50 
± 
0.24 
92.33 
± 
0.31 
77.02 
± 
0.72 
91.29 
± 
0.16 
0.003** 0.269 0.006** 0.053* 
AuPVP 94.5 
± 
0.27 
92.50 
± 
0.24 
76.22 
± 
1.00 
85.58 
± 
0.27 
0.002** 0.026* 0.005** 0.312 
mPEG 94.79 
± 
0.36 
91.84 
± 
0.43 
76.51 
± 
0.14 
90.92 
± 
0.37 
0.009** 0.232 0.005** 0.453 
PVP 96.13 
± 
0.06 
 
81.73 
± 
5.71 
 
82.33 
± 
0.41 
 
93.25 
± 
0.06 
 
5e-6*** 0.621 0.021* 0.289 
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9.3 Appendix C-Vascular study   
Table 1: Average ACh response of vessels before and after incubation without 
NPs (PSS) (n=6) for 30 min. 
ACh 
concentration  
log[ACh ] AVERAGE % 
RELAXATION 
BEFORE 
AVERAGE % 
RELAXATION 
AFTER 
 Paired t-test 
1x10
-8
 -8 5.57 3.68  0.19416 
4x10
-8
 -7.4 14.43 11.62  0.06665 
3.20x10
-7
 -6.5 29.66 17.14  0.01109 
1.28x10
-6
 -5.9 37.46 24.34  0.01950 
5.12x10
-6
 -5.3 41.85 33.45  0.06156 
2.05X10
-5
 -4.7 43.56 37.22  0.10887 
8.19X10
-5
 -4.1 56.88 46.66  0.04676 
1.11x10
-4
  -3.8 63.46 57.53  0.14439 
2.3x10
-4
  -3.5 80.29 68.33  0.09005 
 
 Table 2: Average SNP response of vessels before and after incubation  without 
NPs (PSS) (n=7) for 30 min. 
 
 
 
 
 
 
 
 
 
 
 
SNP concentration Log[SNP] AVERAGE % 
RELAXATION 
BEFORE 
AVERAGE % 
RELAXATION 
AFTER 
Paired t-test 
1x10
-10
  -10 7.72 7.4 0.954391 
8x10
-10
 -9.1 32.86 25.1 0.262224 
3.2x10
-9
 -8.5 62.95 51.4 0.010003 
1.28x10
-8
 -7.9 71.68 72.0 0.976534 
5.12x10
-8
 -7.3 86.64 84.2 0.624957 
2.05x10
-7
 -6.7 95.26 86.5 0.005734 
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Table 3: Average ACh response of vessels before and after incubation with 
AuNPs( n=5)and Control (n=6) for 30 min. 
 
 
 
  
ACh 
concentration  
log[ACh ] AVERAGE % 
RELAXATION 
BEFORE 
AVERAGE % 
RELAXATION 
AFTER 
Paired t-test Un-paired t-test 
1x10
-8
 -8 0.94 -0.64 0.404263 0.326256 
4x10
-8
 -7.4 4.29 5.66 0.800694 0.490163 
3.20x10
-7
 -6.5 8.05 11.67 0.723299 0.566694 
1.28x10
-6
 -5.9 17.50 15.95 0.894688 0.550331 
5.12x10
-6
 -5.3 23.88 28.75 0.611694 0.840879 
2.05X10
-5
 -4.7 29.73 33.90 0.659485 0.927022 
8.19X10
-5
 -4.1 41.37 40.77 0.934868 0.807125 
1.11x10
-4
  -3.8 55.96 53.51 0.784643 0.953815 
2.3x10
-4
  -3.5 65.92 61.84 0.706617 0.77778 
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Table 4: Average SNP response of vessels before and after incubation with 
AuNPs (n=6) Control (n=7) for 30 min. 
 
SNP concentration log[SNP] AVERAGE % 
RELAXATION 
BEFORE 
AVERAGE % 
RELAXATION 
AFTER 
Paired t-test Un paired t-test 
1x10-8 -8 44.48 12.59 0.018 0.004 
4x10-8 -7.4 85.59 43.22 0.001 0.002 
3.20x10-7 -6.5 91.06 55.76 0.001 0.005 
1.28x10-6 -5.9 92.40 65.33 0.002  
5.12x10-6 -5.3 94.70 67.57 0.005  
2.05X10-5 -4.7 95.13 69.36 0.021  
8.19X10-5 -4.1 96.13 72.11 0.037  
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  Table 5: Average ACh dose response before and after incubation with AuNPs 
modified with maximum concentration (9.5x10
-12
 M) PVP( n=6) Control (n=6) 
for 30 min.  
 
ACh 
concentration 
log[ACh ] AVERAGE % 
RELAXATION 
BEFORE 
AVERAGE % 
RELAXATION 
AFTER 
Paired t-test unPaired t-test 
1x10
-8
 -8 3.51 1.60 0.121 0.498321 
4x10
-8
 -7.4 7.89 3.03 0.058 0.227925 
3.20x10
-7
 -6.5 22.09 6.38 0.030 0.195211 
1.28x10
-6
 -5.9 22.63 8.15 0.020 0.053898 
5.12x10
-6
 -5.3 30.56 13.62 0.003 0.016295 
2.05X10
-5
 -4.7 31.89 19.14 0.055 0.04547 
8.19X10
-5
 -4.1 37.53 41.29 0.653 0.544344 
1.11x10
-4
 -3.8 65.43 65.01 0.973 0.477948 
2.3x10
-4
 -3.5 88.44 76.55 0.291 0.399664 
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Table 6: Average SNP dose response after incubation with AuNPs modified  
with maximum concentration (9.5x10
-12
 M) PVP(n=4) and Control (n=7) for 
30 min.  
 
SNP concentration log[SNP] AVERAGE % 
RELAXATION 
BEFORE 
AVERAGE % 
RELAXATION 
AFTER 
Paired t-
test 
Unpaired t-
test 
8X10
-10
 -9 43.11 22.29 0.19005 0.826427 
3.2X10
-9
 -8.5 64.84 42.46 0.07872 0.649323 
1.28 x10
-8
 -8 70.09 52.19 0.06204 0.213642 
3.20x10
-7
 -6.5 73.74 56.97 0.02641  
2.05X10
-5
 -4.7 75.33 61.98 0.02072  
8.19X10
-5
 -4.1 94.49 78.74 0.03673  
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 Table 7: Average ACh dose response before and  after incubation with AuNPs 
modified with minimum 5.9x10
-13M
 PVP (n=4) and Control (n=6) for 30 min. 
 
 
 
 
ACh 
concentration 
log[Ach ] Average % 
relaxation 
BEFORE 
Average % 
relaxation 
AFTER 
Paired t-test Unpaired t-
test 
1x10
-8
 -8 0.9 6.390185 0.42265 0.6458 
4x10
-8
 -7.4 3.45 11.04747 0.185214 0.952266 
3.20x10
-7
 -6.5 17.71 16.38699 0.273383 0.939431 
1.28x10
-6
 -5.9 28.79 22.97609 0.046869 0.892133 
5.12x10
-6
 -5.3 40.83 31.30602 0.016905 0.834884 
2.05X10
-5
 -4.7 42.74 34.18649 0.060844 0.759937 
8.19X10
-5
 -4.1 45.87 40.90224 0.01984 0.486673 
1.11x10
-4
 -3.8 47.76 48.59497 0.108319 0.244744 
2.3x10
-4
 -3.5 50.21 59.44046 0.233044 0.192812 
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Table 8 : Average ACh dose response after  incubation with minimum 5.9X10
-13
 
PVP alone (n=4 )and Control(PSS)(n=5) for 30min. 
 
 
 
 
 
 
 
 
 
 
 
  
  
ACh concentration log[ACh ] CONTROL 
(PSS) n=5 
PVP alone 
min conc 
(n=4) 
Unpaired t-test 
1x10
-8
 -8 3.68 -0.69 0.203875 
4x10
-8
 -7.4 11.62 0.27 0.147566 
3.20x10
-7
 -6.5 17.13 3.660 0.1224 
1.28x10
-6
 -5.9 24.34 11.07 0.190325 
5.12x10
-6
 -5.3 33.44 17.96 0.148184 
2.05X10
-5
 -4.7 37.22 21.81 0.12204 
8.19X10
-5
 -4.1 46.66 28.25 0.053435 
1.11x10
-4
 -3.8 57.52 35.29 0.040891 
2.3x10
-4
 -3.5 68.32 44.65 0.045597 
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Table 9: Average SNP dose response after incubation with AuNPs modified with 
5.9x10
-13
M PVP (n=4) and Control (PSS) (n=5) for 30 min. 
 
 
 
 
  
SNP concentration Log[SNP] CONTROL 
(PSS) n=5 
Average % 
relaxation AFTER 
5.9x10
-13
M 
PVP(AuNPs) 
Unpaired 
t-test 
1x10
-10
 -10 7.39 7.03 0.954 
8x10
-10
 -9.10 25.13 11.13 0.1555 
3.2x10
-9
 -8.49 51.42 22.00 0.0107 
1.28x10
-8
 -7.89 72.02 36.29 0.00019 
5.12x10
-8
 -7.29 84.18 60.23 3.31E-05 
2.05x10
-7
 -6.69 86.51 72.72 0.0288 
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Table10: Average SNP dose response AFTER incubation with minimum 
concentration (5.9X10
-13
) PVP alone (n=3) and Control( PSS)(n=5) for 30min. 
 
 
 
 
 
 
SNP concentration log[SNP] AVERAGE % 
RELAXATION 
AFTER Control 
(PSS) n=5 
AVERAGE % 
RELAXATION 
AFTER PVP ALONE 
(5.9X10
-13
) 
Unpaired t-
test 
1x10
-10
 -10 7.39 4.56 0.447 
8x10
-10
 -9.10 25.13 12.91 0.158 
3.2x10
-9
 -8.49 51.42 32.61 0.060 
1.28x10
-8
 -7.89 72.02 59.86 0.063 
5.12x10
-8
 -7.29 84.18 79.52 0.133 
2.05x10
-7
 -6.69 86.51 89.56 0.341 
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Table 11:  Average ACh response AFTER incubation with AumPEG (2.9 
µg/mL ) and Control (PSS) (n=5) for 30 min. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ACh concentration log[ACh] AVERAGE % 
RELAXATION 
AFTER (5.8  
µg/mL  )  
AumPEG (n=5) 
AVERAGE % 
RELAXATION 
AFTER 
CONTROL 
(PSS) n=5 
Unpaired t-test 
 
1x10
-8
 -8.00 0.91 11.28 0.0883 
4x10
-8
 -7.40 2.55 24.01 0.0116 
3.20x10
-7
 -6.50 6.37 35.00 0.0008 
1.28x10
-6
 -5.90 12.25 38.81 0.0025 
5.12x10
-6
 -5.30 14.63 47.12 0.0007 
2.05X10
-5
 -4.70 18.22 50.98 0.0022 
8.19X10
-5
 -4.10 25.16 54.72 0.0097 
1.11x10
-4
 -3.80 27.96 59.74 0.0122 
2.3x10
-4
 -3.50 40.17 66.22 0.0298 
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Table 12: ACh response AFTER incubation with AumPEG (5.8µg/mL )(N=5) 
and control (PSS) (n=5) for 30 min. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ACh 
concentration 
log[ACh ] AVERAGE % 
RELAXATION 
AFTER (5.8  
µg/mL  )  
AumPEG 
(n=5) 
CONTROL 
(PSS) n=5 
AVERAGE % 
RELAXATION 
AFTER (5.8  
µg/mL  )  
AumPEG 
(n=5)AumPE
G ( 2.9 
µg/mL ) 
AVERAGE % 
RELAXATION 
AFTER (5.8  
µg/mL  )  
AumPEG 
(n=5)PEG 
alone n=5 
 Unpaire
d t-test 
with 
AumPEG   
( 2.9 
µg/mL ) 
 
Unpaire
d t-test 
with PEG 
alone 
( 2.9 
µg/mL ) 
 
1x10
-8
 -8 11.28 5.35 15.95  0.28947 0.523013 
4x10
-8
 -7.4 24.01 16.03 23.98  0.30655 0.997323 
3.20x10
-7
 -6.5 35.00 28.01 31.00  0.36652 0.584608 
1.28x10
-6
 -5.9 38.81 32.07 34.04  0.39418 0.519861 
5.12x10
-6
 -5.3 47.12 42.68 39.47  0.57044 0.289176 
2.05X10
-5
 -4.7 50.98 46.81 42.67  0.62300 0.318654 
8.19X10
-5
 -4.1 54.72 49.39 46.34  0.63891 0.341705 
1.11x10
-4
 -3.8 59.74 52.93 52.88  0.73593 0.467099 
2.3x10
-4
 -3.5 66.22 59.52 61.46  0.76376 0.640546 
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Table 13:  SNP responses BEFORE and  AFTER incubation with AumPEG 
(n=5)( 2.9 µg/mL ) and Control ( PSS) n=5 for 30 min. 
 
 
 
 
 
 
 
 
 
 
 
 
  
SNP 
concentration 
log[SNP ] AVERAGE % 
RELAXATION 
BEFORE 
AVERAGE % 
RELAXATION 
AFTER 
Paired t-test Unpaired 
t-test 
1x10
-10
 -10 4.30 4.11 0.915561 0.9140 
8x10
-10
 -9.1 16.08 13.32 0.508209 0.5175 
3.2x10
-9
 -8.5 35.67 30.53 0.431169 0.3737 
1.28x10
-8
 -7.9 61.11 53.41 0.118424 0.1422 
5.12x10
-8
 -7.3 82.76 73.43 0.138817 0.1231 
2.05x10
-7
 -6.7 91.06 85.75 0.18574 0.1374 
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Table 14:  SNP responses BEFORE  and  AFTER incubation with   
(7.4x10
-8
g/ml) mPEG alone (n=4) ( 2.9 µg/mL ) for 30 min. 
 
 
 
 
 
 
 
  
 
 
Table 15:  SNP response AFTER incubation with PEG alone(n=7) and Control 
(PSS) ( n=5)  for 30 min. 
  
 
 
 
 
 
 
 
 
 
 
 
 
SNP 
concentration 
Log[SNP] AVERAGE % 
RELAXATION 
BEFORE 
AVERAGE % 
RELAXATION 
AFTER 
Paired t-test 
6.66x10
-8
 -7.1 14.04 5.87 0.367756 
6.62x10
-7
 -6.2 26.58 18.81 0.30904 
6.60x10
-6
 -5.2 33.82 28.85 0.49722 
6.50x10
-5
 -4.2 37.62 33.01 0.39023 
6.50x10
-4
 -3.2 45.50 32.66 0.03059 
SNP 
concentration 
log[SNP ] AVERAGE % 
RELAXATION 
AFTER CONTROL 
(PSS) (n=5) 
AVERAGE % 
RELAXATION 
AFTER (PEG 
alone)(n=7) 
Unpaired t-test 
1x10
-10
 -10.00 4.30 3.52 0.75875 
8x10
-10
 -9.10 16.08 9.46 0.22807 
3.2x10
-9
 -8.49 35.67 26.62 0.193659 
1.28x10
-8
 -7.89 61.11 46.78 0.049867 
5.12x10
-8
 -7.29 82.76 67.092 0.042663 
2.05x10
-7
 -6.69 91.06 79.43 0.02456 
